
<html lang="en"     class="pb-page"  data-request-id="5ce5b7d2-9ecc-4acf-a847-04bf9dee1513"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm901776q;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2010.53.issue-8;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Removal of Sphingosine 1-Phosphate Receptor-3 (S1P3) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P1 Agonists with Reduced Effect on Heart Rate" /></meta><meta name="dc.Creator" content="Maiko  Hamada" /></meta><meta name="dc.Creator" content="Mitsuharu  Nakamura" /></meta><meta name="dc.Creator" content="Masatoshi  Kiuchi" /></meta><meta name="dc.Creator" content="Kaoru  Marukawa" /></meta><meta name="dc.Creator" content="Ayumi  Tomatsu" /></meta><meta name="dc.Creator" content="Kyoko  Shimano" /></meta><meta name="dc.Creator" content="Noriko  Sato" /></meta><meta name="dc.Creator" content="Kunio  Sugahara" /></meta><meta name="dc.Creator" content="Mahoko  Asayama" /></meta><meta name="dc.Creator" content="Kan  Takagi" /></meta><meta name="dc.Creator" content="Kunitomo  Adachi" /></meta><meta name="dc.Description" content="A series of 2-substituted 2-aminopropane-1,3-diols having a biphenyl moiety and their phosphate esters were synthesized to obtain sphingosine 1-phosphate receptor-1 (S1P1) receptor agonists with po..." /></meta><meta name="Description" content="A series of 2-substituted 2-aminopropane-1,3-diols having a biphenyl moiety and their phosphate esters were synthesized to obtain sphingosine 1-phosphate receptor-1 (S1P1) receptor agonists with po..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 25, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901776q" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901776q" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901776q" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901776q" /></link>
        
    
    

<title>Removal of Sphingosine 1-Phosphate Receptor-3 (S1P3) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P1 Agonists with Reduced Effect on Heart Rate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901776q" /></meta><meta property="og:title" content="Removal of Sphingosine 1-Phosphate Receptor-3 (S1P3) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P1 Agonists with Reduced Effect on Heart Rate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0005.jpeg" /></meta><meta property="og:description" content="A series of 2-substituted 2-aminopropane-1,3-diols having a biphenyl moiety and their phosphate esters were synthesized to obtain sphingosine 1-phosphate receptor-1 (S1P1) receptor agonists with potent immunomodulatory activity accompanied by little or no effect on heart rate. Many of the synthesized compounds sufficiently decreased the number of peripheral blood lymphocytes. Some of the phosphates had potent agonism at S1P1 but no agonism at S1P3, which had been reported to be a receptor responsible for heart rate reduction. Although high S1P1/S1P3 selectivity was considered to be favorable to reduce the effect on heart rate, almost all the phosphates showed a remarkable heart rate lowering effect in vivo. The results suggest that other factors in addition to S1P3 agonism should be responsible for the heart rate reduction caused by S1P1 agonists. Only 2-amino-2-[2-[2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (6d) was identified as a desired S1P1 receptor agonist having both the immunomodulatory activity and an attenuated effect on heart rate by a unique screening flow using in vivo evaluating systems primarily." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901776q"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901776q">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901776q&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901776q&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901776q&amp;href=/doi/10.1021/jm901776q" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3154-3168</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901775y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901783v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Removal of Sphingosine 1-Phosphate Receptor-3 (S1P<sub>3</sub>) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P<sub>1</sub> Agonists with Reduced Effect on Heart Rate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maiko++Hamada">Maiko Hamada</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mitsuharu++Nakamura">Mitsuharu Nakamura</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masatoshi++Kiuchi">Masatoshi Kiuchi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kaoru++Marukawa">Kaoru Marukawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ayumi++Tomatsu">Ayumi Tomatsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kyoko++Shimano">Kyoko Shimano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Noriko++Sato">Noriko Sato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kunio++Sugahara">Kunio Sugahara</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mahoko++Asayama">Mahoko Asayama</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kan++Takagi">Kan Takagi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kunitomo++Adachi">Kunitomo Adachi</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Research Division, Mitsubishi Tanabe Pharma Corporation, 1-1, Kazusakamatari 1-chome, Kisarazu, Chiba 292-0818, Japan</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +81-45-963-4293. Fax: +81-45-963-4211. E-mail: <a href="/cdn-cgi/l/email-protection#4a0b2e2b29222364013f24233e2527250a272964273e673a222b38272b64292564203a"><span class="__cf_email__" data-cfemail="b1f0d5d0d2d9d89ffac4dfd8c5dedcdef1dcd29fdcc59cc1d9d0c3dcd09fd2de9fdbc1">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901776q&amp;href=/doi/10.1021%2Fjm901776q" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3154–3168</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 25, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 December 2009</li><li><span class="item_label"><b>Published</b> online</span>25 March 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 April 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901776q" title="DOI URL">https://doi.org/10.1021/jm901776q</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3154%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaiko%2BHamada%252C%2BMitsuharu%2BNakamura%252C%2BMasatoshi%2BKiuchi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D8%26contentID%3Djm901776q%26title%3DRemoval%2Bof%2BSphingosine%2B1-Phosphate%2BReceptor-3%2B%2528S1P3%2529%2BAgonism%2Bis%2BEssential%252C%2BBut%2BInadequate%2Bto%2BObtain%2BImmunomodulating%2B2-Aminopropane-1%252C3-diol%2BS1P1%2BAgonists%2Bwith%2BReduced%2BEffect%2Bon%2BHeart%2BRate%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3168%26publicationDate%3DApril%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901776q"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1850</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901776q" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Removal of Sphingosine 1-Phosphate Receptor-3 (S1P3) Agonism is Essential, But Inadequate to Obtain Immunomodulating 2-Aminopropane-1,3-diol S1P1 Agonists with Reduced Effect on Heart Rate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maiko&quot;,&quot;last_name&quot;:&quot;Hamada&quot;},{&quot;first_name&quot;:&quot;Mitsuharu&quot;,&quot;last_name&quot;:&quot;Nakamura&quot;},{&quot;first_name&quot;:&quot;Masatoshi&quot;,&quot;last_name&quot;:&quot;Kiuchi&quot;},{&quot;first_name&quot;:&quot;Kaoru&quot;,&quot;last_name&quot;:&quot;Marukawa&quot;},{&quot;first_name&quot;:&quot;Ayumi&quot;,&quot;last_name&quot;:&quot;Tomatsu&quot;},{&quot;first_name&quot;:&quot;Kyoko&quot;,&quot;last_name&quot;:&quot;Shimano&quot;},{&quot;first_name&quot;:&quot;Noriko&quot;,&quot;last_name&quot;:&quot;Sato&quot;},{&quot;first_name&quot;:&quot;Kunio&quot;,&quot;last_name&quot;:&quot;Sugahara&quot;},{&quot;first_name&quot;:&quot;Mahoko&quot;,&quot;last_name&quot;:&quot;Asayama&quot;},{&quot;first_name&quot;:&quot;Kan&quot;,&quot;last_name&quot;:&quot;Takagi&quot;},{&quot;first_name&quot;:&quot;Kunitomo&quot;,&quot;last_name&quot;:&quot;Adachi&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;3154-3168&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901776q&quot;},&quot;abstract&quot;:&quot;A series of 2-substituted 2-aminopropane-1,3-diols having a biphenyl moiety and their phosphate esters were synthesized to obtain sphingosine 1-phosphate receptor-1 (S1P1) receptor agonists with potent immunomodulatory activity accompanied by little or no effect on heart rate. Many of the synthesized compounds sufficiently decreased the number of peripheral blood lymphocytes. Some of the phosphates had potent agonism at S1P1 but no agonism at S1P3, which had been reported to be a receptor responsible for heart rate reduction. Although high S1P1/S1P3 selectivity was considered to be favorable to reduce the effect on heart rate, almost all the phosphates showed a remarkable heart rate lowering effect in vivo. The results suggest that other factors in addition to S1P3 agonism should be responsible for the heart rate reduction caused by S1P1 agonists. Only 2-amino-2-[2-[2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (6d) was identified as a desired S1P1 receptor agonist having both the immu&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901776q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901776q" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901776q&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901776q" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901776q&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901776q" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901776q&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901776q&amp;href=/doi/10.1021/jm901776q" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901776q" /></input><a href="/doi/pdf/10.1021/jm901776q" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901776q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901776q%26sid%3Dliteratum%253Aachs%26pmid%3D20337461%26genre%3Darticle%26aulast%3DHamada%26date%3D2010%26atitle%3DRemoval%2Bof%2BSphingosine%2B1-Phosphate%2BReceptor-3%2B%2528S1P3%2529%2BAgonism%2Bis%2BEssential%252C%2BBut%2BInadequate%2Bto%2BObtain%2BImmunomodulating%2B2-Aminopropane-1%252C3-diol%2BS1P1%2BAgonists%2Bwith%2BReduced%2BEffect%2Bon%2BHeart%2BRate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D8%26spage%3D3154%26epage%3D3168%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290672" title="Phosphates">Phosphates</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of 2-substituted 2-aminopropane-1,3-diols having a biphenyl moiety and their phosphate esters were synthesized to obtain sphingosine 1-phosphate receptor-1 (S1P<sub>1</sub>) receptor agonists with potent immunomodulatory activity accompanied by little or no effect on heart rate. Many of the synthesized compounds sufficiently decreased the number of peripheral blood lymphocytes. Some of the phosphates had potent agonism at S1P<sub>1</sub> but no agonism at S1P<sub>3</sub>, which had been reported to be a receptor responsible for heart rate reduction. Although high S1P<sub>1</sub>/S1P<sub>3</sub> selectivity was considered to be favorable to reduce the effect on heart rate, almost all the phosphates showed a remarkable heart rate lowering effect in vivo. The results suggest that other factors in addition to S1P<sub>3</sub> agonism should be responsible for the heart rate reduction caused by S1P<sub>1</sub> agonists. Only 2-amino-2-[2-[2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6d</b>) was identified as a desired S1P<sub>1</sub> receptor agonist having both the immunomodulatory activity and an attenuated effect on heart rate by a unique screening flow using in vivo evaluating systems primarily.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45887" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45887" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sphingosine 1-phosphate (S1P<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: S1P, sphingosine 1-phosphate ; S1P<sub>1,</sub> sphingosine 1-phosphate receptor-1; THI, (1<i>R</i>,2<i>S</i>,3<i>R</i>)-2-acetyl-4-(1,2,3,4-tetrahydroxybutyl)imidazole; DMF, <i>N</i>,<i>N</i>-dimethylformamide; DME, 1, 2-dimethoxyethane; S-Phos, 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl; X-Phos, 2-dicychlohexylphosphino-2′,4′,6′-triisopropylbiphenyl; Xantphos, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct; <i>m</i>-CPBA, 3-chloroperoxybenzoic acid; DIPEA, diisopropylethylamine; DMSO, dimethyl sulfoxide; HPLC, high performance liquid chromatography; UPLC, ultra performance liquid chromatography; TMS, tetramethylsilane; TFA, trifluoroacetic acid.</p></div>) is a ubiquitous lysophospholipid and influences multiple physiological systems.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Genetic deletion of S1P receptor-1 (S1P<sub>1</sub>) in mice showed that S1P has important roles in vascular maturation and resulted in embryonic lethality.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> Our group previously reported that a unique immunomodulator <b>1</b> (FTY720, Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>) was discovered by the exploration of chemically modified analogues of a natural compound myriocin using in vivo screens as the main evaluating systems<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> and that compound <b>1</b> showed the activity by decreasing the number of lymphocytes in peripheral blood and lymph drastically.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> During the course of research to clarify the mechanism of action of <b>1</b>, it was revealed that <b>1</b> is converted to its phosphate (<b>1</b>-<b>P</b>) by sphingosine kinase 2<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and <b>1</b>-<b>P</b> acts as an agonist for four S1P receptors (S1P<sub>1,3,4,5</sub>) among five known S1P receptors (S1P<sub>1−5</sub>).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Currently, a large body of evidence shows that S1P<sub>1</sub> plays the main role in the lymphocyte-decreasing effect of <b>1</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Thus the physiological roles of S1P and its receptors have become clear by complementary approaches of genetics and medicinal chemistry.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of FTY720 (<b>1</b>) and the Active Form, FTY720-P (<b>1</b>-<b>P</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>1</b> was shown to be effective in the treatment of multiple sclerosis in phase 2 clinical trials<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and is currently in phase 3 clinical trials. Additionally, (1<i>R</i>,2<i>S</i>,3<i>R</i>)-2-acetyl-4-(1,2,3,4-tetrahydroxybutyl)imidazole (THI), which inhibits S1P lyase in vivo, caused lymphopenia-like <b>1</b><a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and exerted an immunomodulatory effect.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> These facts suggest that modulators of lymphocyte circulation are highly promising as an immnunomodulator.</div><div class="NLM_p">On the other hand, the administration of <b>1</b> was typically associated with a mild and transient reduction in heart rate as an adverse event in the clinical trials.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It was reported that intravenous administration of <b>1</b>-<b>P</b> at a dose of 0.005 mg/kg to normal mice evoked a severe reduction of heart rate, whereas in S1P<sub>3</sub>-deficient mice the administration of <b>1</b>-<b>P</b> produced no change in heart rate.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This genetic evidence clearly indicates that S1P<sub>3</sub> is mainly responsible for the heart rate decreasing effect of <b>1</b> in mice. Consequently, S1P<sub>1</sub>-selective agonists against S1P<sub>3</sub> would be expected as a next generation of the S1P receptor modulator with little or no effect on heart rate. On the basis of this presumption, research to find selective S1P<sub>1</sub> agonists have been actively performed.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">Our attempt to obtain a desired S1P<sub>1</sub> receptor agonist having both the immunomodulatory activity and a reduced effect on heart rate was initiated by reassessment of <b>1</b>-related compounds in our library. Among the phosphates of <b>1</b>-related compounds, the phosphate of biphenyl compound <b>2</b> was found to be inactive at the S1P<sub>3</sub> receptor, although <b>2</b> showed much weaker potency in lymphocyte-decreasing activity than <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). We modified the lipophilic side chain of <b>2</b> and succeeded in obtaining compound <b>6d</b>, which had a reduced heart rate decreasing effect as well as a sufficient immunomodulatory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Interestingly, it was confirmed in this research that most of the compounds with no S1P<sub>3</sub> agonism still reduce heart rate remarkably. This fact strongly suggests that some complicated mechanisms independent of S1P<sub>3</sub> or species difference would contribute to heart rate reduction caused by <b>1</b>. In this paper, we describe the details of the discovery of <b>6d</b> and the relationships between S1P<sub>3</sub> agonism and heart rate decreasing effect.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Lymphocyte-Decreasing Effect, Agonistic Activity at S1P<sub>1</sub> and S1P<sub>3</sub>, and Heart Rate Decreasing Effect of <b>1</b> and Lead Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0001.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="2" align="center">structure</th><th align="center" char="."> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center">A</th><th align="center">B</th><th align="left" char=".">ED<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (mg/kg)</th><th align="left">phosphate</th><th align="left">S1P<sub>1</sub> EC<sub>50</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a><a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (nM)</th><th align="left">S1P<sub>3</sub> EC<sub>50</sub><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (nM)</th><th align="left">ID<sub>50</sub><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a> (mg/kg)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left"> </td><td align="left"> </td><td align="char" char=".">0.02</td><td align="left"><b>1</b>-<b>P</b></td><td align="left">0.35 (0.14−0.91)</td><td align="left">12 (11−13)</td><td align="left">0.012</td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left"> </td><td align="left"> </td><td align="char" char=".">0.40</td><td align="left"><b>2</b>-<b>P</b></td><td align="left">1.0 (0.33−3.5)</td><td align="left">>1000</td><td align="left">0.091</td></tr><tr valign="top"><td align="left"><b>3a</b></td><td align="left">3-Cl</td><td align="left"> </td><td align="char" char=".">0.11</td><td align="left"><b>3a</b>-<b>P</b></td><td align="left">0.64 (0.20−2.1)</td><td align="left">>1000</td><td align="left">NT<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left"> </td><td align="left">2′-F</td><td align="char" char=".">0.10</td><td align="left"><b>4</b>-<b>P</b></td><td align="left">1.1 (0.40−3.0)</td><td align="left">>1000</td><td align="left">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Dose (mg/kg) required to decrease the number of lymphocytes by 50% of vehicle-treated control in mice (5 animals for each compound). Alcohol form of compounds was administered intraperitoneally.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">EC<sub>50</sub> (nM) of phosphate form was determined by Ca mobilization assays. 95% confidence limits are given in parentheses.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Concentration required to show 50% of agonistic activity at S1P (300 nM).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Dose (mg/kg) required to decrease heart rate by 50% of vehicle-treated control in rats. Phosphate form of compounds was administered intravenously (3−6 animals for each compound).</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Not tested.</p></div></div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Lead Compound and Pharmacological Evaluation</h3><div class="NLM_p">To obtain a lead compound that had selective activity at S1P<sub>1</sub>, we tried to check our <b>1</b>-related compound library. We synthesized the phosphate form of compounds in this library (e.g., <b>1</b>-<b>P</b>) and evaluated their S1P<sub>1</sub> and S1P<sub>3</sub> agonistic activities. The results revealed that <b>2</b>-<b>P</b> having a biphenyl moiety in the hydrophobic part had no agonistic activity at S1P<sub>3</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Though the lymphocyte-decreasing effect of <b>2</b> (ED<sub>50</sub> = 0.40 mg/kg) was weaker than that of <b>1</b> (ED<sub>50</sub> = 0.02 mg/kg), compounds <b>3a</b> and <b>4</b>, which have substituents on the biphenyl moiety of <b>2</b>, were approximately 3-fold more potent than <b>2</b> and their phosphates retained the inactivity at S1P<sub>3</sub>. These results prompted us to select <b>2</b> as a lead compound and start our research to obtain S1P<sub>1</sub> agonists with little or no effect on heart rate.</div><div class="NLM_p">The first step of our research procedure was the synthesis and evaluation of the alcohol form of designed compounds. The immunomodulating activity of the alcohol form was estimated by counting the number of lymphocytes in peripheral blood. Since promoting the sequestration of peripheral blood lymphocytes in secondary lymphoid organs dependent on the S1P<sub>1</sub> agonism has been considered to cause immunomodulating activity of <b>1</b>, the lymphocyte-decreasing effect in peripheral blood can be used as a marker for the immunomodulating efficacy of the compounds. This method has been adopted as a simple in vivo screening since the early stage of <b>1</b>-related research when its mechanism of action was uncertain<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and has been widely used for the evaluation of immnomodulatory effects of S1P receptor modulators.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The number of lymphocytes was counted 24 h after intraperitoneal administration to mice, and the results are shown as ED<sub>50</sub> values. Next, the phosphate esters of alcohols having a sufficient lymphocyte-decreasing effect (ED<sub>50</sub> < 0.20 mg/kg) were synthesized, and their S1P<sub>1</sub>/S1P<sub>3</sub> selectivity was evaluated by calcium mobilization assays using transfectants stably expressing the hS1P<sub>1</sub> or hS1P<sub>3</sub> receptor. The EC<sub>50</sub> values of <b>1</b>-<b>P</b> for S1P<sub>1</sub> and S1P<sub>3</sub> were 0.35 and 12 nM, respectively. Then, the influence of the phosphates on heart rate was determined by intravenous administration to anesthetized rats. Compound <b>1</b>-<b>P</b> lowered heart rate intensively, and the ID<sub>50</sub> value was 0.012 mg/kg. Pharmacokinetic profiles usually reflect to in vivo results; however, the maximal heart rate reduction in this experiment was observed promptly (in 1 min) after the intravenous administration of <b>1</b>-<b>P</b>. Therefore, we assumed that the potency of phosphates on heart rate decreasing effect could be evaluated with little influence of pharmacokinetic difference among the compounds by this method.</div><div class="NLM_p">At the beginning of this study, we planned to evaluate mainly the in vitro S1P receptor selectivity of the phosphates because searching for S1P<sub>1</sub> selective compounds seemed to be a reasonable approach to obtain compounds with a reduced effect on heart rate. On the basis of the result in S1P<sub>3</sub> knock out mice, we expected that <b>2</b>-<b>P</b> had no heart rate deceasing effect. However <b>2</b>-<b>P</b> clearly decreased heart rate. Furthermore, the heart rate decreasing effect of <b>2</b>-<b>P</b> was not reduced at all despite the loss of S1P<sub>3</sub> agonism. Although the ID<sub>50</sub> value of <b>2</b>-<b>P</b> (0.091 mg/kg) was higher than that of <b>1</b>-<b>P</b> (0.012 mg/kg), the lymphocyte-decreasing effect of <b>2</b> was much weaker than that of <b>1</b> (0.40 mg/kg/0.020 mg/kg). This observation made us presume that in vitro agonistic activity at S1P<sub>3</sub> does not always correlate well with the in vivo potential of heart rate reduction. Therefore, we decided to adopt an in vivo evaluation of the effect of test compounds on heart rate in addition to in vitro assay.</div><div class="NLM_p last">On the basis of the above preliminary results, the research flow in this study was established as follows: (i) designing compounds and syntheses of the alcohol form, (ii) determination of the lymphocyte-decreasing effect of the alcohols, (iii) syntheses of the phosphate of sufficiently effective compounds (ED<sub>50</sub> < 0.20 mg/kg) and key compounds, and (iv) evaluations of the heart rate decreasing effect in anesthetized rats and in vitro S1P<sub>1</sub>/S1P<sub>3</sub> selectivity of the phosphates.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> describes the synthesis of intermediate bromides <b>9</b>. After conversion of phenethyl alcohols into iodides <b>7</b>, condensation of <b>7</b> and <i>N</i>-protected diethyl aminomalonate gave diesters <b>8</b>. The ester groups of <b>8</b> were reduced to hydroxymethyl groups, which were subsequently protected to give the corresponding bromides <b>9</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1.  Synthesis of Intermediate Bromides <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) NaI, 2-butanone, reflux; (c) <i>N</i>-protected diethyl aminomalonate, NaH, DMF, 60 °C; (d) NaBH<sub>4</sub>, CaCl<sub>2</sub>, EtOH/H<sub>2</sub>O, rt; (e) Ac<sub>2</sub>O, pyridine, rt; (f) 2,2-dimethoxypropane, <i>p-</i>TsOH·H<sub>2</sub>O, acetone, rt; (g) (i) 4 M HCl/EtOAc, (ii) Ac<sub>2</sub>O, pyridine, rt.</p></p></figure><div class="NLM_p">Biphenyl compounds <b>3a</b>−<b>l</b> were synthesized from bromides <b>9</b> through Suzuki coupling, followed by removal of the protecting groups (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2.  Synthesis of Biphenyl Compounds <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (method A) boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, 65 °C; (method B) (i) bis(pinacolate)diboron, PdCl<sub>2</sub>(Cy<sub>3</sub>P)<sub>2</sub>, AcOK, dioxane, 100 °C, (ii) phenyl bromide, Pd(OAc)<sub>2</sub>, S-Phos, K<sub>3</sub>PO<sub>4</sub>, toluene, 100 °C; (a) 35% HCl, EtOH, reflux; (b) LiOH, THF/MeOH/H<sub>2</sub>O, reflux.</p></p></figure><div class="NLM_p">The syntheses of compounds <b>4</b> and <b>5</b> were carried out as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Hydrogenolysis of biphenyl compound <b>10l</b> gave phenol <b>11</b>. After activation of the phenolic hydroxy group of <b>11</b> by conversion into a triflate, Sonogashira reaction of <b>12</b> and 1-pentyne, hydrogenation, and removal of the protecting groups yielded the desired compound <b>4</b>. The diaryl ether <b>5</b> was obtained by coupling of phenol <b>11</b> and <i>p</i>-tolylboronic acid using copper acetate, followed by deprotection.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3.  Synthesis of Compounds <b>4</b> and <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 10% Pd/C, NH<sub>4</sub>CO<sub>2</sub>H, MeOH, rt; (b) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 1-pentyne, PdCl<sub>2</sub>(CH<sub>3</sub>CN)<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C; (d) LiOH, MeOH/H<sub>2</sub>O, reflux; (e) 10% Pd/C, MeOH, rt; (f) 4 M HCl/EtOAc, MeOH/EtOAc, rt; (g) <i>p</i>-tolylboronic acid, Cu(OAc)<sub>2</sub>, pyridine, 4 Å molecular sieves, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">Diaryl sulfides <b>6a</b>−<b>n</b> were prepared from phenyl bromides <b>9</b> through biphenyl bromides <b>13</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). The bromides <b>13</b> transformed from <b>9</b> by a similar palladium-mediated coupling to that described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> were converted to the diaryl sulfides <b>6a</b>−<b>n</b> by a coupling reaction using 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene as the phosphine ligand followed by deprotection.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4.  Synthesis of Diaryl Sulfides <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bis(neopentyl glycolate)diboron, PdCl<sub>2</sub>(Cy<sub>3</sub>P)<sub>2</sub>, AcOK, dioxane, 100 °C; (b) iodobenzene, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, 100 °C; (c) thiol, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, DIPEA, dioxane, reflux; (d) 35% HCl, EtOH, 70 °C.</p></p></figure><div class="NLM_p">The phosphate esters of <b>3</b>, <b>4</b> and <b>5</b> (<b>3</b>-<b>P</b>, <b>4</b>-<b>P</b>, and <b>5</b>-<b>P</b>, respectively) were prepared as outlined in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. First, the 2-aminopropane-1,3-diols were converted into oxazolines to protect the amino group and one of the hydroxyl groups. The remaining hydroxyl group was phosphorylated by a phosphoramidite with 1<i>H</i>-tetrazole, followed by oxidation to give the protected phosphate esters <b>14</b>. Desired phosphate esters were obtained by removing all protective groups under acidic conditions.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0012.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5.  Phosphorylation of <b>3</b>, <b>4</b>, and <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>C(OEt)<sub>3</sub>, DIPEA, DMF, 120 °C; (b) (i) (<i>t</i>-BuO)<sub>2</sub>PN(<i>i</i>-Pr)<sub>2</sub>, 1<i>H</i>-tetrazole, CH<sub>2</sub>Cl<sub>2</sub>, rt; (ii) <i>m</i>-CPBA, rt; (c) 35% HCl, EtOH, 50 °C.</p></p></figure><div class="NLM_p">The phosphate esters of compounds <b>6</b>, which have a sulfur atom, were synthesized through another route shown in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Bromides <b>13</b> were phosphorylated to give intermediates <b>15</b> before coupling with thiols because the process of phosphorylation included an oxidative step. Compounds <b>6</b>-<b>P</b> were prepared by the palladium coupling reaction of intermediates <b>15</b> with thiols, followed by acidic deprotection.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6.  Synthesis of Phosphate Esters of <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 35% HCl, EtOH, 80 °C; (b) CH<sub>3</sub>C(OEt)<sub>3</sub>, DIPEA, DMF, 120 °C; (c) (i) (<i>t</i>-BuO)<sub>2</sub>PN(<i>i</i>-Pr)<sub>2</sub>, 1<i>H</i>-tetrazole, CH<sub>2</sub>Cl<sub>2</sub>, rt; (ii) <i>t</i>-Butyl hydroperoxide, rt; (d) thiol, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, DIPEA, dioxane, reflux; (e) 35% HCl, EtOH, 50 °C.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46182" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46182" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">First, we searched for a strategy to improve the potency of lymphocyte-decreasing effect exhibited by <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Replacement of the pentyl group of <b>2</b> with butoxy (<b>3b</b>) resulted in a slight increase in in vivo activity, and the agonistic activity of the phosphate (<b>3b</b>-<b>P</b>) at S1P<sub>1</sub> was slightly potentiated. This result suggested that the heteroatom was tolerated as a linkage between the biphenyl and the side chain binding to the 4′ position. In addition, the heteroatom linkage was useful for access to various types of side chains. To improve the potency of <b>3b</b>, introduction of chlorine or fluorine into the biphenyl moiety was carried out. The introductions of chlorine into ring A (<b>3c</b>) and fluorine into ring B (<b>3d</b>) were both useful to improve the in vivo activity of <b>3b</b> like the case of <b>2</b>. The fluorine on ring B was more effective than the chlorine on ring A to improve in vivo activity; however, <b>3d</b>-<b>P</b> showed agonistic activity at S1P<sub>3</sub>. Replacing the fluorine with methyl (<b>3e</b>) resulted in notably reduced activity. In attempts to increase the number of fluorine (<b>3f</b>) and to change the substitution position of halogens (<b>3g</b>, <b>3h</b>), no improvement in activity was observed compared to <b>3b</b> although these phosphates had no S1P<sub>3</sub> agonism. The phosphates of the compounds having high activity (<b>3b</b>-<b>P</b>, <b>3c</b>-<b>P</b>, and <b>3d</b>-<b>P</b>) were evaluated for the heart rate decreasing effect. Compound <b>3d</b>-<b>P</b>, which had agonistic activity at S1P<sub>3</sub>, reduced heart rate intensively (ID<sub>50</sub> = 0.009 mg/kg), supporting the hypothesis that the heart rate reduction caused by <b>1</b> is associated with S1P<sub>3</sub> agonism. On the other hand, ID<sub>50</sub> values of <b>3b</b>-<b>P</b> and <b>3c</b>-<b>P</b> were also low (0.008 and 0.013 mg/kg, respectively) in spite of their inactivity at S1P<sub>3</sub>. This result contradicts the reported observation that <b>1</b>-<b>P</b> had no effect on heart rate in S1P<sub>3</sub>-deficient mice. Although the reason why our results of compound-based approach disagreed with the genetic observation was not clear, we continued our research mainly using in vivo evaluating system rather than in vitro S1P<sub>1</sub>/ S1P<sub>3</sub> selectivity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Lymphocyte-Decreasing Effect, Agonistic Activity at S1P<sub>1</sub> and S1P<sub>3</sub>, and Heart Rate Decreasing Effect of Butoxy Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0002.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="2" align="center">structure</th><th align="center" char="."> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center">A</th><th align="center">B</th><th align="center" char=".">ED<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> (mg/kg)</th><th align="center">phosphate</th><th align="center">S1P<sub>1</sub> EC<sub>50</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> (nM)</th><th align="center">S1P<sub>3</sub> EC<sub>50</sub><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (nM)</th><th align="center">ID<sub>50</sub><a class="ref internalNav" href="#t2fn4" aria-label="d">d</a> (mg/kg)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>3b</b></td><td align="left"> </td><td align="left"> </td><td align="char" char=".">0.22</td><td align="left"><b>3b</b>-<b>P</b></td><td align="left">0.81 (0.31−2.4)</td><td align="left">>1000</td><td align="left">0.008</td></tr><tr valign="top"><td align="left"><b>3c</b></td><td align="left">3-Cl</td><td align="left"> </td><td align="char" char=".">0.08</td><td align="left"><b>3c</b>-<b>P</b></td><td align="left">0.62 (0.22−1.8)</td><td align="left">>1000</td><td align="left">0.013</td></tr><tr valign="top"><td align="left"><b>3d</b></td><td align="left"> </td><td align="left">2′-F</td><td align="char" char=".">0.06</td><td align="left"><b>3d</b>-<b>P</b></td><td align="left">0.53 (0.18−1.6)</td><td align="left">51 (17−150)</td><td align="left">0.009</td></tr><tr valign="top"><td align="left"><b>3e</b></td><td align="left"> </td><td align="left">2′-Me</td><td align="char" char=".">3.4</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3f</b></td><td align="left"> </td><td align="left">2′-F, 5′-F</td><td align="char" char=".">0.15</td><td align="left"><b>3f</b>-<b>P</b></td><td align="left">1.2 (0.40−3.3)</td><td align="left">>1000</td><td align="left">NT<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>3g</b></td><td align="left"> </td><td align="left">3′-F</td><td align="char" char=".">0.21</td><td align="left"><b>3g</b>-<b>P</b></td><td align="left">1.3 (0.40−4.3)</td><td align="left">>1000</td><td align="left">NT</td></tr><tr valign="top"><td align="left"><b>3h</b></td><td align="left"> </td><td align="left">3′-Cl</td><td align="char" char=".">1.3</td><td align="left"><b>3h</b>-<b>P</b></td><td align="left">3.1 (0.42−23)</td><td align="left">>1000</td><td align="left">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Dose (mg/kg) required to decrease the number of lymphocytes by 50% of vehicle-treated control in mice (5 animals for each compound). Alcohol form of compounds was administered intraperitoneally.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">EC<sub>50</sub> (nM) of phosphate form was determined by Ca mobilization assays. 95% confidence limits are given in parentheses.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Concentration required to show 50% of agonistic activity at S1P (300 nM).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Dose (mg/kg) required to decrease heart rate by 50% of vehicle-treated control in rats. Phosphate form of compounds was administered intravenously (3−6 animals for each compound).</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Not tested.</p></div></div></div><div class="NLM_p">The results of replacement of the butoxy group of <b>3b</b> with phenoxy or benzyloxy groups were summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Compound <b>3i</b> exhibited comparable lymphocyte-decreasing activity to the butoxy analogue <b>3b</b> regardless of weak S1P<sub>1</sub> agonistic activity of the phosphate <b>3i</b>-<b>P</b>. The heart rate decreasing effect of <b>3i</b>-<b>P</b> (ID<sub>50</sub> = 0.14 mg/kg) was remarkably weaker than that of <b>3b</b>-<b>P</b> (0.008 mg/kg), suggesting that the phenyl ring in the side chain would be a favorable substituent in order to reduce the effect on heart rate without losing lymphocyte-decreasing activity. The introduction of chlorine on ring A (<b>3j</b> and <b>3k</b>) led to a slight improvement in lymphocyte-decreasing activity, and the introduction of fluorine on ring B (<b>3l</b>) drastically improved the activity equal to that of <b>1</b>. The phosphate of <b>3l</b> (<b>3l</b>-<b>P</b>) still had S1P<sub>3</sub> agonistic activity; however, <b>5</b>-<b>P</b> which had a tolyl group instead of the benzyl group showed a weaker agonistic activity at S1P<sub>3</sub> than <b>3l</b>-<b>P</b>. On the other hand, <b>5</b> maintained a comparable lymphocyte-decreasing effect to <b>3l</b>. These findings verified that the conversion of the alkoxy group into the phenoxy or benzyloxy group was effective in increasing the lymphocyte-decreasing effect and that the <i>p</i>-tolyl group was a substituent to attenuate the S1P<sub>3</sub> agonism. The phosphates of compounds having the improved activity (<b>3k</b>-<b>P</b>, <b>3l</b>-<b>P</b>, and <b>5</b>-<b>P</b>) strongly decreased heart rate like <b>1</b>-<b>P</b> irrespective of their different potencies of S1P<sub>3</sub> agonism. Consequently, no desired compounds having both potent lymphocyte-decreasing activity and little or no effect on heart rate were found in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Lymphocyte-Decreasing Effect, Agonistic Activity at S1P<sub>1</sub> and S1P<sub>3</sub>, and Heart Rate Decreasing Effect of Benzyloxy and Phenoxy Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0003.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="3" align="center">structure</th><th align="center" char="."> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center">A</th><th align="center">B</th><th align="center">R</th><th align="center" char=".">ED<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (mg/kg)</th><th align="center">phosphate</th><th align="left">S1P<sub>1</sub> EC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a><a class="ref internalNav" href="#t3fn3" aria-label="c">c</a> (nM)</th><th align="center">S1P<sub>3</sub> EC<sub>50</sub><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (nM)</th><th align="left">ID<sub>50</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> (mg/kg)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>3i</b></td><td align="left"> </td><td align="left"> </td><td align="left">phenyl</td><td align="char" char=".">0.25</td><td align="left"><b>3i</b>-<b>P</b></td><td align="left">21<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></td><td align="left">>1000</td><td align="left">0.14</td></tr><tr valign="top"><td align="left"><b>3j</b></td><td align="left">3-Cl</td><td align="left"> </td><td align="left">phenyl</td><td align="char" char=".">0.16</td><td align="left"><b>3j</b>-<b>P</b></td><td align="left">4.7 (0.24−92)</td><td align="left">>1000</td><td align="left">0.087</td></tr><tr valign="top"><td align="left"><b>3k</b></td><td align="left">3-Cl</td><td align="left"> </td><td align="left">benzyl</td><td align="char" char=".">0.13</td><td align="left"><b>3k</b>-<b>P</b></td><td align="left">1.6 (0.27−8.9)</td><td align="left">13 (3.9−44)</td><td align="left">0.017</td></tr><tr valign="top"><td align="left"><b>3l</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">benzyl</td><td align="char" char=".">0.01</td><td align="left"><b>3l</b>-<b>P</b></td><td align="left">1.1 (0.25−4.0)</td><td align="left">4.1 (2.9−5.6)</td><td align="left">0.014</td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-Me-phenyl</td><td align="char" char=".">0.04</td><td align="left"><b>5</b>-<b>P</b></td><td align="left">1.8 (0.58−5.9)</td><td align="left">83 (35−199)</td><td align="left">0.016</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Dose (mg/kg) required to decrease the number of lymphocytes by 50% of vehicle-treated control in mice (5 animals for each compound). Alcohol form of compounds was administered intraperitoneally.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">EC<sub>50</sub> (nM) of phosphate form was determined by Ca mobilization assays. 95% confidence limits are given in parentheses.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Concentration required to show 50% of agonistic activity at S1P (300 nM).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Dose (mg/kg) required to decrease heart rate by 50% of vehicle-treated control in rats. Phosphate form of compounds was administered intravenously (3−6 animals for each compound).</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">This value is reported as mean for <i>n</i> = 2 determinations.</p></div></div></div><div class="NLM_p">Our next attempt was replacement of the side chain of <b>3b</b> with a phenylthio or benzylthio group (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Lymphocyte-Decreasing Effect, Agonistic Activity at S1P<sub>1</sub> and S1P<sub>3</sub>, and Heart Rate Decreasing Effect of Benzylthio and Phenylthio Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0004.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th colspan="3" align="center">structure</th><th align="center" char="."> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th><th align="center"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center">A</th><th align="center">B</th><th align="center">R</th><th align="center" char=".">ED<sub>50</sub><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> (mg/kg)</th><th align="center">phosphate</th><th align="center">S1P<sub>1</sub> EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (nM)</th><th align="center">S1P<sub>3</sub> EC<sub>50</sub><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> (nM)</th><th align="center">ID<sub>50</sub><a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> (mg/kg)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>6a</b></td><td align="left">3-Cl</td><td align="left"> </td><td align="left">benzyl</td><td align="char" char=".">0.08</td><td align="left"><b>6a</b>-<b>P</b></td><td align="left">2.1 (0.77−5.8)</td><td align="left">>1000</td><td align="left">0.018</td></tr><tr valign="top"><td align="left"><b>6b</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">benzyl</td><td align="char" char=".">0.04</td><td align="left"><b>6b</b>-<b>P</b></td><td align="left">0.84 (0.24−3.0)</td><td align="left">4.9 (3.3−7.4)</td><td align="left">0.008</td></tr><tr valign="top"><td align="left"><b>6c</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">phenyl</td><td align="char" char=".">0.42</td><td align="left"><b>6c</b>-<b>P</b></td><td align="left">3.6<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td align="left">>1000</td><td align="left">NT<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top"><td align="left"><b>6d</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-Me-phenyl</td><td align="char" char=".">0.05</td><td align="left"><b>6d</b>-<b>P</b></td><td align="left">3.0 (0.56−16)</td><td align="left">>1000</td><td align="left">0.10</td></tr><tr valign="top"><td align="left"><b>6e</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">3-Me-phenyl</td><td align="char" char=".">0.13</td><td align="left"><b>6e</b>-<b>P</b></td><td align="left">2.0 (0.29−14)</td><td align="left">>1000</td><td align="left">0.063</td></tr><tr valign="top"><td align="left"><b>6f</b></td><td align="left">3-Cl</td><td align="left">2′-F</td><td align="left">4-Me-phenyl</td><td align="char" char=".">0.04</td><td align="left"><b>6f</b>-<b>P</b></td><td align="left">4.2 (0.46−38)</td><td align="left">>1000</td><td align="left">0.016</td></tr><tr valign="top"><td align="left"><b>6g</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-Et-phenyl</td><td align="char" char=".">0.04</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6h</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-<i>i</i>-Pr-phenyl</td><td align="char" char=".">0.15</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6i</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-F-phenyl</td><td align="char" char=".">0.07</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6j</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">3-F-phenyl</td><td align="char" char=".">0.16</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6k</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-Cl-phenyl</td><td align="char" char=".">0.18</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6l</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-CF<sub>3</sub>-phenyl</td><td align="char" char=".">0.34</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6m</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">4-MeO-phenyl</td><td align="char" char=".">0.28</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>6n</b></td><td align="left"> </td><td align="left">2′-F</td><td align="left">3-MeO-phenyl</td><td align="char" char=".">0.11</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Dose (mg/kg) required to decrease the number of lymphocytes by 50% of vehicle-treated control in mice (five animals for each compound). Alcohol form of compounds was administered intraperitoneally.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">EC<sub>50</sub> (nM) of phosphate form was determined by Ca mobilization assays. 95% confidence limits are given in parentheses.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Concentration required to show 50% of agonistic activity at S1P (300 nM).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Dose (mg/kg) required to decrease heart rate by 50% of vehicle-treated control in rats. Phosphate form of compounds was administered intravenously (3−6 animals for each compound).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Not tested.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">This value is reported as mean for <i>n</i> = 2 determinations.</p></div></div></div><div class="NLM_p">Because we established and reported an efficient synthetic method for the preparation of diphenyl sulfide in the research of S1P receptor modulators,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> the method was applied to the biphenyl compounds in this study. First we replaced the side chain with the benzylthio group because the benzyloxy derivatives <b>3k</b> and <b>3l</b> showed good activity. Compound <b>6a</b>, which has a chlorine atom on ring A, exhibited comparable activity to the phenoxy analogue <b>3k</b>. Changing chlorine into fluorine (<b>6b</b>) led to better in vivo activity. However, the phosphate of <b>6b</b> (<b>6b</b>-<b>P</b>) showed miserable results in S1P<sub>1</sub>/S1P<sub>3</sub> selectivity and the heart rate decreasing effect. The potency of <b>6b</b>-<b>P</b> on heart rate decreasing (ID<sub>50</sub> = 0.008 mg/kg) was even higher than that of <b>1</b>-<b>P</b> (0.012 mg/kg). On the basis of results of Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, we expected that replacement of the benzylthio group with the phenylthio group could be effective to reduce agonistic activity at the S1P<sub>3</sub> receptor. Fortunately, our expectation was supported by the result that <b>6c</b>-<b>P</b> was not an agonist at S1P<sub>3</sub> although the lymphocyte-decreasing effect of <b>6c</b> was approximately 10-fold weaker than that of <b>6b</b>. Next, we added substituents on the terminal phenyl ring of <b>6c</b> to improve the activity. Because the phenylthio group is smaller than the benzylthio group by one methylene, a methyl group was introduced into the terminal phenyl ring to retain the total length of the side chain. Both the para- and meta-substituted derivatives, <b>6d</b> and <b>6e</b>, respectively, showed improved activity in terms of lymphocyte-decreasing effect. Especially, <b>6d</b> was equipotent to <b>6b</b>. The results of the phosphates (<b>6d</b>-<b>P</b> and <b>6e</b>-<b>P</b>) in the heart rate measuring study were interesting. The heart rate decreasing effect of <b>6d</b>-<b>P</b> was attenuated. More precisely, the ID<sub>50</sub> values of <b>6d</b>-<b>P</b> and <b>1</b>-<b>P</b> were 0.10 and 0.012 mg/kg, respectively whereas their ED<sub>50</sub> values on lymphopenia (0.05 and 0.02 mg/kg) were closer than their ID<sub>50</sub> values. On the other hand, <b>6e</b>-<b>P</b> produced more intense reduction of heart rate than <b>6d</b>-<b>P</b> although <b>6e</b>-<b>P</b> had a similar in vitro profile to <b>6d</b>-<b>P</b>. Chlorine was introduced into ring A of <b>6d</b> to explore more active compounds. The compound <b>6f</b> was equipotent to <b>6d</b>, but the phosphate <b>6f</b>-<b>P</b> showed a strong effect on heart rate like <b>1</b>-<b>P</b>. Next, the substituents on the terminal phenyl were examined. Although replacement of the methyl group of <b>6d</b> with an ethyl group (<b>6g</b>) was tolerated, replacement with a more bulky group (<b>6h</b>) yielded less lymphocyte-decreasing activity. Adoption of halogens (<b>6i</b>, <b>6j</b>, and <b>6k</b>) also led to weaker activity. Among the halogens, fluorine (<b>6i</b>) was preferable to chlorine (<b>6k</b>), and para-substituted derivative (<b>6i</b>) was better than meta-substituted derivative (<b>6j</b>) like the case of the methyl substituent (<b>6d</b> and <b>6e</b>). Introduction of a trifluoromethyl group into unsubstituted compound <b>6c</b> did not influence activity (<b>6l</b>). The activity of <i>meta</i>-methoxy compound <b>6n</b> was stronger than that of para-substituted compound <b>6m</b>. The modification of the terminal phenyl of <b>6d</b> resulted in no significant improvement. Consequently, <b>6d</b> was the only compound having both the significant lymphocyte-decreasing activity and the reduced effect on heart rate in this study.</div><div class="NLM_p">The most advantageous compound <b>6d</b> was subjected to detailed pharmacological evaluations. Compounds <b>1</b> and <b>6d</b> had comparable oral lymphocyte-decreasing activity in rats with ED<sub>50</sub> values of 0.040 mg/kg (0.029−0.056; 95% confidence limit) and 0.084 mg/kg (0.064−0.11; 95% confidence limit), respectively. Next, the effect of orally administered <b>6d</b> on heart rate was measured in conscious rats using a telemetry system. Compound <b>1</b> significantly reduced the heart rate at doses of 3 mg/kg and higher in this test. On the other hand, <b>6d</b> had no clear influence on heart rate at a dose of 10 mg/kg (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). These data indicated that <b>6d</b> have both the sufficient immunomodulatory activity and a low adverse action on heart.</div><figure id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of compounds <b>1</b> (A) and <b>6d</b> (B) on heart rate in conscious rats (10 mg/kg, po). ΔHeart rate means the change (beat/min) of post-treatment value (day 0) compared to the mean of pretreatment values (from day −3 to day −1) at the corresponding time of each day in the same animals. *: p < 0.05, ** : p < 0.01, significantly different from the corresponding value in the vehicle group (<i>n</i> = 3 or 4, paired <i>t</i>-test). Vehicle background date represent the mean ± SD of each time point data (<i>n</i> = 38). </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The genetic studies using fetal liver chimeric mice with specific deletion of S1P<sub>1</sub> from hematopoietic cells and S1P<sub>3</sub>-deficient mice revealed that S1P<sub>1</sub> and S1P<sub>3</sub> regulate lymphocyte circulation and reduction of heart rate, respectively.<a onclick="showRef(event, 'ref10 ref15'); return false;" href="javascript:void(0);" class="ref ref10 ref15">(10, 15)</a> It was reported that KRP-203 (not shown), which has the same 2-aminopropane-1,3-diol skeleton as <b>1</b>, had a comparable lymphocyte-decreasing effect to <b>1</b> and a reduced heart rate decreasing effect.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> It appears that KRP-203 reduced the effect on heart rate to almost the same level as compound <b>6d</b> according to the report. The phosphate (KRP-203-P) was an agonist at S1P<sub>1</sub>, but inactive at S1P<sub>3</sub>. The S1P<sub>1</sub>/S1P<sub>3</sub> selectivity was presumed to be important for reduction of the effect on heart rate.</div><div class="NLM_p">In the beginning of our research, we identified <b>2</b> as a lead compound that was inactive against S1P<sub>3</sub> on this hypothesis by the screening of our <b>1</b>-related compound library. Then the pentyl group of <b>2</b> was converted into alkoxy, phenoxy, and phenylthio groups to improve the activity. As a result, lots of compounds showed a remarkable lymphocyte-decreasing effect. All the phosphates of the favorably active compounds having S1P<sub>3</sub> agonism (e.g., <b>3k</b>-<b>P</b>, <b>3l</b>-<b>P</b>, <b>5</b>-<b>P</b>, and <b>6b</b>-<b>P</b>) provoked an intensive decrease of heart rate. This result supported that S1P<sub>3</sub> was responsible for the reduction of heart rate caused by <b>1</b>. Additionally, the fact that <b>6d</b>-<b>P</b> was inactive at S1P<sub>3</sub> receptor-like KRP-203-P indicates that elimination of S1P<sub>3</sub> receptor agonism should be necessary to reduce the effect on heart rate. However, most of the phosphates having no agonism at S1P<sub>3</sub> also significantly influenced heart rate. For instance, the phosphates of both <i>meta</i>-methyl (<b>6e</b>-<b>P</b>) and chloro-substituted (<b>6f</b>-<b>P</b>) derivatives remarkably lowered heart rate, although neither of them showed any agonistic activity at S1P<sub>3</sub>. This fact contradicted the result of the genetic study that <b>1</b> had no effect on heart rate in S1P<sub>3</sub>-deficient mice and exploded the previously reported assumption that the research of compounds having no agonism at S1P<sub>3</sub> would directly lead to find the desirable S1P<sub>1</sub> agonist with little or no effect on heart rate. Although the cause of the disagreement between the genetic and our compound-based results is unclear, there are some possibilities: (i) species difference of the heart rate reduction mechanism between the S1P<sub>3</sub>-deficient mice<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and the rats used here, (ii) difference of intravital environments between S1P<sub>3</sub>-deficient mice and wild-type animals exposed to no exogenous S1P<sub>3</sub> agonism but to endogenous S1P<sub>3</sub> agonism by natural S1P, and (iii) existence of other signaling pathways undetectable by using our calcium mobilization assay.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> It is likely that other factors in addition to S1P<sub>3</sub> participate in the heart rate reduction caused by S1P receptor modulators.</div><div class="NLM_p">Although it is relatively easy to obtain compounds without S1P<sub>3</sub> agonism, it is rather difficult to find compounds with a reduced effect on heart rate among them. The structure of <b>6d</b> is similar to that of KRP-203, which has two additional phenyl rings compared to <b>1</b> and a sulfur atom in the hydrophobic part. These structural and physicochemical properties may relate to the reduced effect on heart rate of both compounds. Furthermore, the pathogenic mechanism of S1P receptor modulators on the heart rate reduction may be revealed by using compounds having a similar structure and a different potency on heart rate reduction (e.g., <b>6d</b> and <b>6f</b>).</div><div class="NLM_p last">Because S1P<sub>3</sub> agonism showed no consistent relationship to the heart rate decreasing effect at the early stage of this research, the in vivo evaluation in rats was promptly adopted to estimate the potency of the phosphates for heart rate reduction. Thereby we constructed the original screening strategy based on not only in vitro S1P<sub>1</sub>/S1P<sub>3</sub> selectivity but also simple in vivo systems and found compound <b>6d</b> whose effect on heart rate was attenuated. The detailed pharmacological evaluation revealed that oral administration of <b>6d</b> in rats provided the excellent lymphocyte-decreasing effect and the attenuated effect on heart rate. To the best of our knowledge, this is the first successful example on finding S1P<sub>1</sub> agonists with sufficient immunomodulatory activity and little or no effect on heart rate by a medicinal chemical approach.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">2-Substituted 2-aminopropane-1,3-diols having a biphenyl moiety were synthesized to obtain immunomodulating S1P<sub>1</sub> receptor agonists with little or no effect on heart rate. The phosphate of <b>2</b> was identified as a lead compound with S1P<sub>1</sub> selectivity against S1P<sub>3</sub> by a screening of <b>1</b> analogue library. The structural evolution of <b>2</b> led to lots of biphenyl compounds showing considerable lymphocyte-decreasing effect. Several phosphate esters of them were potent S1P<sub>1</sub> receptor agonists having high selectivity against S1P<sub>3</sub>; however, significant effects on heart rate remained in almost all of the phosphates. The results suggested that other factors in addition to S1P<sub>3</sub> agonism should be considered to clarify the cause of heart rate reduction by S1P<sub>1</sub> receptor agonists. The syntheses of analogues and our original screening strategy using in vivo evaluating systems primarily revealed that <b>6d</b> had potent lymphocyte-decreasing effect by intraperitoneal administration to mice and that the effect on heart rate of the phosphate <b>6d</b>-<b>P</b> was attenuated by intravenous administration to anesthetized rats. It was then confirmed that the oral administration of <b>6d</b> to rats brought a similar immnomodulatory efficacy to that of <b>1</b> and no influence on heart rate at a dose of 10 mg/kg.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div class="NLM_p last">Silica gel column chromatography was performed on a Moritex Purif-α2 system using Purif-Pack 30 or 60 μm silica gel columns and the described solvents as eluent under gradient condition. Preparative HPLC was performed on a Shimadzu HPLC system using Capcell Pak C18 UG80 (5 μm 20 mm × 250 mm) under gradient condition (CH<sub>3</sub>CN/H<sub>2</sub>O + 0.05% TFA). <sup>1</sup>H NMR spectra were recorded on a Bruker AVANCE 400 (400 MHz) spectrometer. Chemical shifts are expressed in ppm relative to tetramethylsilane (TMS) as an internal standard. Mass spectra were measured in a combination with a Waters Acquity UPLC system (CH<sub>3</sub>CN + 0.05% TFA/H<sub>2</sub>O + 0.05% TFA) and a Micromass ZQ (ESI) spectrometer. Melting points were obtained on a Büchi 535 melting point apparatus and are uncorrected. Elemental analyses were performed on a Perkin-Elmer 2400 II CHN analyzer. All compounds showed >95% purity, according to UPLC or the elemental analyses.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-(4-Bromophenyl)ethyl Iodide (<b>7a</b>)</h3><div class="NLM_p last">Methanesulfonyl chloride (11.5 mL, 148 mmol) was added to a solution of 2-(4-bromophenyl)ethyl alcohol (25.0 g, 124 mmol) and triethylamine (22.6 mL, 163 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL) at 0 °C. The suspension was stirred at room temperature for 2 h. The reaction mixture was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to yield a red oil (39.1 g). Sodium iodide (18.6 g, 124 mmol) was added to a solution of the oil in 2-butanone (400 mL), and the suspension was heated under reflux for 4.5 h. The reaction mixture was diluted with EtOAc and washed with water, 10% aqueous sodium thiosulfate, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification of the residue by silica gel column chromatography (hexane/EtOAc) gave the title compound (34.2 g, 91%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.13 (2H, t, <i>J</i> = 7.5 Hz), 3.32 (2H, t, <i>J</i> = 7.5 Hz), 7.07 (2H, d, <i>J</i> = 8.4 Hz), 7.44 (2H, d, <i>J</i> = 8.4 Hz).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-(4-Bromo-2-chlorophenyl)ethyl Iodide (<b>7b</b>)</h3><div class="NLM_p last">The title compound was synthesized from 2-(4-bromo-2-chlorophenyl)ethyl alcohol using a similar procedure to that described for <b>7a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 3.22−3.28 (2H, m), 3.32−3.38 (2H, m), 7.12 (1H, d, <i>J</i> = 8.1 Hz), 7.36 (1H, dd, <i>J</i> = 1.8, 8.4 Hz), 7.53 (1H, d, <i>J</i> = 2.1 Hz).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Diethyl 2-Acetamido-2-[2-(4-bromophenyl)ethyl]malonate (<b>8a</b>)</h3><div class="NLM_p last">A solution of diethyl acetamidomalonate (28.7 g, 132 mmol) in DMF (55 mL) was added dropwise to a suspension of NaH (60% dispersion in mineral oil, 5.72 g, 143 mmol) in DMF (110 mL) at 0 °C. After stirring at room temperature for 45 min, <b>7a</b> (34.2 g, 110 mmol) was added dropwise to the reaction mixture at 0 °C. After stirring at room temperature for 1 h and an additional 2 h at 60 °C, the reaction mixture was poured into iced water and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel column chromatography (hexane/EtOAc) gave the title compound (35.4 g, 78%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.23 (6H, t, <i>J</i> = 7.2 Hz), 2.00 (3H, s), 2.44 (2H, dd, <i>J</i> = 9.0, 10.8 Hz), 3.32 (2H, dd, <i>J</i> = 9.0, 10.8 Hz), 4.16−4.25 (4H, m), 6.76 (1H, brs), 7.02 (2H, d, <i>J</i> = 8.4 Hz), 7.38 (2H, d, <i>J</i> = 8.4 Hz).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Diethyl 2-[2-(4-Bromo-2-chlorophenyl)ethyl]-2-(<i>tert-</i>butoxycarbonylamino)malonate (<b>8b</b>)</h3><div class="NLM_p last">The title compound was synthesized from <b>7b</b> and diethyl <i>tert-</i>butoxycarbonylaminomalonate using a similar procedure to that described for <b>8a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.26 (6H, t, <i>J</i> = 7.1 Hz), 1.44 (9H, s), 2.57 (4H, brs), 4.16−4.30 (4H, m), 6.01 (1H, brs), 7.05 (1H, d, <i>J</i> = 8.1 Hz), 7.30 (1H, dd, <i>J</i> = 1.8, 8.4 Hz), 7.49 (1H, d, <i>J</i> = 1.8 Hz).</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-Acetamido-2-[2-(4-bromophenyl)ethyl]propane-1,3-diol Diacetate (<b>9a</b>)</h3><div class="NLM_p last">NaBH<sub>4</sub> (13.4 g, 354 mmol) was added portionwise to a solution of <b>8a</b> (35.4 g, 88.4 mmol) and CaCl<sub>2</sub> (20.6 g, 185 mmol) in water (55 mL) and EtOH (310 mL). After stirring at room temperature overnight, 1 M aqueous HCl was added to the reaction mixture and the mixture was extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in pyridine (300 mL). Acetic anhydride (25.0 mL, 340 mmol) was added to the solution at 0 °C. After stirring at room temperature overnight, ice and water (300 mL) were added to the reaction mixture. The mixture was extracted with EtOAc, and the organic layer was washed successively with water, 0.5 M aqueous HCl, saturated NaHCO<sub>3</sub>, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was precipitated from hexane/EtOAc (1/1) to give the title compound (11.4 g) as a white solid. The mother liquid was concentrated in vacuo. Purification of the residue by silica gel column chromatography (hexane/EtOAc) gave the second crop of the title compound (4.8 g). The total yield was 16.2 g (46%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.99 (3H, s), 2.10 (6H, s), 2.16−2.22 (2H, m), 2.53−2.59 (2H, m), 4.32 (4H, s), 5.68 (1H, brs), 7.06 (2H, d, <i>J</i> = 8.4 Hz), 7.40 (2H, d, <i>J</i> = 8.4 Hz).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-[5-[2-(4-Bromophenyl)ethyl]-2,2-dimethyl-1,3-dioxane-5-yl]acetamide (<b>9b</b>)</h3><div class="NLM_p last">NaBH<sub>4</sub> (21.8 g, 576 mmol) was added portionwise to a solution of <b>8a</b> (57.8 g, 144 mmol) and CaCl<sub>2</sub> (32.0 g, 288 mmol) in water (100 mL) and EtOH (500 mL). After stirring at room temperature overnight, 1 M aqueous HCl was added to the reaction mixture, and the mixture was extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in acetone (200 mL). 2,2-Dimethoxypropane (41.9 g, 402 mmol) and a catalytic amount of <i>p</i>-toluenesulfonic acid monohydrate was added to the solution. After stirring at room temperature overnight, the mixture was concentrated in vacuo. The residue was washed with saturated NaHCO<sub>3</sub> to give the title compound as a white solid (41.5 g, 81%). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.43 (6H, s), 2.03 (3H, s), 2.01−2.06 (2H, m), 2.46−2.52 (2H, m), 3.67 (2H, d, <i>J</i> = 11.7 Hz), 3.95 (2H, d, <i>J</i> = 12.0 Hz), 5.76 (1H, brs), 7.05 (2H, d, <i>J</i> = 8.4 Hz), 7.38 (2H, d, <i>J</i> = 8.4 Hz).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Acetamido-2-[2-(4-bromo-2-chlorophenyl)ethyl]propane-1,3-diol Diacetate (<b>9c</b>)</h3><div class="NLM_p last">NaBH<sub>4</sub> (66.6 g, 1760 mmol) was added portionwise to a solution of <b>8b</b> (217 g, 440 mmol) and CaCl<sub>2</sub> (97.7 g, 880 mmol) in THF (543 mL), water (1085 mL), and EtOH (2170 mL) at 0 °C. After stirring at room temperature for 14 h, 1 M HCl (1085 mL) was added to the reaction mixture and the mixture was extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in 4 M HCl solution in EtOAc (326 mL). After stirring at 30 °C for 1 h, the mixture was concentrated in vacuo. Aqueous NaOH (0.1 M, 2713 mL) was added to the reaction mixture. The mixture was extracted with EtOAc, and the organic layer was washed with brine. The organic layer was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was dissolved in pyridine (271 mL). Acetic anhydride (270 mL) was added to the solution at 0 °C. After stirring at room temperature for 11 h, EtOAc (2710 mL), 1 M NaOH (1084 mL), and 9% NaHCO<sub>3</sub> (5420 mL) were added to the reaction mixture. The mixture was extracted with EtOAc, and the organic layer was washed successively with 1 M HCl, 9% NaHCO<sub>3</sub>, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was precipitated from IPE/<i>n</i>-heptane (1/1) to give the title compound (135 g, 62%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.00 (3H, s), 2.10 (6H, s), 2.12−2.16 (2H, m), 2.66−2.72 (2H, m), 4.36 (4H, s), 5.75 (1H, brs), 7.10 (1H, d, <i>J</i> = 8.2 Hz), 7.32 (1H, dd, <i>J</i> = 1.9, 7.5 Hz), 7.70 (1H, d, <i>J</i> = 1.9 Hz).</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-[2-(4-Bromo-2-chlorophenyl)ethyl]-2-(<i>tert-</i>butoxycarbonylamino)propane-1,3-diol Diacetate (<b>9d</b>)</h3><div class="NLM_p last">The title compound was synthesized from <b>8b</b> using a similar procedure to that described for <b>9a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.46 (9H, s), 2.03−2.07 (2H, m), 2.09 (6H, s), 2.67−2.73 (2H, m), 4.29 (4H, s), 4.75 (1H, brs), 7.09 (1H, d, <i>J</i> = 8.2 Hz), 7.32 (1H, dd, <i>J</i> = 2.0, 8.4 Hz), 7.50 (1H, d, <i>J</i> = 2.0 Hz).</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(<i>tert-</i>Butoxycarbonylamino)-2-[2-(3-chloro-4′-pentylbiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10a</b>)</h3><div class="NLM_p">A mixture of <b>9d</b> (493 mg, 1.00 mmol), 4-pentylphenylboronic acid (230 mg, 1.19 mmol), tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.010 mmol), and NaHCO<sub>3</sub> (504 mg, 5.99 mmol) in 1,2-dimethoxyethane (6.0 mL) and water (2.0 mL) was heated at 65 °C for 4 h. Water was added to the reaction mixture, and the resulting mixture was extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the title compound (450 mg, 80%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.90 (3H, t, <i>J</i> = 6.6 Hz), 1.32−1.35 (4H, m), 1.47 (9H, s), 1.64−1.66 (2H, m), 2.04−2.20 (2H, m), 2.09 (6H, s), 2.64 (2H, t, <i>J</i> = 7.5 Hz), 2.75−2.80 (2H, m), 4.32 (4H, s), 4.79 (1H, brs), 7.23−7.27 (3H, m), 7.39−7.47 (3H, m), 7.56 (1H, d, <i>J</i> = 2.0 Hz).</div><div class="NLM_p last">The compounds <b>10b</b>−<b>l</b> were synthesized using a similar procedure to that described for <b>10a</b>. Synthetic route for each compound is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-Acetamido-2-[2-(4′-butoxybiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.2 Hz), 1.48−1.54 (2H, m), 1.75−1.82 (2H, m), 1.96 (3H, s), 2.10 (6H, s), 2.22−2.26 (2H, m), 2.62−2.66 (2H, m), 4.00 (2H, t, <i>J</i> = 6.4 Hz), 4.37 (4H, s), 5.65 (1H, brs), 6.94−6.96 (2H, m), 7.23 (2H, d, <i>J</i> = 8.0 Hz), 7.46−7.50 (4H, m).</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-[2-(4′-Butoxy-3-chlorobiphenyl-4-yl)ethyl]-2-(<i>tert-</i>butoxycarbonylamino)propane-1,3-diol Diacetate (<b>10c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.5 Hz), 1.46 (9H, s), 1.47−1.58 (2H, m), 1.70−1.88 (2H, m), 2.05 (6H, s), 2.04−2.10 (2H, m), 2.73−2.79 (2H, m), 4.00 (2H, t, <i>J</i> = 6.3 Hz), 4.32 (4H, s), 4.78 (1H, brs), 6.95 (2H, d, <i>J</i> = 8.4 Hz), 7.23−7.26 (1H, m), 7.35−7.38 (1H, m), 7.45−7.52 (3H, m).</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Acetamido-2-[2-(4′-butoxy-2′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.6 Hz), 1.48−1.53 (2H, m), 1.75−1.82 (2H, m), 1.96 (3H, s), 2.09 (6H, s), 2.23−2.27 (2H, m), 2.63−2.67 (2H, m), 3.98 (2H, t, <i>J</i> = 6.4 Hz), 4.37 (4H, s), 5.64 (1H, brs), 6.67−6.76 (2H, m), 7.24 (2H, d, <i>J</i> = 8.0 Hz), 7.30 (1H, t, <i>J</i> = 8.8 Hz), 7.42−7.44 (2H, m).</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Acetamido-2-[2-(4′-butoxy-2′-methylbiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10e</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.4 Hz), 1.48−1.54 (2H, m), 1.74−1.80 (2H, m), 1.97 (3H, s), 2.10 (6H, s), 2.24 (3H, s), 2.26−2.29 (2H, m), 2.63−2.68 (2H, m), 3.98 (2H, t, <i>J</i> = 6.4 Hz), 4.37 (4H, s), 5.66 (1H, brs), 6.75−6.81 (2H, m), 7.11 (1H, d, <i>J</i> = 8.4 Hz), 7.21 (4H, brs).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Acetamido-2-[2-(4′-butoxy-2′,5′-difluorobiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.6 Hz), 1.49−1.57 (2H, m), 1.79−1.86 (2H, m), 1.97 (3H, s), 2.10 (6H, s), 2.23−2.27 (2H, m), 2.63−2.67 (2H, m), 4.04 (2H, t, <i>J</i> = 6.4 Hz), 4.36 (4H, s), 5.65 (1H, brs), 6.76 (1H, dd, <i>J</i> = 7.1, 11.7 Hz), 7.15 (1H, dd, <i>J</i> = 7.3, 11.8 Hz), 7.24−7.26 (2H, m), 7.41 (2H, d, <i>J</i> = 8.3 Hz).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Acetamido-2-[2-(4′-butoxy-3′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10g</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.95 (3H, t, <i>J</i> = 7.6 Hz), 1.50−1.55 (2H, m), 1.79−1.86 (2H, m), 1.97 (3H, s), 2.10 (6H, s), 2.22−2.64 (2H, m), 2.62−2.67 (2H, m), 4.07 (2H, t, <i>J</i> = 6.4 Hz), 4.36 (4H, s), 5.67 (1H, brs), 7.00 (1H, t, <i>J</i> = 8.6 Hz), 7.22−7.31 (4H, m), 7.44 (2H, d, <i>J</i> = 8.0 Hz).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-Acetamido-2-[2-(4′-butoxy-3′-chlorobiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10h</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.01 (3H, t, <i>J</i> = 7.6 Hz), 1.52−1.58 (2H, m), 1.82−1.86 (2H, m), 1.97 (3H, s), 2.01 (6H, s), 2.22−2.26 (2H, m), 2.62−2.67 (2H, m), 4.07 (2H, t, <i>J</i> = 6.4 Hz), 4.36 (4H, s), 5.67 (1H, brs), 6.97 (1H, d, <i>J</i> = 8.4 Hz), 7.24 (2H, d, <i>J</i> = 8.0 Hz), 7.38−7.40 (1H, m), 7.44 (2H, d, <i>J</i> = 8.0 Hz), 7.57 (1H, d, <i>J</i> = 2.4 Hz).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Acetamido-2-[2-(4′-phenoxybiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10i</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.97 (3H, s), 2.10 (6H, s), 2.22−2.28 (2H, m), 2.63−2.68 (2H, m), 4.37 (4H, s), 5.68 (1H, brs), 7.04−7.11 (5H, m), 7.23−7.26 (2H, m), 7.32−7.38 (2H, m), 7.47−7.54 (4H, m).</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(<i>tert-</i>Butoxycarbonylamino)-2-[2-(3-chloro-4′-phenoxybiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10j</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.47 (9H, s), 2.10 (6H, s), 2.08−2.15 (2H, m), 2.75−2.81 (2H, m), 4.32 (4H, s), 4.78 (1H, brs), 7.04−7.13 (4H, m), 7.25−7.28 (2H, m), 7.34−7.39 (3H, m), 7.49−7.54 (3H, m).</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-[2-(4′-Benzyloxy-3-chlorobiphenyl-4-yl)ethyl]-2-(<i>tert-</i>butoxycarbonylamino)propane-1,3-diol Diacetate (<b>10k</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.47 (9H, s), 2.10 (6H, s), 2.04−2.14 (2H, m), 2.74−2.80 (2H, m), 4.32 (4H, s), 4.77 (1H, brs), 5.11 (2H, s), 7.04 (2H, d, <i>J</i> = 8.4 Hz), 7.23−7.26 (1H, m), 7.35−7.52 (9H, m).</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Acetamido-2-[2-(4′-benzyloxy-2′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>10l</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.98 (3H, s), 2.10 (6H, s), 2.19−2.28 (2H, m), 2.62−2.68 (2H, m), 4.37 (4H, s), 5.09 (2H, s), 5.68 (1H, brs), 6.76−6.84 (2H, m), 7.23−7.44 (10H, m).</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Amino-2-[2-(3-chloro-4′-pentylbiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3a</b>)</h3><div class="NLM_p last">A solution of <b>10a</b> (450 mg, 0.803 mmol) in EtOH (9.0 mL) was added to 35% HCl (3.0 mL), and the mixture was refluxed for 3 h. After the organic solvent was distilled off in vacuo, the yielded solid was collected to afford the title compound (320 mg, 97%) as white crystals; mp 185−187 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 376 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.87 (3H, t, <i>J</i> = 6.6 Hz), 1.19−1.41 (4H, m), 1.49−1.66 (2H, m), 1.73−1.89 (2H, m), 2.52−2.63 (2H, m), 2.68−2.82 (2H, m), 3.57 (4H, d, <i>J</i> = 4.5 Hz), 5.40−5.41 (2H, m), 7.28 (2H, d, <i>J</i> = 8.1 Hz), 7.42 (1H, d, <i>J</i> = 8.1 Hz), 7.58−7.60 (3H, m), 7.68 (1H, d, <i>J</i> = 1.8 Hz), 7.84 (3H, brs). Anal. (C<sub>22</sub>H<sub>30</sub>ClNO<sub>2</sub>·HCl) C, H, N.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-Amino-2-[2-(4′-butoxybiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3b</b>)</h3><div class="NLM_p">A solution of <b>10b</b> (570 mg, 1.21 mmol) in MeOH (5.0 mL) and THF (4 mL) was added to a solution of lithium hydroxide monohydrate (255 mg, 6.07 mmol) in water (5.0 mL), and the mixture was refluxed for 4 h. After cooling to room temperature, the reaction mixture was poured into water and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was dissolved in 4 M HCl solution in EtOAc (6.0 mL) and MeOH (6.0 mL), and the solvent was distilled off in vacuo. The yielded white crystalline solid was collected and washed with EtOAc to give the title compound (384 mg, 83%); mp 201−203 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 344 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.94 (3H, t, <i>J</i> = 7.2 Hz), 1.40−1.50 (2H, m), 1.68−1.75 (2H, m), 1.80−1.85 (2H, m), 2.61−2.66 (2H, m), 3.54 (4H, d, <i>J</i> = 5.2 Hz), 4.00 (2H, t, <i>J</i> = 6.4 Hz), 5.39 (2H, t, <i>J</i> = 5.2 Hz), 6.98−7.01 (2H, m), 7.26 (2H, d, <i>J</i> = 8.4 Hz), 7.53−7.57 (4H, m), 7.87 (3H, brs). Anal. (C<sub>21</sub>H<sub>29</sub>NO<sub>3</sub>·HCl) C, H, N.</div><div class="NLM_p last">The compounds <b>3c</b>−<b>l</b> were synthesized using a similar procedure to that described for <b>3a</b> or <b>3b</b>. The synthetic route for each compound is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Some compounds were isolated as free base before converting into hydrochloride salt.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-Amino-2-[2-(4′-butoxy-3-chlorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3c</b>)</h3><div class="NLM_p last">mp 188−190 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 378 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.94 (3H, t, <i>J</i> = 7.2 Hz), 1.41−1.49 (2H, m), 1.69−1.84 (4H, m), 2.73−2.76 (2H, m), 3.57 (4H, d, <i>J</i> = 4.8 Hz), 4.01 (2H, t, <i>J</i> = 6.3 Hz), 5.44 (2H, t, <i>J</i> = 4.8 Hz), 7.01 (2H, d, <i>J</i> = 8.7 Hz), 7.40 (1H, d, <i>J</i> = 8.1 Hz), 7.55−7.70 (4H, m), 7.87 (3H, brs). Anal. (C<sub>21</sub>H<sub>28</sub>ClNO<sub>3</sub>·HCl·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-Amino-2-[2-(4′-butoxy-2′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3d</b>)</h3><div class="NLM_p last">mp 163−165 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 362 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.94 (3H, t, <i>J</i> = 7.6 Hz), 1.42−1.47 (2H, m), 1.68−1.75 (2H, m), 1.81−1.85 (2H, m), 2.63−2.67 (2H, m), 3.55 (4H, d, <i>J</i> = 4.8 Hz), 4.02 (2H, t, <i>J</i> = 6.8 Hz), 5.39 (2H, t, <i>J</i> = 4.8 Hz), 6.85−6.92 (2H, m), 7.29 (2H, d, <i>J</i> = 8.4 Hz), 7.38−7.44 (3H, m), 7.84 (3H, brs). Anal. (C<sub>21</sub>H<sub>28</sub>FNO<sub>3</sub>·HCl) C, H, N.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Amino-2-[2-(4′-butoxy-2′-methylbiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3e</b>)</h3><div class="NLM_p last">mp 136−138 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 358 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.94 (3H, t, <i>J</i> = 7.6 Hz), 1.40−1.49 (2H, m), 1.67−1.74 (2H, m), 1.82−1.87 (2H, m), 2.20 (3H, s), 2.63−2.67 (2H, m), 3.55 (4H, d, <i>J</i> = 5.2 Hz), 3.98 (2H, t, <i>J</i> = 6.4 Hz), 5.38 (2H, t, <i>J</i> = 5.2 Hz), 6.80 (1H, dd, <i>J</i> = 2.4, 8.4 Hz), 6.85 (1H, d, <i>J</i> = 2.4 Hz), 7.08 (1H, d, <i>J</i> = 8.4 Hz), 7.21−7.26 (4H, m), 7.85 (3H, brs). Anal. (C<sub>22</sub>H<sub>31</sub>NO<sub>3</sub>·HCl·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-Amino-2-[2-(4′-butoxy-2′,5′-difluorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3f</b>)</h3><div class="NLM_p last">mp 182−184 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 380 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.95 (3H, t, <i>J</i> = 7.2 Hz), 1.42−1.48 (2H, m), 1.70−1.78 (2H, m), 1.80−1.85 (2H, m), 2.50−2.67 (2H, m), 3.54 (4H, d, <i>J</i> = 5.1 Hz), 4.10 (2H, t, <i>J</i> = 6.6 Hz), 5.39 (2H, t, <i>J</i> = 4.9 Hz), 7.21 (1H, dd, <i>J</i> = 7.4, 12.3 Hz), 7.30 (2H, d, <i>J</i> = 8.3 Hz), 7.40 (1H, dd, <i>J</i> = 7.0, 12.2 Hz), 7.46 (2H, d, <i>J</i> = 6.7 Hz), 7.85 (3H, brs). Anal. (C<sub>21</sub>H<sub>27</sub>F<sub>2</sub>NO<sub>3</sub>·HCl) C, H, N.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2-Amino-2-[2-(4′-butoxy-3′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3g</b>)</h3><div class="NLM_p last">mp 164−166 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 362 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.95 (3H, t, <i>J</i> = 7.6 Hz), 1.43−1.48 (2H, m), 1.70−1.77 (2H, m), 1.80−1.84 (2H, m), 2.61−2.66 (2H, m), 3.54 (4H, d, <i>J</i> = 4.8 Hz), 4.08 (2H, t, <i>J</i> = 6.4 Hz), 5.38 (2H, t, <i>J</i> = 4.8 Hz), 7.22 (1H, t, <i>J</i> = 8.8 Hz), 7.27 (2H, d, <i>J</i> = 8.0 Hz), 7.40−7.43 (1H, m), 7.50−7.53 (1H, m), 7.58 (2H, d, <i>J</i> = 8.0 Hz), 7.81 (3H, brs). Anal. (C<sub>21</sub>H<sub>28</sub>FNO<sub>3</sub>·HCl·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 2-Amino-2-[2-(4′-butoxy-3′-chlorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3h</b>)</h3><div class="NLM_p last">mp 154−156 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 378 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.95 (3H, t, <i>J</i> = 7.6 Hz), 1.45−1.51 (2H, m), 1.71−1.78 (2H, m), 1.80−1.85 (2H, m), 2.62−2.66 (2H, m), 3.54 (4H, d, <i>J</i> = 5.2 Hz), 4.10 (2H, t, <i>J</i> = 6.4 Hz), 5.39 (2H, t, <i>J</i> = 5.2 Hz), 7.21 (1H, d, <i>J</i> = 8.8 Hz), 7.28 (2H, d, <i>J</i> = 8.4 Hz), 7.56−7.59 (3H, m), 7.69 (1H, d, <i>J</i> = 2.4 Hz), 7.85 (3H, brs). Anal. (C<sub>21</sub>H<sub>28</sub>ClNO<sub>3</sub>·HCl·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 2-Amino-2-[2-(4′-phenoxybiphenyl-4-yl)ethyl]propane-1,3-diol (<b>3i</b>)</h3><div class="NLM_p last">mp 149−150 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 364 [M + H]. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.73−1.78 (2H, m), 2.67−2.73 (2H, m), 3.53 (2H, d, <i>J</i> = 10.8 Hz), 3.63 (2H, d, <i>J</i> = 10.8 Hz), 7.04−7.12 (4H, m), 7.25−7.27 (4H, m), 7.32−7.38 (1H, m), 7.47−7.54 (4H, m). Anal. (C<sub>23</sub>H<sub>25</sub>NO<sub>3</sub>·0.3H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Amino-2-[2-(3-chloro-4′-phenoxybiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3j</b>)</h3><div class="NLM_p last">mp 211−212 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 398 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.80−1.86 (2H, m), 2.75−2.81 (2H, m), 3.58 (4H, d, <i>J</i> = 4.8 Hz), 5.41 (2H, t, <i>J</i> = 4.8 Hz), 7.08 (4H, d, <i>J</i> = 8.4 Hz), 7.18 (1H, t, <i>J</i> = 7.5 Hz), 7.40−7.45 (3H, m), 7.59−7.62 (1H, m), 7.69−7.72 (3H, m), 7.88 (3H, brs). Anal. (C<sub>23</sub>H<sub>24</sub>ClNO<sub>3</sub>·HCl) C, H, N.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-Amino-2-[2-(4′-benzyloxy-3-chlorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>3k</b>)</h3><div class="NLM_p last">mp 186−187 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 412 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.79−1.85 (2H, m), 2.73−2.79 (2H, m), 3.57 (4H, d, <i>J</i> = 4.8 Hz), 5.16 (2H, s), 5.40 (2H, t, <i>J</i> = 5.1 Hz), 7.10 (2H, d, <i>J</i> = 8.7 Hz), 7.38−7.48 (6H, m), 7.55−7.66 (4H, m), 7.85 (3H, brs). Anal. (C<sub>24</sub>H<sub>26</sub>ClNO<sub>3</sub>·HCl) C, H, N.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Amino-2-[2-(4′-benzyloxy-2′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol (<b>3l</b>)</h3><div class="NLM_p last">mp 166−167 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 396 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.30 (2H, s), 1.47−1.55 (2H, m), 2.59−2.65 (2H, m), 3.23−3.26 (4H, m), 4.48 (2H, brs), 5.17 (2H, s), 6.93−7.03 (2H, m), 7.26 (1H, d, <i>J</i> = 8.4 Hz), 7.36 (2H, d, <i>J</i> = 8.4 Hz), 7.39−7.49 (7H, m). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>3</sub>·1.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-Acetamido-2-[2-(2′-fluoro-4′-hydroxybiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>11</b>)</h3><div class="NLM_p last">A mixture of <b>10l</b> (0.86 g, 1.6 mmol) and ammonium formate (517 mg, 8.19 mmol) in MeOH (30 mL) was stirred under hydrogen atmosphere in the presence of 10% Pd/C (0.30 g) for 6 h. After removal of the catalyst by filtration, the filtrate was concentrated in vacuo, diluted with water, and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the title compound (0.56 g, 87%) as a white solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.04 (3H, s), 2.11 (6H, s), 2.29−2.34 (2H, m), 2.61−2.67 (2H, m), 4.38 (4H, s), 6.06 (1H, brs), 6.64−6.71 (2H, m), 7.10−7.27 (3H, m), 7.38 (2H, dd, <i>J</i> = 1.2, 8.1 Hz), 8.42 (1H, brs).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 2-Acetamido-2-[2-[2′-fluoro-4′-(trifluoromethanesulfonyloxy)biphenyl-4-yl]ethyl]propane-1,3-diol Diacetate (<b>12</b>)</h3><div class="NLM_p last">A solution of trifluoromethanesulfonic anhydride (0.30 mL, 1.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was added dropwise to a solution of <b>11</b> (507 mg, 1.17 mmol) and pyridine (0.58 mL, 11 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3.0 mL) at 0 °C. After stirring at room temperature for 2.5 h, the reaction was quenched with saturated NaHCO<sub>3</sub> and extracted with CHCl<sub>3</sub>. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the title compound (460 mg, 70%) as a pale-yellow solid. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.98 (3H, s), 2.01 (6H, s), 2.25−2.29 (2H, m), 2.65−2.69 (2H, m), 4.36 (4H, s), 5.68 (1H, brs), 7.11−7.18 (2H, m), 7.29 (2H, d, <i>J</i> = 8.0 Hz), 7.43 (2H, dd, <i>J</i> = 1.3, 8.3 Hz), 7.49 (1H, t, <i>J</i> = 8.2 Hz).</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 2-Amino-2-[2-(2′-fluoro-4′-pentylbiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>4</b>)</h3><div class="NLM_p last">To a mixture of <b>12</b> (150 mg, 0.266 mmol), bis(acetonitrile)dichloropalladium(II) (2.8 mg, 0.010 mmol), 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (X-Phos, 15.2 mg, 0.0318 mmol), and cesium carbonate (225 mg, 0.690 mmol) in CH<sub>3</sub>CN (1.0 mL) was added 1-pentyne (0.13 mL, 1.3 mmol). The mixture was stirred at 60 °C for 5 h, poured into water, and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was dissolved in MeOH (2.0 mL) and added to a solution of lithium hydroxide monohydrate (56 mg, 1.3 mmol) in water (2.0 mL). The mixture was refluxed for 3 h. After cooling to room temperature, the reaction mixture was poured into water and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Purification of the residue by silica gel chromatography (CHCl<sub>3</sub>/MeOH) gave 2-acetamido-2-[2-[2′-fluoro-4′-(1-pentynyl)biphenyl-4-yl]ethyl]propane-1,3-diol diacetate (67 mg, 70%) as a pale-yellow solid. A solution of the solid in MeOH (10 mL) was stirred under hydrogen atmosphere in the presence of 10% Pd/C (20 mg) for 4 h at room temperature. After removal of the catalyst by filtration, the filtrate was concentrated in vacuo. To a solution of the residue in EtOAc (2.0 mL) and MeOH (2.0 mL) was added 4 M HCl solution in EtOAc (1.0 mL). After the solution was concentrated in vacuo, the residue was collected by filtration to give the title compound (44 mg, 87%) as a white solid. mp 154−156 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 360 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 0.88 (3H, t, <i>J</i> = 6.8 Hz), 1.27−1.35 (4H, m), 1.56−1.64 (2H, m), 1.81−1.85 (2H, m), 2.51−2.67 (4H, m), 3.54 (4H, d, <i>J</i> = 5.0 Hz), 5.41 (2H, t, <i>J</i> = 4.9 Hz), 7.11−7.15 (2H, m), 7.30 (2H, d, <i>J</i> = 8.0 Hz), 7.40 (1H, t, <i>J</i> = 8.5 Hz), 7.46 (2H, d, <i>J</i> = 6.7 Hz), 7.84 (3H, brs). Anal. (C<sub>22</sub>H<sub>30</sub>FNO<sub>2</sub>·HCl·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 2-Amino-2-[2-[2′-fluoro-4′-(4-methylphenoxy)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>5</b>)</h3><div class="NLM_p last">A mixture of <b>11</b> (278 mg, 0.644 mmol), 4-methylphenylboronic acid (175 mg, 1.28 mmol), Cu(OAc)<sub>2</sub> (117 mg, 0.644 mmol), pyridine (255 mg, 2.84 mmol), and powdered molecular sieves 4 Å (500 mg) in CH<sub>2</sub>Cl<sub>2</sub> (5.0 mL) was stirred at room temperature for 9 h. The reaction mixture was poured into 2% aqueous solution of citric acid and extracted with CHCl<sub>3</sub>. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the protected title compound (260 mg, 77%) as a white solid. To a solution of the solid in MeOH (10 mL) was added 1 M aqueous LiOH (10 mL), and the mixture was refluxed for 2 h. The reaction mixture was concentrated in vacuo, and the resultant solid was collected by filtration. Purification of the solid by preparative HPLC gave the title compound (59 mg, 21%) as a white solid. mp 154−156 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 396 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.72−1.78 (2H, m), 2.36 (3H, s), 2.67−2.72 (2H, m), 3.54 (2H, d, <i>J</i> = 10.5 Hz), 3.63 (2H, d, <i>J</i> = 10.8 Hz), 6.72−6.83 (2H, m), 6.98 (2H, d, <i>J</i> = 8.7 Hz), 7.18 (2H, d, <i>J</i> = 8.4 Hz), 7.25−7.28 (2H, m), 7.34 (1H, t, <i>J</i> = 8.6 Hz), 7.44 (2H, dd, <i>J</i> = 1.5, 8.1 Hz). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>3</sub>) C, H, N.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-[5-[2-(4′-Bromo-2′-fluorobiphenyl-4-yl)ethyl]-2,2-dimethyl-1,3-dioxane-5-yl]acetamide (<b>13a</b>)</h3><div class="NLM_p last">A mixture of <b>9b</b> (7.13 g, 20.0 mmol), bis(neopentyl glycolato)diboron (4.97 g, 22.0 mmol), potassium acetate (5.89 g, 60.0 mmol), and dichlorobis(tricyclohexylphosphine)palladium(II) (738 mg, 1.00 mmol) in 1,4-dioxane (80 mL) was heated at 100 °C. After 6 h, the mixture was allowed to cool to room temperature and poured into water. The mixture was extracted with EtOAc and washed with brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was precipitated from water to give a brown solid. To a mixture of the solid, 1-bromo-3-fluoro-4-iodobenzene (5.95 g, 19.7 mmol) and NaHCO<sub>3</sub> (9.48 g, 112 mmol) in 1,2-dimethoxyethane (120 mL) and water (40 mL) was added tetrakis(triphenylphosphine)palladium(0) (434 mg, 0.375 mmol). After stirring at 100 °C for 8 h, 1-bromo-3-fluoro-4-iodobenzene (2.83 g, 9.4 mmol) and tetrakis(triphenylphosphine)palladium(0) (217 mg, 0.188 mmol) was added to the mixture. The mixture was stirred at 100 °C for another 8 h and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the title compound (5.28 g, 58%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.35 (6H, s), 1.87 (3H, s), 1.98−2.04 (2H, m), 2.47−2.53 (2H, m), 3.71 (2H, d, <i>J</i> = 11.8 Hz), 3.97 (2H, d, <i>J</i> = 11.6 Hz), 7.27 (2H, d, <i>J</i> = 8.1 Hz), 7.44−7.52 (4H, m), 7.61−7.66 (2H, m).</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-Acetamido-2-[2-(4′-bromo-3-chloro-2′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Diacetate (<b>13b</b>)</h3><div class="NLM_p last">The title compound was synthesized from <b>9c</b> using a similar procedure to that described for <b>13a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 2.01 (3H, s), 2.11 (6H, s), 2.18−2.24 (2H, m), 2.75−2.81 (2H, m), 4.39 (4H, s), 5.74 (1H, brs), 7.24−7.38 (5H, m), 7.50 (1H, s).</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 2-Amino-2-[2-(4′-benzylthio-2′-fluorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>6b</b>)</h3><div class="NLM_p">A mixture of <b>13a</b> (450 mg, 0.999 mmol), benzyl mercaptan (137 mg, 1.13 mmol), tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct (25.9 mg, 0.0250 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos, 29.8 mg, 0.0515 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (258 mg, 1.99 mmol) in 1,4-dioxane (5.0 mL) was refluxed for 7 h. After being poured into water, the mixture was extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the protected title compound. The compound was dissolved in MeOH (6.0 mL), and 35% HCl (3.0 mL) was added to the solution. The mixture was stirred at 70 °C for 3.5 h, concentrated in vacuo, and diluted with diisopropyl ether. The yielded solid was collected by filtration to give the title compound (362 mg, 94%) as a pale-yellow solid. mp 218−219 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 412 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.80−1.85 (2H, m), 2.63−2.68 (2H, m), 3.54 (4H, d, <i>J</i> = 4.5 Hz), 4.34 (2H, s), 5.40 (2H, t, <i>J</i> = 4.9 Hz), 7.22−7.35 (7H, m), 7.41−7.47 (5H, m), 7.83 (3H, brs). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>2</sub>S·HCl) C, H, N.</div><div class="NLM_p last">The compounds <b>6a</b>,<b>c</b>−<b>n</b> were synthesized using a similar procedure to that described for <b>6b</b>. Synthetic route for each compound is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>. Some compounds were isolated as free base before converting into hydrochloride salt.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 2-Amino-2-[2-(4′-benzylthio-3-chlorobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>6a</b>)</h3><div class="NLM_p last">mp 167−168 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 428 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.78−1.84 (2H, m), 2.74−2.79 (2H, m), 3.57 (4H, d, <i>J</i> = 4.8 Hz), 4.30 (2H, s), 5.42 (2H, t, <i>J</i> = 4.8 Hz), 7.24−7.43 (8H, m), 7.60−7.70 (4H, m), 7.87 (3H, brs). Anal. (C<sub>24</sub>H<sub>26</sub>ClNO<sub>2</sub>S·HCl·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 2-Amino-2-[2-(2′-fluoro-4′-phenylthiobiphenyl-4-yl)ethyl]propane-1,3-diol Hydrochloride (<b>6c</b>)</h3><div class="NLM_p last">mp 154−155 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 398 [M + H]. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.79−1.85 (2H, m), 2.63−2.69 (2H, m), 3.54 (4H, d, <i>J</i> = 4.5 Hz), 5.41 (2H, t, <i>J</i> = 5.0 Hz), 7.13−7.17 (2H, m), 7.32 (2H, d, <i>J</i> = 8.4 Hz), 7.44−7.53 (8H, m), 7.83 (3H, brs). Anal. (C<sub>23</sub>H<sub>24</sub>FNO<sub>2</sub>S·HCl) C, H, N.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-Amino-2-[2-[2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6d</b>)</h3><div class="NLM_p last">The title compound was obtained by purification using preparative HPLC. mp 135−136 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 412 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.30 (2H, brs), 1.49−1.54 (2H, m), 2.35 (3H, s), 2.60−2.65 (2H, m), 3.19−3.29 (4H, m), 4.47 (2H, brs), 7.04 (2H, d, <i>J</i> = 9.9 Hz), 7.29 (4H, m), 7.39−7.48 (5H, m). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>2</sub>S) C, H, N.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-Amino-2-[2-[2′-fluoro-4′-(3-methylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol Hydrochloride (<b>6e</b>)</h3><div class="NLM_p last">mp 148−150 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 412 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.79−1.85 (2H, m), 2.35 (3H, s), 2.63−2.68 (2H, m), 3.53−3.54 (4H, m), 5.39 (2H, t, <i>J</i> = 4.7 Hz), 7.10−7.14 (2H, m), 7.23−7.49 (9H, m), 7.81 (3H, brs). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>2</sub>S·HCl·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-Amino-2-[2-[3-chloro-2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6f</b>)</h3><div class="NLM_p last">mp 98−100 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 446 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.29 (2H, brs), 1.47−1.53 (2H, m), 2.35 (3H, s), 2.72−2.77 (2H, m), 3.21−3.30 (4H, m), 4.49 (2H, t, <i>J</i> = 4.7 Hz), 7.01−7.06 (2H, m), 7.30 (2H, d, <i>J</i> = 8.0 Hz), 7.38−7.52 (6H, m). Anal. (C<sub>24</sub>H<sub>25</sub>ClFNO<sub>2</sub>S·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-Amino-2-[2-[4′-(4-ethylphenylthio)-2′-fluorobiphenyl-4-yl]ethyl]propane-1,3-diol (<b>6g</b>)</h3><div class="NLM_p last">mp 115−117 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 426 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.20 (3H, t, <i>J</i> = 7.5 Hz), 1.29 (2H, brs), 1.49−1.54 (2H, m), 2.60−2.68 (4H, m), 3.21−3.29 (4H, m), 4.46 (2H, t, <i>J</i> = 5.1 Hz), 7.05−7.08 (2H, m), 7.09−7.34 (4H, m), 7.40−7.49 (5H, m). Anal. (C<sub>25</sub>H<sub>28</sub>FNO<sub>2</sub>S·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-Amino-2-[2-[2′-fluoro-4′-(4-isopropylphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol Hydrochloride (<b>6h</b>)</h3><div class="NLM_p last">mp 245−246 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 440 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.20 (6H, d, <i>J</i> = 6.9 Hz), 1.77−1.83 (2H, m), 2.61−2.66 (2H, m), 2.91 (1H, sept, <i>J</i> = 6.9 Hz), 3.52 (4H, d, <i>J</i> = 4.6 Hz), 5.39 (2H, t, <i>J</i> = 4.6 Hz), 7.05−7.09 (2H, m), 7.28−7.35 (4H, m), 7.41−7.46 (5H, m), 7.83 (3H, brs). Anal. (C<sub>26</sub>H<sub>30</sub>FNO<sub>2</sub>S·HCl) C, H, N.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 2-Amino-2-[2-[2′-fluoro-4′-(4-fluorophenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6i</b>)</h3><div class="NLM_p last">mp 137−139 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 416 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.29 (2H, brs), 1.49−1.55 (2H, m), 2.60−2.66 (2H, m), 3.19−3.29 (4H, m), 4.46 (2H, t, <i>J</i> = 5.2 Hz), 7.07−7.26 (2H, m), 7.29−7.60 (9H, m). Anal. (C<sub>23</sub>H<sub>23</sub>F<sub>2</sub>NO<sub>2</sub>S) C, H, N.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 2-Amino-2-[2-[2′-fluoro-4′-(3-fluorophenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6j</b>)</h3><div class="NLM_p last">mp 137−139 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 416 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.30 (2H, brs), 1.50−1.56 (2H, m), 2.61−2.67 (2H, m), 3.19−3.30 (4H, m), 4.47 (2H, t, <i>J</i> = 5.4 Hz), 7.23−7.33 (7H, m), 7.44−7.55 (4H, m). Anal. (C<sub>23</sub>H<sub>23</sub>F<sub>2</sub>NO<sub>2</sub>S·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 2-Amino-2-[2-[4′-(4-chlorophenylthio)-2′-fluorobiphenyl-4-yl]ethyl]propane-1,3-diol (<b>6k</b>)</h3><div class="NLM_p last">mp 135−136 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 432 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.31 (2H, brs), 1.50−1.55 (2H, m), 2.61−2.66 (2H, m), 3.20−3.28 (4H, m), 4.46 (2H, brs), 7.16−7.30 (4H, m), 7.43−7.55 (7H, m). Anal. (C<sub>23</sub>H<sub>23</sub>ClFNO<sub>2</sub>S·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 2-Amino-2-[2-[2′-fluoro-4′-[4-(trifluoromethyl)phenylthio]biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6l</b>)</h3><div class="NLM_p last">mp 128−130 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 466 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.32 (2H, brs), 1.51−1.56 (2H, m), 2.62−2.68 (2H, m), 3.22−3.29 (4H, m), 4.48 (2H, t, <i>J</i> = 5.2 Hz), 7.30−7.38 (3H, m), 7.44−7.52 (5H, m), 7.61 (1H, t, <i>J</i> = 8.2 Hz), 7.74 (2H, d, <i>J</i> = 8.4 Hz). Anal. (C<sub>24</sub>H<sub>23</sub>F<sub>4</sub>NO<sub>2</sub>S·0.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 2-Amino-2-[2-[2′-fluoro-4′-(4-methoxyphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol Hydrochloride (<b>6m</b>)</h3><div class="NLM_p last">mp 246−247 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 428 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.75−1.81 (2H, m), 2.59−2.65 (2H, m), 3.50 (4H, d, <i>J</i> = 4.3 Hz), 3.80 (3H, s), 5.36 (2H, brs), 6.92−6.96 (2H, m), 7.05 (2H, d, <i>J</i> = 6.6 Hz), 7.28 (2H, d, <i>J</i> = 8.2 Hz), 7.41−7.43 (3H, m), 7.50 (2H, d, <i>J</i> = 8.8 Hz), 7.69 (3H, brs). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>3</sub>S·HCl·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 2-Amino-2-[2-[2′-fluoro-4′-(3-methoxyphenylthio)biphenyl-4-yl]ethyl]propane-1,3-diol (<b>6n</b>)</h3><div class="NLM_p last">mp 108−110 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 428 [M + H]. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.55−1.61 (2H, m), 2.61−2.66 (2H, m), 3.26−3.33 (4H, m), 3.76 (3H, s), 4.64 (2H, brs), 6.92−7.08 (3H, m), 7.15−7.58 (8H, m). Anal. (C<sub>24</sub>H<sub>26</sub>FNO<sub>3</sub>S·1.5H<sub>2</sub>O) C, N. H: calcd, 6.43; found, 6.00.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 4-(Di-<i>tert-</i>butylphosphoryloxymethyl)-4-[2-(3-chloro-4′-pentylbiphenyl-4-yl)ethyl]-2-methyl-2-oxazoline (<b>14a</b>)</h3><div class="NLM_p">A solution of <b>3a</b> (180 mg, 0.436 mmol), <i>N</i>,<i>N</i>-diisopropylethylamine (0.16 mL, 0.89 mmol), and triethyl orthoacetate (0.095 mL, 0.52 mmol) in DMF (2.0 mL) was heated at 120 °C for 5 h. The reaction mixture was poured into water and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. To a solution of the residue in CH<sub>2</sub>Cl<sub>2</sub> (4.4 mL) were added 1<i>H</i>-tetrazole (61 mg, 0.87 mmol) and di-<i>tert-</i>butyl <i>N</i>,<i>N</i>-diisopropylphosphoramidite (0.28 mL, 0.88 mmol) at 0 °C. After stirring at room temperature for 2 h, <i>m</i>-CPBA (65%, 201 mg, 0.75 mmol) was added to the mixture at 0 °C. The mixture was stirred at room temperature for 1 h, poured into saturated NaHCO<sub>3</sub>, and extracted with CHCl<sub>3</sub>. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the title compound (159 mg, 62%) as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.90 (3H, t, <i>J</i> = 6.6 Hz), 1.23−1.45 (4H, m), 1.48 (18H, s), 1.56−1.72 (2H, m), 1.78−1.98 (2H, m), 2.03 (3H, s), 2.63 (2H, t, <i>J</i> = 7.5 Hz), 2.66−2.88 (2H, m), 3.85−4.02 (2H, m), 4.12 (1H, d, <i>J</i> = 9.0 Hz), 4.38 (1H, d, <i>J</i> = 8.7 Hz), 7.23−7.28 (3H, m), 7.38−7.47 (3H, m), 7.55 (1H, d, <i>J</i> = 1.8 Hz).</div><div class="NLM_p last">The compounds <b>14b</b>−<b>n</b> were synthesized using a similar procedure to that described for <b>14a</b>. Synthetic route for each compound is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 4-[2-(4′-Butoxybiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14b</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.98 (3H, t, <i>J</i> = 7.2 Hz), 1.49 (18H, s), 1.50−1.56 (2H, m), 1.75−2.04 (4H, m), 2.02 (3H, s), 2.65−2.70 (2H, m), 3.88−3.91 (1H, m), 3.95−4.02 (4H, m), 4.35 (1H, d, <i>J</i> = 8.7 Hz), 6.95 (2H, d, <i>J</i> = 8.7 Hz), 7.23 (2H, d, <i>J</i> = 8.2 Hz), 7.46 (2H, d, <i>J</i> = 8.1 Hz), 7.48 (2H, d, <i>J</i> = 8.7 Hz).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 4-[2-(4′-Butoxy-3-chlorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14c</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.2 Hz), 1.36−1.58 (2H, m), 1.50 (18H, s), 1.68−1.97 (4H, m), 2.03 (3H, s), 2.65−2.90 (2H, m), 3.86−4.02 (2H, m), 4.00 (2H, t, <i>J</i> = 6.6 Hz), 4.12 (1H, d, <i>J</i> = 8.7 Hz), 4.38 (1H, d, <i>J</i> = 8.7 Hz), 6.95 (2H, d, <i>J</i> = 8.7 Hz), 7.25 (1H, d, <i>J</i> = 6.9 Hz), 7.36 (1H, dd, <i>J</i> = 1.5, 7.8 Hz), 7.45−7.52 (3H, m).</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 4-[2-(4′-Butoxy-2′-fluorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14d</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.4 Hz), 1.48 (18H, d, <i>J</i> = 3.2 Hz), 1.51−1.55 (2H, m), 1.75−1.82 (2H, m), 1.85−1.89 (1H, m), 1.97−2.02 (1H, m), 2.02 (3H, s), 2.66−2.71 (2H, m), 3.88−3.92 (1H, m), 3.96−4.03 (4H, m), 4.36 (1H, d, <i>J</i> = 8.8 Hz), 6.67−6.71 (1H, m), 6.73−6.76 (1H, m), 7.24 (2H, d, <i>J</i> = 8.0 Hz), 7.31 (1H, t, <i>J</i> = 8.8 Hz), 7.41−7.43 (2H, m).</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 4-[2-(4′-Butoxy-2′,5′-difluorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14f</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.99 (3H, t, <i>J</i> = 7.4 Hz), 1.48 (18H, d, <i>J</i> = 3.3 Hz), 1.51−1.55 (2H, m), 1.79−1.88 (3H, m), 1.96−2.02 (1H, m), 2.01 (3H, s), 2.67−2.71 (2H, m), 3.89 (1H, dd, <i>J</i> = 4.6, 9.8 Hz), 3.98 (1H, dd, <i>J</i> = 5.2, 10.0 Hz), 4.02−4.13 (3H, m), 4.35 (1H, d, <i>J</i> = 8.9 Hz), 6.75 (1H, dd, <i>J</i> = 7.1, 11.7 Hz), 7.14 (1H, dd, <i>J</i> = 7.3, 11.7 Hz), 7.23−7.26 (2H, m), 7.41 (2H, d, <i>J</i> = 7.8 Hz).</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 4-[2-(4′-Butoxy-3′-fluorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14g</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.00 (3H, t, <i>J</i> = 7.2 Hz), 1.48 (18H, d, <i>J</i> = 3.2 Hz), 1.51−1.57 (2H, m), 1.79−1.88 (3H, m), 1.96−2.03 (1H, m), 2.02 (3H, s), 2.66−2.70 (2H, m), 3.89 (1H, dd, <i>J</i> = 4.8, 10.0 Hz), 3.98 (1H, dd, <i>J</i> = 5.2, 10.0 Hz), 4.01 (1H, d, <i>J</i> = 8.8 Hz), 4.07 (2H, t, <i>J</i> = 6.4 Hz), 4.35 (1H, d, <i>J</i> = 8.8 Hz), 7.00 (1H, t, <i>J</i> = 8.4 Hz), 7.22−7.32 (4H, m), 7.41−7.43 (2H, d, <i>J</i> = 8.4 Hz).</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 4-[2-(4′-Butoxy-3′-chlorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14h</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.00 (3H, t, <i>J</i> = 7.2 Hz), 1.48 (18H, d, <i>J</i> = 3.6 Hz), 1.48−1.56 (2H, m), 1.81−1.88 (3H, m), 1.95−2.04 (1H, m), 2.03 (3H, s), 2.66−2.70 (2H, m), 3.89 (1H, dd, <i>J</i> = 4.8, 10.0 Hz), 3.97 (1H, dd, <i>J</i> = 5.2, 10.0 Hz), 4.01 (1H, d, <i>J</i> = 8.8 Hz), 4.07 (2H, t, <i>J</i> = 6.4 Hz), 4.35 (1H, d, <i>J</i> = 8.8 Hz), 6.96 (1H, d, <i>J</i> = 8.8 Hz), 7.23 (2H, d, <i>J</i> = 8.0 Hz), 7.39 (1H, dd, <i>J</i> = 2.4, 8.4 Hz), 7.43 (2H, d, <i>J</i> = 8.0 Hz), 7.58 (1H, d, <i>J</i> = 2.0 Hz).</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 4-(Di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-4-[2-(4′-phenoxybiphenyl-4-yl)ethyl]-2-oxazoline (<b>14i</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 1.40 (18H, d, <i>J</i> = 2.2 Hz), 1.72−1.86 (2H, m), 1.92 (3H, s), 2.50−2.56 (1H, m), 2.60−2.68 (1H, m), 3.77−3.84 (2H, m), 4.07 (1H, d, <i>J</i> = 8.8 Hz), 4.14 (1H, d, <i>J</i> = 8.8 Hz), 7.05−7.08 (4H, m), 7.16 (1H, t, <i>J</i> = 7.2 Hz), 7.29 (2H, d, <i>J</i> = 8.2 Hz), 7.39−7.44 (2H, m), 7.55 (2H, d, <i>J</i> = 8.1 Hz), 7.64−7.68 (2H, m).</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 4-(Di-<i>tert-</i>butylphosphoryloxymethyl)-4-[2-(3-chloro-4′-phenoxybiphenyl-4-yl)ethyl]-2-methyl-2-oxazoline (<b>14j</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49 (18H, s), 1.80−2.02 (2H, m), 2.04 (3H, s), 2.68−2.92 (2H, m), 3.86−4.02 (2H, m), 4.13 (1H, d, <i>J</i> = 8.6 Hz), 4.39 (1H, d, <i>J</i> = 8.8 Hz), 7.04−7.13 (5H, m), 7.28 (1H, d, <i>J</i> = 8.0 Hz), 7.33−7.39 (3H, m), 7.49−7.54 (3H, m).</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 4-[2-(4′-Benzyloxy-3-chlorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14k</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49 (18H, s), 1.78−2.00 (2H, m), 2.03 (3H, s), 2.64−2.90 (2H, m), 3.86−4.00 (2H, m), 4.12 (1H, d, <i>J</i> = 8.9 Hz), 4.38 (1H, d, <i>J</i> = 8.9 Hz), 5.11 (2H, s), 7.04 (2H, d, <i>J</i> = 8.5 Hz), 7.25−7.52 (10H, m).</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 4-[2-(4′-Benzyloxy-2′-fluorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>14l</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49 (18H, s), 1.76−1.94 (2H, m), 2.02 (3H, s), 2.61−2.72 (2H, m), 3.87−4.03 (3H, m), 4.33−4.37 (1H, m), 5.09 (2H, s), 6.76−6.84 (2H, m), 7.23−7.46 (10H, m).</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 4-(Di-<i>tert-</i>butylphosphoryloxymethyl)-4-[2-(2′-fluoro-4′-pentylbiphenyl-4-yl)ethyl]-2-methyl-2-oxazoline (<b>14m</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 0.91 (3H, t, <i>J</i> = 6.9 Hz), 1.33−1.38 (4H, m), 1.48 (18H, s), 1.61−1.68 (2H, m), 1.82−1.89 (1H, m), 1.97−2.05 (1H, m), 2.02 (3H, s), 2.62 (2H, t, <i>J</i> = 7.9 Hz), 2.69 (2H, t, <i>J</i> = 8.6 Hz), 3.89 (1H, dd, <i>J</i> = 4.7, 10.0 Hz), 3.97 (1H, dd, <i>J</i> = 4.9, 10.1 Hz), 4.01 (1H, d, <i>J</i> = 8.8 Hz), 4.36 (1H, d, <i>J</i> = 8.8 Hz), 6.94−7.01 (2H, m), 7.24−7.26 (2H, m), 7.31 (1H, t, <i>J</i> = 8.0 Hz), 7.45 (2H, dd, <i>J</i> = 1.3, 8.3 Hz).</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 4-(Di-<i>tert-</i>butylphosphoryloxymethyl)-4-[2-[2′-fluoro-4′-(4-methylphenoxy)biphenyl-4-yl]ethyl]-2-methyl-2-oxazoline (<b>14n</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49 (18H, s), 1.80−2.10 (2H, m), 2.02 (3H, s), 2.36 (3H, s), 2.69 (2H, t, <i>J</i> = 8.6 Hz), 3.90 (1H, dd, <i>J</i> = 4.5, 9.9 Hz), 3.98 (1H, dd, <i>J</i> = 4.8, 9.9 Hz), 4.02 (1H, d, <i>J</i> = 8.4 Hz), 4.36 (1H, d, <i>J</i> = 8.7 Hz), 6.72−6.82 (2H, m), 6.96−6.99 (2H, m), 7.17−7.44 (7H, m).</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 2-Amino-4-(3-chloro-4′-pentylbiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3a</b>-<b>P</b>)</h3><div class="NLM_p">A solution of <b>14a</b> (159 mg, 0.268 mmol) in EtOH (2.5 mL) and 35% HCl (0.50 mL) was heated at 50 °C for 3 h. After addition of water (20 mL), the yielded solid was collected and washed with water to afford the title compound (79 mg, 64%) as a white solid. mp 229−238 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 456 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 0.93 (3H, t, <i>J</i> = 6.6 Hz), 1.29−1.48 (4H, m), 1.60−1.74 (2H, m), 1.95−2.08 (2H, m), 2.66 (2H, t, <i>J</i> = 7.5 Hz), 2.84−2.94 (2H, m), 3.72−3.85 (2H, m), 3.98−4.14 (2H, m), 7.27 (2H, d, <i>J</i> = 8.1 Hz), 7.43 (1H, d, <i>J</i> = 8.1 Hz), 7.50−7.53 (3H, m), 7.62 (1H, d, <i>J</i> = 1.5 Hz). Anal. (C<sub>22</sub>H<sub>31</sub>ClNO<sub>5</sub>P) C, H, N.</div><div class="NLM_p last">The compounds <b>3</b>(<b>b</b>−<b>l</b>)-<b>P</b>, <b>4</b>-<b>P</b>, and <b>5</b>-<b>P</b> were synthesized using a similar procedure to that described for <b>3a</b>-<b>P</b>. Synthetic route for each compound is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 2-Amino-4-(4′-butoxybiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3b</b>-<b>P</b>)</h3><div class="NLM_p last">mp 222−225 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 424 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.00 (3H, t, <i>J</i> = 7.2 Hz), 1.50−1.55 (2H, m), 1.75−1.79 (2H, m), 1.97−2.02 (2H, m), 2.69−2.75 (2H, m), 3.72 (2H, brs), 4.00 (4H, t, <i>J</i> = 6.1 Hz), 6.96 (2H, d, <i>J</i> = 8.4 Hz), 7.29 (2H, d, <i>J</i> = 7.6 Hz), 7.48−7.51 (4H, m). Anal. (C<sub>21</sub>H<sub>30</sub>NO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 2-Amino-4-(4′-butoxy-3-chlorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3c</b>-<b>P</b>)</h3><div class="NLM_p last">mp 219 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 458 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.02 (3H, t, <i>J</i> = 7.3 Hz), 1.46−1.60 (2H, m), 1.74−1.85 (2H, m), 1.99−2.05 (2H, m), 2.85−2.90 (2H, m), 3.72−3.85 (2H, m), 3.98−4.14 (4H, m), 7.00 (2H, d, <i>J</i> = 8.6 Hz), 7.40 (1H, d, <i>J</i> = 7.9 Hz), 7.46−7.54 (3H, m), 7.59 (1H, d, <i>J</i> = 1.6 Hz). Anal. (C<sub>21</sub>H<sub>29</sub>ClNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> 2-Amino-4-(4′-butoxy-2′-fluorobiphenyl-4-yl)-2-(phosphoryloxymethy)butanol (<b>3d</b>-<b>P</b>)</h3><div class="NLM_p last">mp 220−223 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 442 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.00 (3H, t, <i>J</i> = 7.2 Hz), 1.49−1.55 (2H, m), 1.74−1.81 (2H, m), 1.99−2.04 (2H, m), 2.70−2.76 (2H, m), 3.69−3.76 (2H, m), 3.97−4.06 (4H, m), 6.72−6.75 (1H, m), 6.78−6.81 (1H, m), 7.29−7.36 (3H, m), 7.41 (2H, d, <i>J</i> = 8.4 Hz). Anal. (C<sub>21</sub>H<sub>29</sub>FNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> 2-Amino-4-(4′-butoxy-2′,5′-difluorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3f</b>-<b>P</b>)</h3><div class="NLM_p last">mp 228−231 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 460 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.00 (3H, t, <i>J</i> = 7.5 Hz), 1.49−1.58 (2H, m), 1.77−1.84 (2H, m), 1.99−2.04 (2H, m), 2.70−2.77 (2H, m), 3.72 (2H, d, <i>J</i> = 2.2 Hz), 3.98−4.04 (2H, m), 4.08 (2H, t, <i>J</i> = 6.4 Hz), 6.96 (1H, dd, <i>J</i> = 7.2, 12.0 Hz), 7.19 (1H, dd, <i>J</i> = 7.6, 11.8 Hz), 7.32 (2H, d, <i>J</i> = 8.2 Hz), 7.43 (2H, d, <i>J</i> = 8.3 Hz). Anal. (C<sub>21</sub>H<sub>28</sub>F<sub>2</sub>NO<sub>6</sub>P·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 2-Amino-4-(4′-butoxy-3′-fluorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3g</b>-<b>P</b>)</h3><div class="NLM_p last">mp 224−227 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 442 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.00 (3H, t, <i>J</i> = 7.2 Hz), 1.49−1.58 (2H, m), 1.76−1.83 (2H, m), 1.99−2.04 (2H, m), 2.69−2.76 (2H, m), 3.69−3.76 (2H, m), 3.97−4.04 (2H, m), 4.08 (2H, t, <i>J</i> = 6.4 Hz), 7.10−7.14 (1H, m), 7.30−7.35 (4H, m), 7.50 (2H, d, <i>J</i> = 8.0 Hz). Anal. (C<sub>21</sub>H<sub>29</sub>FNO<sub>6</sub>P·0.1H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 2-Amino-4-(4′-butoxy-3′-chlorobiphenyl-4-yl)-2-(phosphoryloxymethylbutanol (<b>3h</b>-<b>P</b>)</h3><div class="NLM_p last">mp 221−224 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 458 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.01 (3H, t, <i>J</i> = 7.5 Hz), 1.54−1.59 (2H, m), 1.78−1.83 (2H, m), 1.98−2.02 (2H, m), 2.69−2.73 (2H, m), 3.72 (2H, d, <i>J</i> = 2.3 Hz), 3.99−4.04 (2H, m), 4.09 (2H, t, <i>J</i> = 6.3 Hz), 7.10 (1H, d, <i>J</i> = 8.6 Hz), 7.31 (2H, d, <i>J</i> = 8.0 Hz), 7.46−7.50 (3H, m), 7.59 (1H, d, <i>J</i> = 2.2 Hz). Anal. (C<sub>21</sub>H<sub>29</sub>ClNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 2-Amino-4-(4′-phenoxybiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3i</b>-<b>P</b>)</h3><div class="NLM_p last">mp 207−209 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 444 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.98−2.04 (2H, m), 2.70−2.76 (2H, m), 3.73 (2H, d, <i>J</i> = 1.1 Hz), 3.98−4.07 (2H, m), 7.01−7.05 (4H, m), 7.12 (1H, t, <i>J</i> = 7.7 Hz), 7.32 (2H, d, <i>J</i> = 8.0 Hz), 7.36 (2H, t, <i>J</i> = 8.3 Hz), 7.53 (2H, d, <i>J</i> = 8.0 Hz), 7.58 (2H, d, <i>J</i> = 8.6 Hz). Anal. (C<sub>23</sub>H<sub>26</sub>NO<sub>6</sub>P·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 2-Amino-4-(3-chloro-4′-phenoxybiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3j</b>-<b>P</b>)</h3><div class="NLM_p last">mp 218 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 478 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 2.00−2.05 (2H, m), 2.86−2.92 (2H, m), 3.72−3.85 (2H, m), 3.98−4.14 (2H, m), 7.03−7.08 (5H, m), 7.36−7.51 (3H, m), 7.60−7.64 (4H, m). Anal. (C<sub>23</sub>H<sub>25</sub>ClNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 2-Amino-4-(4′-benzyloxy-3-chlorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3k</b>-<b>P</b>)</h3><div class="NLM_p last">mp 241 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 492 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 2.00−2.04 (2H, m), 2.85−2.90 (2H, m), 3.72−3.85 (2H, m), 3.98−4.14 (2H, m), 5.15 (2H, s), 7.09 (2H, d, <i>J</i> = 8.4 Hz), 7.32−7.60 (10H, m). Anal. (C<sub>24</sub>H<sub>27</sub>ClNO<sub>6</sub>P·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 2-Amino-4-(4′-benzyloxy-2′-fluorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>3l</b>-<b>P</b>)</h3><div class="NLM_p last">mp 241−243 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 476 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 2.02−2.05 (2H, m), 2.72−2.77 (2H, m), 3.71−3.73 (2H, m), 4.07−4.09 (2H, m), 5.12 (2H, s), 6.82−6.90 (2H, m), 7.29−7.46 (10H, m). Anal. (C<sub>24</sub>H<sub>27</sub>FNO<sub>6</sub>P·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 2-Amino-4-(2′-fluoro-4′-pentylbiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>4</b>-<b>P</b>)</h3><div class="NLM_p last">mp 225−228 °C (dec); MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 440 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 0.92 (3H, t, <i>J</i> = 6.8 Hz), 1.33−1.37 (4H, m), 1.61−1.67 (2H, m), 1.98−2.04 (2H, m), 2.62−2.66 (2H, m), 2.70−2.76 (2H, m), 3.72 (2H, d, <i>J</i> = 2.4 Hz), 3.97−4.04 (2H, m), 6.98 (1H, d, <i>J</i> = 11.1 Hz), 7.05 (1H, d, <i>J</i> = 8.0 Hz), 7.31−7.36 (3H, m), 7.45 (2H, d, <i>J</i> = 7.9 Hz). Anal. (C<sub>22</sub>H<sub>31</sub>FNO<sub>5</sub>P) C, H, N.</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> 2-Amino-4-[2′-fluoro-4′-(4-methylphenoxy)biphenyl-4-yl]-2-(phosphoryloxymethyl)butanol (<b>5</b>-<b>P</b>)</h3><div class="NLM_p last">mp 218−220 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 476 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.96−2.08 (2H, m), 2.35 (3H, s), 2.64−2.80 (2H, m), 3.72 (2H, s), 3.95−4.08 (2H, m), 6.71−6.83 (2H, m), 6.96 (2H, d, <i>J</i> = 8.4 Hz), 7.22 (2H, d, <i>J</i> = 8.4 Hz), 7.31−7.45 (5H, m). Anal. (C<sub>24</sub>H<sub>27</sub>FNO<sub>6</sub>P) C, H, N.</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> 4-[2-(4′-Bromo-2′-fluorobiphenyl-4-yl)ethyl]-4-(di-<i>tert</i>-butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>15a</b>)</h3><div class="NLM_p last">To a solution of <b>13a</b> (2.50 g, 5.55 mmol) in EtOH (50 mL) was added 35% HCl (25 mL). After stirring at 80 °C for 4 h, the reaction was concentrated in vacuo and neutralized with 1 M aqueous NaOH. The yielded precipitate was collected by filtration to give the deprotected compound (1.36 g, 86%). A solution of the compound, <i>N</i>,<i>N</i>-diisopropylethylamine (0.57 g, 4.4 mmol), and triethyl orthoacetate (0.72 g, 4.4 mmol) in DMF (5.0 mL) was heated at 120 °C for 3 h. The reaction mixture was poured into water and extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. To the solution of the residue in CH<sub>2</sub>Cl<sub>2</sub> (37 mL) was added 1<i>H</i>-tetrazole (389 mg, 5.55 mmol) and di-<i>tert</i>-butyl <i>N,N</i>-diisopropylphosphoramidite (1.54 g, 5.55 mmol) at 0 °C. After stirring at room temperature for 2 h, a solution of <i>tert</i>-butyl hydroperoxide in decane (5−6 M, 2.22 mL) was added to the solution at 0 °C. The mixture was stirred for 10 min, poured into saturated NaHCO<sub>3</sub>, and extracted with CHCl<sub>3</sub>. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the title compound (0.98 g, 30%) as a colorless oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49 (18H, s), 1.87−2.02 (2H, m), 2.04 (3H, s), 2.70 (2H, t, <i>J</i> = 8.6 Hz), 3.86−4.01 (3H, m), 4.36 (1H, d, <i>J</i> = 8.9 Hz), 7.26−7.44 (7H, m).</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> 4-[2-(4′-Bromo-3-chloro-2′-fluorobiphenyl-4-yl)ethyl]-4-(di-<i>tert-</i>butylphosphoryloxymethyl)-2-methyl-2-oxazoline (<b>15b</b>)</h3><div class="NLM_p last">The title compound was synthesized from <b>13b</b> using a similar procedure to that described for <b>15a</b>. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 1.49 (18H, s), 1.85−1.95 (2H, m), 2.03 (3H, s), 2.73−2.85 (2H, m), 3.92 (1H, dd, <i>J</i> = 4.8, 9.9 Hz), 3.99 (1H, dd, <i>J</i> = 4.8, 9.9 Hz), 4.11 (1H, d, <i>J</i> = 9.0 Hz), 4.38 (1H, d, <i>J</i> = 8.7 Hz), 7.24−7.37 (5H, m), 7.49 (1H, s).</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> 2-Amino-4-(4′-benzylthio-2′-fluorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>6b</b>-<b>P</b>)</h3><div class="NLM_p">A mixture of <b>15a</b> (280 mg, 0.479 mmol), benzyl mercaptan (66 mg, 0.53 mmol), tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct (12.4 mg, 0.0119 mmol), 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (Xantphos, 14.3 mg, 0.0247 mmol), and <i>N</i>,<i>N</i>-diisopropylethylamine (124 mg, 0.959 mmol) in 1,4-dioxane (2.0 mL) was refluxed for 5 h. After being poured into water, the mixture was extracted with EtOAc. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification of the residue by silica gel chromatography (hexane/EtOAc) gave the protected title compound. To a solution of the compound in EtOH (5.0 mL) was added 35% HCl (1.0 mL). The mixture was stirred at 50 °C for 4 h and diluted with water. The yielded solid was collected by filtration to give the title compound (74 mg, 31%) as a white solid. mMp 167−170 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 492 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.99−2.06 (2H, m), 2.70−2.80 (2H, m), 3.73 (2H, s), 4.09 (2H, d, <i>J</i> = 5.1 Hz), 4.22 (2H, s), 7.10−7.37 (10H, m), 7.43−7.46 (2H, m). Anal. (C<sub>24</sub>H<sub>27</sub>FNO<sub>5</sub>PS·1.5H<sub>2</sub>O) C, H, N.</div><div class="NLM_p last">The compounds <b>6</b>(<b>a</b>,<b>c</b>−<b>f</b>)-<b>P</b> were synthesized using a similar procedure to that described for <b>6b</b>-<b>P</b>. Synthetic route for each compound is summarized in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> 2-Amino-4-(4′-benzylthio-3-chlorobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>6a</b>-<b>P</b>)</h3><div class="NLM_p last">mp 236−238 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 508 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.98−2.02 (2H, m), 2.84−2.88 (2H, m), 3.72−3.80 (2H, m), 4.00−4.09 (2H, m), 4.19 (2H, s), 7.19−7.29 (3H, m), 7.33 (2H, d, <i>J</i> = 7.4 Hz), 7.38 (2H, d, <i>J</i> = 8.2 Hz), 7.42 (1H, d, <i>J</i> = 7.9 Hz), 7.48−7.52 (3H, m), 7.61 (1H, d, <i>J</i> = 1.5 Hz). Anal. (C<sub>24</sub>H<sub>27</sub>ClNO<sub>5</sub>PS·1.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> 2-Amino-4-(2′-fluoro-4′-phenylthiobiphenyl-4-yl)-2-(phosphoryloxymethyl)butanol (<b>6c</b>-<b>P</b>)</h3><div class="NLM_p last">mp 208−212 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 478 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.94−2.05 (2H, m), 2.68−2.80 (2H, m), 3.73 (2H, s), 3.93−4.08 (2H, m), 7.03−7.06 (1H, m), 7.13 (1H, d, <i>J</i> = 8.4 Hz), 7.34−7.49 (10H, m). Anal. (C<sub>23</sub>H<sub>25</sub>FNO<sub>5</sub>PS·0.25H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> 2-Amino-4-[2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]-2-(phosphoryloxymethyl)butanol (<b>6d</b>-<b>P</b>)</h3><div class="NLM_p last">mp 236−238 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 492 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.98−2.08 (2H, m), 2.38 (3H, s), 2.68−2.82 (2H, m), 3.72 (2H, s), 3.94−4.10 (2H, m), 6.91 (1H, d, <i>J</i> = 11.4 Hz), 7.05 (1H, d, <i>J</i> = 8.1 Hz), 7.24−7.45 (9H, m). Anal. (C<sub>24</sub>H<sub>27</sub>FNO<sub>5</sub>PS) C, H, N.</div></div><div id="sec5_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> 2-Amino-4-[2′-fluoro-4′-(3-methylphenylthio)biphenyl-4-yl]-2-(phosphoryloxymethyl)butanol (<b>6e</b>-<b>P</b>)</h3><div class="NLM_p last">mp 212−213 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 492 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.97−2.05 (2H, m), 2.34 (3H, s), 2.68−2.82 (2H, m), 3.72 (2H, s), 3.92−4.10 (2H, m), 6.97 (1H, d, <i>J</i> = 11.4 Hz), 7.09 (1H, d, <i>J</i> = 9.9 Hz), 7.18−7.47 (9H, m). Anal. (C<sub>24</sub>H<sub>27</sub>FNO<sub>5</sub>PS·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> 2-Amino-4-[3-chloro-2′-fluoro-4′-(4-methylphenylthio)biphenyl-4-yl]-2-(phosphoryloxymethyl)butanol (<b>6f</b>-<b>P</b>)</h3><div class="NLM_p last">mp 214−216 °C; MS (ESI<sup>+</sup>) <i>m</i>/<i>z</i> 526 [M + H]. <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 1.93−2.02 (2H, m), 2.39 (3H, s), 2.85−2.91 (2H, m), 3.68−3.82 (2H, m), 3.95−4.10 (2H, m), 6.91 (1H, d, <i>J</i> = 11.1 Hz), 7.04 (1H, d, <i>J</i> = 8.4 Hz), 7.27 (2H, d, <i>J</i> = 7.8 Hz), 7.35−7.42 (5H, m), 7.53 (1H, s). Anal. (C<sub>24</sub>H<sub>26</sub>ClFNO<sub>5</sub>PS) C, H, N.</div></div><div id="sec5_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Intracellular Ca<sup>2+</sup> Mobilization Assay</h3><div class="NLM_p last">Chem-1 or CHO cells stably expressing human S1P receptors (hS1P)<sub>1</sub> or hS1P<sub>3</sub> respectively were loaded with 5 μM Fura-2 AM (Dojindo, Kumamoto, Japan) for 90 min at 37 °C. After two washes, the cells were suspended at a concentration of 3 × 10<sup>5</sup> cells/mL in HBSS containing 0.1% BSA (fatty acid free) and 1.25 mM probenecid (pH 7.4). The cells (3 × 10<sup>4</sup> cells/well) in HBSS containing 0.1% BSA (fatty acid free) and 1.25 mM probenecid (pH 7.4) were plated in black wall 96-well plates, and then the changes in fluorescence were monitored at 37 °C at excitation wavelengths of 340 and 380 nm and an emission wavelength of 540 nm using a functional drug screening system (FDSS3000, Hamamatsu Photonics, Shizuoka, Japan). Ten seconds after the start of monitoring, the serial dilutions of S1P or test compounds were added and the maximal change in Ca<sup>2+</sup> concentration after stimulator addition was quantitated.</div></div><div id="sec5_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Mouse Lymphocyte Reduction Assay</h3><div class="NLM_p last">Male BALB/c mice were purchased from Japan SLC, Inc. (Hamamatsu, Japan). Test compounds were intraperitoneally administered. Twenty-four hours later, a peripheral blood sample was collected from the posterior vena cava by using a heparinized syringe and hemolyzed and fixed by using TQ-Prep (Beckman Coulter, CA). The number of CD3<sup>+</sup> pan-T cells and CD45R<sup>+</sup> pan-B cells was determined by two-color flow cytometry (Cytomics FC 500, Beckman Coulter, CA) using fluorescein isothiocyanate (FITC)-conjugated hamster antimouse CD3e (CD3ε chain) monoclonal antibody (Mab) (Clone 145−2C11, BD Bioscience, CA) and R-phycoerythrin (R-PE)-conjugated rat antimouse CD45R (B220) Mab (Clone RA3−6B2, BD Bioscience, CA).</div></div><div id="sec5_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Rat Lymphocyte Reduction Assay</h3><div class="NLM_p last">Male F344 rats were purchased from Charles Liver Japan Inc. (Yokohama, Japan). Test compounds were orally administered. Twenty-four hours later, a peripheral blood sample was collected from the posterior vena cava by using a heparinized syringe and hemolyzed and fixed by using TQ-Prep (Beckman Coulter, CA). The number of CD3<sup>+</sup> pan-T cells and CD45RA<sup>+</sup> pan-B cells was determined by two-color flow cytometry (Cytomics FC 500, Beckman Coulter, CA) using FITC-conjugated mouse antirat CD3 Mab (Clone 1F4, BD Bioscience, CA) and R-phycoerythrin (R-PE)-conjugated mouse antirat CD45RA Mab (Clone OX-33, BD Bioscience, CA).</div></div><div id="sec5_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Measurement of Heart Rate in Anesthetized Rats</h3><div class="NLM_p last">Male Sprague−Dawley rats purchased from Charles Liver Japan Inc. were anesthetized with an intraperitoneal injection of pentobarbital sodium (50 mg/kg). The lead II electrocardiogram (ECG) was recorded, and heart rate was counted by the detection of R wave in ECG. Test compounds were intravenously injected for approximately 30 s. The heart rate was measured before administration, and 1, 2, 3, 4, 5, 10, and 15 min after the intravenous administration of test compound. The maximal heart rate was showed at one minute point. This test was carried out at doses ranging from 0.03 mg/kg to 3 mg/kg.</div></div><div id="sec5_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Measurement of Heart Rate Using Telemetry System</h3><div class="NLM_p last">Rats (CD (SD) IGS) purchased from Charles Liver Japan Inc. were used at 10−12 weeks of age. A transmitter (TL11M2-C50-PXT, Data Science International) was implanted in the lateral abdominal subcutaneous tissue. The pressure sensor catheter of transmitter was inserted into the abdominal aorta. Test compounds were homogeneously suspended with 0.5% HPMC (METOLOSE 60SH-50, Shin-Etsu Chemical Co., Ltd.) and administered orally. Heart rate was monitored by data acquisition system in the telemetry system (Dataquest, A.R.T., Science International). Frequency of data sampling was for 15 s in every 5 min.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i112"><a href="/doi/suppl/10.1021/jm901776q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10481" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10481" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Tables giving the synthetic routes of alcohol compounds and phosphate compounds, preparation details of <b>6a</b> and <b>6a</b>-<b>P</b>, and elemental analysis data. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901776q/suppl_file/jm901776q_si_001.pdf">jm901776q_si_001.pdf (105.34 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm901776q" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kunitomo Adachi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d392b7b2b0bbbafd98a6bdbaa7bcbebc93beb0fdbea7fea3bbb2a1beb2fdb0bcfdb9a3"><span class="__cf_email__" data-cfemail="e7a68386848f8ec9ac92898e93888a88a78a84c98a93ca978f86958a86c98488c98d97">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maiko Hamada</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitsuharu Nakamura</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masatoshi Kiuchi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kaoru Marukawa</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayumi Tomatsu</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kyoko Shimano</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noriko Sato</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kunio Sugahara</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama, Kanagawa 227-0033, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mahoko Asayama</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1-1, Kazusakamatari 1-chome, Kisarazu, Chiba 292-0818, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kan Takagi</span> - <span class="hlFld-Affiliation affiliation">Research Division, Mitsubishi Tanabe Pharma Corporation, 1-1, Kazusakamatari 1-chome, Kisarazu, Chiba 292-0818, Japan</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76475" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76475" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Sachiko Mochizuki and Makio Ohtsuki for performing the lymphocyte reduction assay.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate: an enigmatic signaling lipid</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1038%2Fnrm1103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=12728273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=397-407&author=S.+Spiegelauthor=S.+Milstien&title=Sphingosine-1-phosphate%3A+an+enigmatic+signaling+lipid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate: an enigmatic signalling lipid</span></div><div class="casAuthors">Spiegel, Sarah; Milstien, Sheldon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">397-407</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The evolutionarily conserved actions of the sphingolipid metabolite, sphingosine-1-phosphate (S1P), in yeast, plants, and mammals have shown that it has important functions.  In higher eukaryotes, S1P is the ligand for a family of 5 G protein-coupled receptors.  These S1P receptors are differentially expressed, coupled to various G proteins, and regulate angiogenesis, vascular maturation, cardiac development, and immunity, and are important for directed cell movement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0XUAxYZwqLVg90H21EOLACvtfcHk0liNCg-xkxXRog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7o%253D&md5=689a33cfeb4bae72637b64cd90e6c910</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1103%26sid%3Dliteratum%253Aachs%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DMilstien%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%253A%2520an%2520enigmatic%2520signaling%2520lipid%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D397%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptors and the development of the vascular system</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1582</span><span class="NLM_x"> (</span><span class="NLM_issue">1−3</span><span class="NLM_x">) </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1582&publication_year=2002&pages=222-227&issue=1%E2%88%923&author=M.+L.+Allendeauthor=R.+L.+Proia&title=Sphingosine-1-phosphate+receptors+and+the+development+of+the+vascular+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DSphingosine-1-phosphate%2520receptors%2520and%2520the%2520development%2520of%2520the%2520vascular%2520system%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1582%26issue%3D1%25E2%2588%25923%26spage%3D222%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">G-protein-coupled receptor S1P<sub>1</sub> acts within endothelial cells to regulate vascular maturation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3665</span><span class="NLM_x">–</span> <span class="NLM_lpage">3667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=3665-3667&author=M.+L.+Allendeauthor=T.+Yamashitaauthor=R.+L.+Proia&title=G-protein-coupled+receptor+S1P1+acts+within+endothelial+cells+to+regulate+vascular+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DG-protein-coupled%2520receptor%2520S1P1%2520acts%2520within%2520endothelial%2520cells%2520to%2520regulate%2520vascular%2520maturation%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D3665%26epage%3D3667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure−activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=853-856&author=K.+Adachiauthor=T.+Koharaauthor=N.+Nakaoauthor=M.+Aritaauthor=K.+Chibaauthor=T.+Mishinaauthor=S.+Sasakiauthor=T.+Fujita&title=Design%2C+synthesis%2C+and+structure%E2%88%92activity+relationships+of+2-substituted-2-amino-1%2C3-propanediols%3A+discovery+of+a+novel+immunosuppressant%2C+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DNakao%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25202-substituted-2-amino-1%252C3-propanediols%253A%2520discovery%2520of%2520a%2520novel%2520immunosuppressant%252C%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D853%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span> </span><span class="NLM_article-title">Synthesis and Immunosuppressive Activity of 2-Substituted 2-Aminopropane-1,3-diols and 2-Aminoethanols</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2946</span><span class="NLM_x">–</span> <span class="NLM_lpage">2961</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000173z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2946-2961&author=M.+Kiuchiauthor=K.+Adachiauthor=T.+Koharaauthor=M.+Minoguchiauthor=T.+Hananoauthor=Y.+Aokiauthor=T.+Mishinaauthor=M.+Aritaauthor=N.+Nakaoauthor=M.+Ohtsukiauthor=Y.+Hoshinoauthor=K.+Teshimaauthor=K.+Chibaauthor=S.+Sasakiauthor=T.+Fujita&title=Synthesis+and+Immunosuppressive+Activity+of+2-Substituted+2-Aminopropane-1%2C3-diols+and+2-Aminoethanols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm000173z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000173z%26sid%3Dliteratum%253Aachs%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DMinoguchi%26aufirst%3DM.%26aulast%3DHanano%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DMishina%26aufirst%3DT.%26aulast%3DArita%26aufirst%3DM.%26aulast%3DNakao%26aufirst%3DN.%26aulast%3DOhtsuki%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DTeshima%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520Immunosuppressive%2520Activity%2520of%25202-Substituted%25202-Aminopropane-1%252C3-diols%2520and%25202-Aminoethanols%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2946%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masubuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span> </span><span class="NLM_article-title">FTY720, a Novel Immunosuppressant, Induces Sequestration of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing in Rats. I. FTY720 Selectively Decreases the Number of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">5037</span><span class="NLM_x">–</span> <span class="NLM_lpage">5044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=9590253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=5037-5044&author=K.+Chibaauthor=Y.+Yanagawaauthor=Y.+Masubuchiauthor=H.+Kataokaauthor=T.+Kawaguchiauthor=M.+Ohtsukiauthor=Y.+Hoshino&title=FTY720%2C+a+Novel+Immunosuppressant%2C+Induces+Sequestration+of+Circulating+Mature+Lymphocytes+by+Acceleration+of+Lymphocyte+Homing+in+Rats.+I.+FTY720+Selectively+Decreases+the+Number+of+Circulating+Mature+Lymphocytes+by+Acceleration+of+Lymphocyte+Homing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing</span></div><div class="casAuthors">Chiba, Kenji; Yanagawa, Yoshiki; Masubuchi, Yumi; Kataoka, Hirotoshi; Kawaguchi, Takafumi; Ohtsuki, Makio; Hoshino, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5037-5044</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">FTY720, given i.v. or orally at 0.03 mg/kg or more, prolonged skin allograft survival in a dose-dependent manner and showed more potent immunosuppressive activity than cyclosporin A (CsA) or tacrolimus (FK506) in MHC-incompatible rat strains of WKAH donors and F344 recipients.  However, unlike CsA or FK506, FTY720 up to 1000 nM did not affect IL-2 prodn. in allogeneic MLC.  Within 3-24 h after a single oral administration of FTY720 at 0.1-1 mg/kg, the no. of lymphocytes in the rats was markedly decreased in the peripheral blood and thoracic duct lymph and partially in spleen.  By contrast, the no. of lymphocytes in peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN), and Peyer's patches (PP) was increased at the same time.  I.v. transfusion of calcein-labeled rat lymphocytes into rats revealed that FTY720 accelerated lymphocyte homing to PLN, MLN, and PP, dose dependently.  Since FTY720-induced lymphocyte homing was completely blocked by simultaneous treatment of the calcein-labeled lymphocytes with mAbs against CD62L, CD49d, and CD11a before the transfusion, the acceleration of lymphocyte homing by FTY720 appears to be mediated by lymphocyte-homing receptors.  Thus, FTY720 sequesters circulating mature lymphocytes into PLN, MLN, and PP by acceleration of lymphocyte homing and thereby decreases the no. of lymphocytes in peripheral blood, thoracic duct lymph, and spleen.  Based on these observations, sequestration of circulating mature-lymphocytes is presumed to be a main mechanism of the immunosuppressive activity of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeImxxYccaHrVg90H21EOLACvtfcHk0lgxCkHrNEbhkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D&md5=db7da181424c790a0fb07c0dc60badae</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DYanagawa%26aufirst%3DY.%26aulast%3DMasubuchi%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DOhtsuki%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DY.%26atitle%3DFTY720%252C%2520a%2520Novel%2520Immunosuppressant%252C%2520Induces%2520Sequestration%2520of%2520Circulating%2520Mature%2520Lymphocytes%2520by%2520Acceleration%2520of%2520Lymphocyte%2520Homing%2520in%2520Rats.%2520I.%2520FTY720%2520Selectively%2520Decreases%2520the%2520Number%2520of%2520Circulating%2520Mature%2520Lymphocytes%2520by%2520Acceleration%2520of%2520Lymphocyte%2520Homing%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D160%26spage%3D5037%26epage%3D5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheasley-O’Neill, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setiady, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zigler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcin, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, K. S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhard, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson-White, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">36865</span><span class="NLM_x">–</span> <span class="NLM_lpage">36872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=36865-36872&author=Y.+Kharelauthor=S.+Leeauthor=A.+H.+Snyderauthor=S.+L.+Sheasley-O%E2%80%99Neillauthor=M.+A.+Morrisauthor=Y.+Setiadyauthor=R.+Zhuauthor=M.+A.+Ziglerauthor=T.+L.+Burcinauthor=K.+Leyauthor=K.+S.+K.+Tungauthor=V.+H.+Engelhardauthor=T.+L.+Macdonaldauthor=S.+Pearson-Whiteauthor=K.+R.+Lynch&title=Sphingosine+Kinase+2+Is+Required+for+Modulation+of+Lymphocyte+Traffic+by+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DSheasley-O%25E2%2580%2599Neill%26aufirst%3DS.%2BL.%26aulast%3DMorris%26aufirst%3DM.%2BA.%26aulast%3DSetiady%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DZigler%26aufirst%3DM.%2BA.%26aulast%3DBurcin%26aufirst%3DT.%2BL.%26aulast%3DLey%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DK.%2BS.%2BK.%26aulast%3DEngelhard%26aufirst%3DV.%2BH.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26aulast%3DPearson-White%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DSphingosine%2520Kinase%25202%2520Is%2520Required%2520for%2520Modulation%2520of%2520Lymphocyte%2520Traffic%2520by%2520FTY720%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D36865%26epage%3D36872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.+J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1-Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+FTY720+Targets+Sphingosine+1-Phosphate+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0li2hpPAkwa0lA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520FTY720%2520Targets%2520Sphingosine%25201-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span> </span><span class="NLM_article-title">Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1056%2FNEJMoa052643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=16971719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1124-1140&author=L.+Kapposauthor=J.+Antelauthor=G.+Comiauthor=X.+Montalbanauthor=P.+O%E2%80%99Connorauthor=C.+H.+Polmanauthor=T.+Haasauthor=A.+A.+Kornauthor=G.+Karlssonauthor=E.+W.+Radue&title=Oral+Fingolimod+%28FTY720%29+for+Relapsing+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1140</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis.  We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 mo with magnetic resonance imaging (MRI) and clin. evaluations (core study, months 0 to 6).  The primary end point was the total no. of gadolinium-enhanced lesions recorded on T1-weighted MRI at monthly intervals for 6 mo.  In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses.  A total of 255 patients completed the core study.  The median total no. of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P < 0.001) and 5.0 mg of fingolimod (3 lesions, P = 0.006) than with placebo (5 lesions).  The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P = 0.009) and 0.36 in the group given 5.0 mg of fingolimod (P = 0.01).  For the 227 patients who completed the extension study, the no. of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod.  Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea.  Clin. asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group).  One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group.  Fingolimod was also assocd. with an initial redn. in the heart rate and a modest decrease in the forced expiratory vol. in 1 s.  In this proof-of-concept study, fingolimod reduced the no. of lesions detected on MRI and clin. disease activity in patients with multiple sclerosis.  Evaluation in larger, longer-term studies is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4MSvDIuvV7Vg90H21EOLACvtfcHk0lgSxHjGInlepg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D&md5=2a84e8f5fb92091782406da9dcbc1453</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052643%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DAntel%26aufirst%3DJ.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DHaas%26aufirst%3DT.%26aulast%3DKorn%26aufirst%3DA.%2BA.%26aulast%3DKarlsson%26aufirst%3DG.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26atitle%3DOral%2520Fingolimod%2520%2528FTY720%2529%2520for%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1124%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2005&pages=1735-1739&author=S.+R.+Schwabauthor=J.+P.+Pereiraauthor=M.+Matloubianauthor=Y.+Xuauthor=Y.+Huangauthor=J.+G.+Cyster&title=Lymphocyte+Sequestration+Through+S1P+Lyase+Inhibition+and+Disruption+of+S1P+Gradients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520Sequestration%2520Through%2520S1P%2520Lyase%2520Inhibition%2520and%2520Disruption%2520of%2520S1P%2520Gradients%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D1735%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bagdanoff, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoviel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouraldeen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessop, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazelwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baugh, S. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardyan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terranova, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digeorge-Foushee, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaffield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Main, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oravecz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span> </span><span class="NLM_article-title">Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3941</span><span class="NLM_x">–</span> <span class="NLM_lpage">3953</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900278w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3941-3953&author=J.+T.+Bagdanoffauthor=M.+S.+Donovielauthor=A.+Nouraldeenauthor=J.+Tarverauthor=Q.+Fuauthor=M.+Carlsenauthor=T.+C.+Jessopauthor=H.+Zhangauthor=J.+Hazelwoodauthor=H.+Nguyenauthor=S.+D.+P.+Baughauthor=M.+Gardyanauthor=K.+M.+Terranovaauthor=J.+Barbosaauthor=J.+Yanauthor=M.+Bednarzauthor=S.+Layekauthor=L.+F.+Courtneyauthor=J.+Taylorauthor=A.+M.+Digeorge-Fousheeauthor=S.+Gopinathanauthor=D.+Bruceauthor=T.+Smithauthor=L.+Moranauthor=E.+O%E2%80%99Neillauthor=J.+Kramerauthor=Z.+Laiauthor=S.+D.+Kimballauthor=Q.+Liuauthor=W.+Sunauthor=S.+Yuauthor=J.+Swaffieldauthor=A.+Wilsonauthor=A.+Mainauthor=K.+G.+Carsonauthor=T.+Oraveczauthor=D.+J.+Augeri&title=Inhibition+of+Sphingosine-1-Phosphate+Lyase+for+the+Treatment+of+Autoimmune+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900278w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900278w%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26aulast%3DDonoviel%26aufirst%3DM.%2BS.%26aulast%3DNouraldeen%26aufirst%3DA.%26aulast%3DTarver%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DQ.%26aulast%3DCarlsen%26aufirst%3DM.%26aulast%3DJessop%26aufirst%3DT.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHazelwood%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DBaugh%26aufirst%3DS.%2BD.%2BP.%26aulast%3DGardyan%26aufirst%3DM.%26aulast%3DTerranova%26aufirst%3DK.%2BM.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DLayek%26aufirst%3DS.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DDigeorge-Foushee%26aufirst%3DA.%2BM.%26aulast%3DGopinathan%26aufirst%3DS.%26aulast%3DBruce%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DMoran%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DSwaffield%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DMain%26aufirst%3DA.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DOravecz%26aufirst%3DT.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520Sphingosine-1-Phosphate%2520Lyase%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3941%26epage%3D3953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Dragun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsche, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehler, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumaye, H. H.</span><span> </span><span class="NLM_article-title">FTY720: Early Clinical Experience</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">544S</span><span class="NLM_x">–</span> <span class="NLM_lpage">548S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=544S-548S&author=D.+Dragunauthor=L+Fritscheauthor=T+Boehlerauthor=H.+Petersauthor=K.+Buddeauthor=H.+H.+Neumaye&title=FTY720%3A+Early+Clinical+Experience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDragun%26aufirst%3DD.%26aulast%3DFritsche%26aufirst%3DL%26aulast%3DBoehler%26aufirst%3DT%26aulast%3DPeters%26aufirst%3DH.%26aulast%3DBudde%26aufirst%3DK.%26aulast%3DNeumaye%26aufirst%3DH.%2BH.%26atitle%3DFTY720%253A%2520Early%2520Clinical%2520Experience%26jtitle%3DTransplant.%2520Proc.%26date%3D2004%26volume%3D36%26spage%3D544S%26epage%3D548S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+Cell+Regulation+and+Cardiovascular+Effects+of+Sphingosine+1-Phosphate+Receptor+Agonists+in+Rodents+Are+Mediated+via+Distinct+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0lgU0KaB4HCvlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520Cell%2520Regulation%2520and%2520Cardiovascular%2520Effects%2520of%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonists%2520in%2520Rodents%2520Are%2520Mediated%2520via%2520Distinct%2520Receptor%2520Subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pally, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-H., B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. A</span><span> </span><span class="NLM_article-title">Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1227</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1016%2Fj.chembiol.2006.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=17114004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cis7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1227-1234&author=S.+Panauthor=Y.+Miauthor=C.+Pallyauthor=C.+Beerliauthor=A.+Chenauthor=D.+Gueriniauthor=K.+Hinterdingauthor=B.+Nuesslein-H.author=T.+Tuntlandauthor=S.+Lefebvreauthor=Y.+Liuauthor=W.+Gaoauthor=A.+Chuauthor=V.+Brinkmannauthor=C.+Brunsauthor=M.+Streiffauthor=C.+Cannetauthor=N.+Cookeauthor=N.+A+Gray&title=Monoselective+Sphingosine-1-Phosphate+Receptor-1+Agonist+Prevents+Allograft+Rejection+in+a+Stringent+Rat+Heart+Transplantation+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model</span></div><div class="casAuthors">Pan, Shifeng; Mi, Yuan; Pally, Charles; Beerli, Christian; Chen, Alice; Guerini, Danilo; Hinterding, Klaus; Nuesslein-Hildesheim, Barbara; Tuntland, Tove; Lefebvre, Sophie; Liu, Yi; Gao, Wenqi; Chu, Alan; Brinkmann, Volker; Bruns, Christian; Streiff, Markus; Cannet, Catherine; Cooke, Nigel; Gray, Nathanael</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1227-1234</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">FTY720 is an immunomodulator with demonstrated efficacy in a phase II trial of relapsing multiple sclerosis.  FTY720-phosphate, the active metabolite generated upon phosphorylation in vivo, acts as a potent agonist on 4 of the 5 known sphingosine-1-phosphate (S1P1) receptors.  AUY954, an aminocarboxylate analog of FTY720, is a low nanomolar, monoselective agonist of the S1P1 receptor.  Due to its selectivity and pharmacokinetic profile, AUY954 is an excellent pharmacol. probe of S1P1-dependent phenomena.  Oral administration of AUY954 induces a profound and reversible redn. of circulating lymphocytes and, in combination with RAD001 (Certican/Everolimus, an mTOR inhibitor), is capable of prolonging the survival of cardiac allografts in a stringent rat transplantation model.  This demonstrates that a selective agonist of the S1P1 receptor is sufficient to achieve efficacy in an animal model of transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHaf5xvh0gbbVg90H21EOLACvtfcHk0lgU0KaB4HCvlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cis7fO&md5=1cedf319326d9dacca79276ec93b408d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DPally%26aufirst%3DC.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DNuesslein-H.%26aufirst%3DB.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DCannet%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DN.%2BA%26atitle%3DMonoselective%2520Sphingosine-1-Phosphate%2520Receptor-1%2520Agonist%2520Prevents%2520Allograft%2520Rejection%2520in%2520a%2520Stringent%2520Rat%2520Heart%2520Transplantation%2520Model%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D1227%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P<sub>1</sub>) with enhanced pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=828-831&author=L.+Yanauthor=P.+Huoauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=S.+M.+Mandala&title=SAR+studies+of+3-arylpropionic+acids+as+potent+and+selective+agonists+of+sphingosine-1-phosphate+receptor-1+%28S1P1%29+with+enhanced+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DSAR%2520studies%2520of%25203-arylpropionic%2520acids%2520as%2520potent%2520and%2520selective%2520agonists%2520of%2520sphingosine-1-phosphate%2520receptor-1%2520%2528S1P1%2529%2520with%2520enhanced%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D828%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. A</span><span> </span><span class="NLM_article-title">Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+A+Mandala&title=Rational+Utilization+of+High-Throughput+Screening+Affords+Selective%2C+Orally+Bioavailable+1-Benzyl-3-carboxyazetidine+Sphingosine-1-phosphate-1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%2BA%26atitle%3DRational%2520Utilization%2520of%2520High-Throughput%2520Screening%2520Affords%2520Selective%252C%2520Orally%2520Bioavailable%25201-Benzyl-3-carboxyazetidine%2520Sphingosine-1-phosphate-1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of the Immunomodulating Compound KRP-203</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1055%2Fs-2007-983721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVyju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=1927-1929&author=M.+Hamadaauthor=M.+Kiuchiauthor=K.+Adachi&title=Efficient+Synthesis+of+the+Immunomodulating+Compound+KRP-203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of the immunomodulating compound KRP-203</span></div><div class="casAuthors">Hamada, Maiko; Kiuchi, Masatoshi; Adachi, Kunitomo</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1927-1929</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A practical and concise synthesis of KRP-203 I was achieved by utilizing a palladium coupling reaction mediated by XantPhos and Pd2(dba)3 as the key step.  The coupling reaction of aryl bromide with 3-hydroxythiophenol proceeded chemoselectively to give phenol in spite of the presence of a chlorine and hydroxyl substituent on starting material.  Phenol was converted into KRP-203 by benzylation and removal of the protecting groups in high yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMYRwXxbNirVg90H21EOLACvtfcHk0ljND5iaf-VdLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVyju74%253D&md5=8931eb11f2ae5ae67f20d6edf3f13eb6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-983721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-983721%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DEfficient%2520Synthesis%2520of%2520the%2520Immunomodulating%2520Compound%2520KRP-203%26jtitle%3DSynthesis%26date%3D2007%26spage%3D1927%26epage%3D1929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a Novel Synthetic Immunosuppressant, Prolongs Graft Survival and Attenuates Chronic Rejection in Rat Skin and Heart Allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+Novel+Synthetic+Immunosuppressant%2C+Prolongs+Graft+Survival+and+Attenuates+Chronic+Rejection+in+Rat+Skin+and+Heart+Allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520Novel%2520Synthetic%2520Immunosuppressant%252C%2520Prolongs%2520Graft%2520Survival%2520and%2520Attenuates%2520Chronic%2520Rejection%2520in%2520Rat%2520Skin%2520and%2520Heart%2520Allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jongsma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Unen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Loenen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span> </span><span class="NLM_article-title">Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P<sub>3</sub>)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1111%2Fj.1476-5381.2009.00134.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=19309361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=1305-1311&author=M.+Jongsmaauthor=J.+van+Unenauthor=P.+B.+van+Loenenauthor=M.+C.+Michelauthor=S.+L.+M.+Petersauthor=A.+E.+Alewijnse&title=Different+response+patterns+of+several+ligands+at+the+sphingosine-1-phosphate+receptor+subtype+3+%28S1P3%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P3)</span></div><div class="casAuthors">Jongsma, M.; van Unen, J.; van Loenen, P. B.; Michel, M. C.; Peters, S. L. M.; Alewijnse, A. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1305-1311</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Recently, some ligands targeting the sphingosine-1-phosphate receptor subtype 3 (S1P3) have become available.  The characterization of these compds. was mainly based on one functional read-out system, although S1P3 receptors are known to activate different signal transduction pathways.  Therefore, this study pharmacol. characterizes these compds. using different assays.  Using CHO-Flpln cells expressing the human S1P3 receptor the potencies and maximal effects of S1P, FTY720-P, VPC23019, VPC23153, and VPC24191 were detd. in three different assays [inhibition of cAMP accumulation, elevation of intracellular calcium concns. ([Ca2+]i) and S1P3 receptor internalization].  All compds. tested inhibited forskolin-induced cAMP accumulation, increased [Ca2+]i and induced S1P3 receptor internalization but with different potencies and maximal effects.  S1P was the most potent compd. in all assays followed by FTY720-P.  The VPC compds. were generally less potent than S1P and FTY720-P.  Regarding the maximal effects, all compds. except VPC23153, behaved as full agonists in the cAMP accumulation assay.  In the calcium assay, FTY720-P, VPC23019 and VPC24191 displayed partial and VPC23153 weak partial agonist activity, relative to S1P.  Interestingly, treatment with the Gi inactivator Pertussis toxin, did not affect S1P-induced [Ca2+]i elevations but inhibited those in response to the other compds., by about 50%.  This study demonstrated differential response patterns at the S1P3 receptor for a range of ligands.  These differences could indicate the presence of functional selectivity at this receptor as FTY720-P and the VPC compds. seemed to signal predominantly via Gi - whereas S1P activated Gi and Gq-coupled pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtJwYh4HYe37Vg90H21EOLACvtfcHk0lhsIw00ad0ycg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWmurk%253D&md5=9d02bf85020813c9cd4e7c31e067bb03</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00134.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00134.x%26sid%3Dliteratum%253Aachs%26aulast%3DJongsma%26aufirst%3DM.%26aulast%3Dvan%2BUnen%26aufirst%3DJ.%26aulast%3Dvan%2BLoenen%26aufirst%3DP.%2BB.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26atitle%3DDifferent%2520response%2520patterns%2520of%2520several%2520ligands%2520at%2520the%2520sphingosine-1-phosphate%2520receptor%2520subtype%25203%2520%2528S1P3%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D1305%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Matej Zore, Shella Gilbert-Girard, Inés Reigada, Jayendra Z. Patel, Kirsi Savijoki, Adyary Fallarero, <span class="NLM_string-name hlFld-ContribAuthor">Jari Yli-Kauhaluoma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2021,</strong> <em>6 </em>
                                    (28)
                                     , 18465-18486. <a href="https://doi.org/10.1021/acsomega.1c02591" title="DOI URL">https://doi.org/10.1021/acsomega.1c02591</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.1c02591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.1c02591%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BFingolimod%252BDerivatives%252Bas%252BAntibacterial%252BAgents%26aulast%3DZore%26aufirst%3DMatej%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18052021%26date%3D29062021%26date%3D09072021%26volume%3D6%26issue%3D28%26spage%3D18465%26epage%3D18486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">David  Lehmann</span>, <span class="hlFld-ContribAuthor ">Solange  Meyer</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, and <span class="hlFld-ContribAuthor ">Beat  Steiner</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 78-97. <a href="https://doi.org/10.1021/jm401456d" title="DOI URL">https://doi.org/10.1021/jm401456d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401456d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401456d%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B-%252BPart%252B2%25253A%252BFrom%252BBicyclo%25255B3.1.0%25255Dhexane-Fused%252BThiophenes%252Bto%252BIsobutyl%252BSubstituted%252BThiophenes%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D20092013%26date%3D17122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D78%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Stefan  Abele</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Ruben  de Kanter</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">Julien  Grimont</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Cyrille  Lescop</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, <span class="hlFld-ContribAuthor ">Gunther  Schmidt</span>, <span class="hlFld-ContribAuthor ">Jürgen  Seifert</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, and <span class="hlFld-ContribAuthor ">Thomas  Weller</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (1)
                                     , 110-130. <a href="https://doi.org/10.1021/jm4014696" title="DOI URL">https://doi.org/10.1021/jm4014696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B%2525E2%252588%252592%252BPart%252B3%25253A%252BFrom%252BThiophenes%252Bto%252BPyridines%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D23092013%26date%3D24122013%26date%3D09012014%26volume%3D57%26issue%3D1%26spage%3D110%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin H.  Bolli</span>, <span class="hlFld-ContribAuthor ">Claus  Müller</span>, <span class="hlFld-ContribAuthor ">Boris  Mathys</span>, <span class="hlFld-ContribAuthor ">Stefan  Abele</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker</span>, <span class="hlFld-ContribAuthor ">Roberto  Bravo</span>, <span class="hlFld-ContribAuthor ">Daniel  Bur</span>, <span class="hlFld-ContribAuthor ">Patrick  Hess</span>, <span class="hlFld-ContribAuthor ">Christopher  Kohl</span>, <span class="hlFld-ContribAuthor ">David  Lehmann</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">Markus  Rey</span>, <span class="hlFld-ContribAuthor ">Solange  Meyer</span>, <span class="hlFld-ContribAuthor ">Michael  Scherz</span>, <span class="hlFld-ContribAuthor ">Gunther  Schmidt</span>, <span class="hlFld-ContribAuthor ">Beat  Steiner</span>, <span class="hlFld-ContribAuthor ">Alexander  Treiber</span>, <span class="hlFld-ContribAuthor ">Jörg  Velker</span>, and <span class="hlFld-ContribAuthor ">Thomas  Weller</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (23)
                                     , 9737-9755. <a href="https://doi.org/10.1021/jm4014373" title="DOI URL">https://doi.org/10.1021/jm4014373</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4014373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4014373%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BS1P1%252BReceptor%252BAgonists%252B%2525E2%252580%252593%252BPart%252B1%25253A%252BFrom%252BPyrazoles%252Bto%252BThiophenes%26aulast%3DBolli%26aufirst%3DMartin%2BH.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D18092013%26date%3D22112013%26date%3D12122013%26volume%3D56%26issue%3D23%26spage%3D9737%26epage%3D9755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul E.  Harrington</span>, <span class="hlFld-ContribAuthor ">Michael D.  Croghan</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">Mike  Frohn</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Pickrell</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Kelvin K. C.  Sham</span>, <span class="hlFld-ContribAuthor ">Andrew  Tasker</span>, <span class="hlFld-ContribAuthor ">Heather A.  Arnett</span>, <span class="hlFld-ContribAuthor ">Michael  Fiorino</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Michele  McElvain</span>, <span class="hlFld-ContribAuthor ">Henry G.  Morrison</span>, <span class="hlFld-ContribAuthor ">Han  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Xuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Min  Wong</span>, and <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (1)
                                     , 74-78. <a href="https://doi.org/10.1021/ml200252b" title="DOI URL">https://doi.org/10.1021/ml200252b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml200252b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml200252b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252Ba%252BPotent%25252C%252BOrally%252BActive%252BS1P1%252BAgonist%252BContaining%252Ba%252BQuinolinone%252BCore%26aulast%3DHarrington%26aufirst%3DPaul%2BE.%26date%3D2012%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D21102011%26date%3D23112011%26date%3D29112011%26date%3D12012012%26date%3D23112011%26volume%3D3%26issue%3D1%26spage%3D74%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Kelvin K. C.  Sham</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Pickrell</span>, <span class="hlFld-ContribAuthor ">Paul E.  Harrington</span>, <span class="hlFld-ContribAuthor ">Michael J.  Frohn</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Michael D.  Croghan</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Han  Xu</span>, <span class="hlFld-ContribAuthor ">Michele  McElvain</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Xuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael  Fiorino</span>, <span class="hlFld-ContribAuthor ">Michelle  Horner</span>, <span class="hlFld-ContribAuthor ">Henry G.  Morrison</span>, <span class="hlFld-ContribAuthor ">Heather A.  Arnett</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">Min  Wong</span>, and <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>  . </span><span class="cited-content_cbyCitation_article-title">4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (10)
                                     , 752-757. <a href="https://doi.org/10.1021/ml2001399" title="DOI URL">https://doi.org/10.1021/ml2001399</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml2001399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml2001399%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Methoxy-N-%25255B2-%252528trifluoromethyl%252529biphenyl-4-ylcarbamoyl%25255Dnicotinamide%25253A%252BA%252BPotent%252Band%252BSelective%252BAgonist%252Bof%252BS1P1%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D10062011%26date%3D29072011%26date%3D02082011%26date%3D13102011%26date%3D29072011%26volume%3D2%26issue%3D10%26spage%3D752%26epage%3D757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krista M.  Wager</span> and <span class="hlFld-ContribAuthor ">Matthew H.  Daniels</span>  . </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Cross-Coupling of Benzyl Thioacetates and Aryl Halides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (15)
                                     , 4052-4055. <a href="https://doi.org/10.1021/ol201564j" title="DOI URL">https://doi.org/10.1021/ol201564j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol201564j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol201564j%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BCross-Coupling%252Bof%252BBenzyl%252BThioacetates%252Band%252BAryl%252BHalides%26aulast%3DWager%26aufirst%3DKrista%2BM.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D10062011%26date%3D05072011%26date%3D05082011%26volume%3D13%26issue%3D15%26spage%3D4052%26epage%3D4055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emmanuel H.  Demont</span>, <span class="hlFld-ContribAuthor ">Benjamin I.  Andrews</span>, <span class="hlFld-ContribAuthor ">Rino A.  Bit</span>, <span class="hlFld-ContribAuthor ">Colin A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jason W. B.  Cooke</span>, <span class="hlFld-ContribAuthor ">Nigel  Deeks</span>, <span class="hlFld-ContribAuthor ">Sapna  Desai</span>, <span class="hlFld-ContribAuthor ">Simon J.  Dowell</span>, <span class="hlFld-ContribAuthor ">Pam  Gaskin</span>, <span class="hlFld-ContribAuthor ">James R. J.  Gray</span>, <span class="hlFld-ContribAuthor ">Andrea  Haynes</span>, <span class="hlFld-ContribAuthor ">Duncan S.  Holmes</span>, <span class="hlFld-ContribAuthor ">Umesh  Kumar</span>, <span class="hlFld-ContribAuthor ">Mary A.  Morse</span>, <span class="hlFld-ContribAuthor ">Greg J.  Osborne</span>, <span class="hlFld-ContribAuthor ">Terry  Panchal</span>, <span class="hlFld-ContribAuthor ">Bela  Patel</span>, <span class="hlFld-ContribAuthor ">Alcide  Perboni</span>, <span class="hlFld-ContribAuthor ">Simon  Taylor</span>, <span class="hlFld-ContribAuthor ">Robert  Watson</span>, <span class="hlFld-ContribAuthor ">Jason  Witherington</span>, and <span class="hlFld-ContribAuthor ">Robert  Willis</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Selective S1P1 Receptor Agonist Efficacious at Low Oral Dose and Devoid of Effects on Heart Rate. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (6)
                                     , 444-449. <a href="https://doi.org/10.1021/ml2000214" title="DOI URL">https://doi.org/10.1021/ml2000214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml2000214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml2000214%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BSelective%252BS1P1%252BReceptor%252BAgonist%252BEfficacious%252Bat%252BLow%252BOral%252BDose%252Band%252BDevoid%252Bof%252BEffects%252Bon%252BHeart%252BRate%26aulast%3DDemont%26aufirst%3DEmmanuel%2BH.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D26012011%26date%3D24032011%26date%3D31032011%26date%3D09062011%26date%3D24032011%26volume%3D2%26issue%3D6%26spage%3D444%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Nina  Xue</span>, <span class="hlFld-ContribAuthor ">Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Rong  Fu</span>, <span class="hlFld-ContribAuthor ">Mingjin  Wang</span>, <span class="hlFld-ContribAuthor ">Ming  Ji</span>, <span class="hlFld-ContribAuthor ">Fangfang  Lai</span>, <span class="hlFld-ContribAuthor ">Jinping  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Qiong  Xiao</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Zhang</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>, <span class="hlFld-ContribAuthor ">Liping  Bai</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Shuan  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 276-288. <a href="https://doi.org/10.1016/j.apsb.2019.11.006" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DA%252Bnovel%252BS1P1%252Bmodulator%252BIMMH002%252Bameliorates%252Bpsoriasis%252Bin%252Bmultiple%252Banimal%252Bmodels%26aulast%3DJin%26aufirst%3DJing%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D276%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Lv</span>, <span class="hlFld-ContribAuthor ">Chengcheng  Song</span>, <span class="hlFld-ContribAuthor ">Youhong  Niu</span>, <span class="hlFld-ContribAuthor ">Qin  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Shan  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-Substituted Iminosugar Derivatives and Evaluation of Their Immunosuppressive Activities. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (4)
                                     , 338-351. <a href="https://doi.org/10.1002/cmdc.201700706" title="DOI URL">https://doi.org/10.1002/cmdc.201700706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700706%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Bof%252BN-Substituted%252BIminosugar%252BDerivatives%252Band%252BEvaluation%252Bof%252BTheir%252BImmunosuppressive%252BActivities%26aulast%3DLv%26aufirst%3DZhuo%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D4%26spage%3D338%26epage%3D351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serkan  Yavuz</span>, <span class="hlFld-ContribAuthor ">Aysu  Çetin</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Doğukan  Doyduk</span>, <span class="hlFld-ContribAuthor ">Ali  Dişli</span>, <span class="hlFld-ContribAuthor ">Gurbet  Çelik Turgut</span>, <span class="hlFld-ContribAuthor ">Alaattin  Şen</span>, <span class="hlFld-ContribAuthor ">Yılmaz  Yıldırır</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Functional Investigations of Computer Designed Novel Cladribine-Like Compounds for the Treatment of Multiple Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (11)
                                     , 1700185. <a href="https://doi.org/10.1002/ardp.201700185" title="DOI URL">https://doi.org/10.1002/ardp.201700185</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700185%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BFunctional%252BInvestigations%252Bof%252BComputer%252BDesigned%252BNovel%252BCladribine-Like%252BCompounds%252Bfor%252Bthe%252BTreatment%252Bof%252BMultiple%252BSclerosis%26aulast%3DYavuz%26aufirst%3DSerkan%26date%3D2017%26date%3D2017%26volume%3D350%26issue%3D11%26spage%3D1700185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ambra  Vestri</span>, <span class="hlFld-ContribAuthor ">Federica  Pierucci</span>, <span class="hlFld-ContribAuthor ">Alessia  Frati</span>, <span class="hlFld-ContribAuthor ">Lucia  Monaco</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Meacci</span>. </span><span class="cited-content_cbyCitation_article-title">Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fphar.2017.00296" title="DOI URL">https://doi.org/10.3389/fphar.2017.00296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2017.00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2017.00296%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DSphingosine%252B1-Phosphate%252BReceptors%25253A%252BDo%252BThey%252BHave%252Ba%252BTherapeutic%252BPotential%252Bin%252BCardiac%252BFibrosis%25253F%26aulast%3DVestri%26aufirst%3DAmbra%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomohiko  Harada</span>, <span class="hlFld-ContribAuthor ">Darren  Wilbraham</span>, <span class="hlFld-ContribAuthor ">Guillemette  La Borderie</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Inoue</span>, <span class="hlFld-ContribAuthor ">Jim  Bush</span>, <span class="hlFld-ContribAuthor ">A. John  Camm</span>. </span><span class="cited-content_cbyCitation_article-title">Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Clinical Pharmacology</span><span> <strong>2017,</strong> <em>83 </em>
                                    (5)
                                     , 1011-1027. <a href="https://doi.org/10.1111/bcp.13203" title="DOI URL">https://doi.org/10.1111/bcp.13203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bcp.13203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbcp.13203%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Clinical%2520Pharmacology%26atitle%3DCardiac%252Beffects%252Bof%252Bamiselimod%252Bcompared%252Bwith%252Bfingolimod%252Band%252Bplacebo%25253A%252Bresults%252Bof%252Ba%252Brandomised%25252C%252Bparallel%2525E2%252580%252590group%25252C%252Bphase%252BI%252Bstudy%252Bin%252Bhealthy%252Bsubjects%26aulast%3DHarada%26aufirst%3DTomohiko%26date%3D2017%26date%3D2017%26volume%3D83%26issue%3D5%26spage%3D1011%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gurbet Çelik  Turgut</span>, <span class="hlFld-ContribAuthor ">Doğukan  Doyduk</span>, <span class="hlFld-ContribAuthor ">Yılmaz  Yıldırır</span>, <span class="hlFld-ContribAuthor ">Serkan  Yavuz</span>, <span class="hlFld-ContribAuthor ">Atilla  Akdemir</span>, <span class="hlFld-ContribAuthor ">Ali  Dişli</span>, <span class="hlFld-ContribAuthor ">Alaattin  Şen</span>. </span><span class="cited-content_cbyCitation_article-title">Computer design, synthesis, and bioactivity analyses of drugs like fingolimod used in the treatment of multiple sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (2)
                                     , 483-495. <a href="https://doi.org/10.1016/j.bmc.2016.11.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DComputer%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbioactivity%252Banalyses%252Bof%252Bdrugs%252Blike%252Bfingolimod%252Bused%252Bin%252Bthe%252Btreatment%252Bof%252Bmultiple%252Bsclerosis%26aulast%3DTurgut%26aufirst%3DGurbet%2B%25C3%2587elik%26date%3D2017%26volume%3D25%26issue%3D2%26spage%3D483%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Wu</span>, <span class="hlFld-ContribAuthor ">Yiguang  Tian</span>, <span class="hlFld-ContribAuthor ">Shanping  Wang</span>, <span class="hlFld-ContribAuthor ">Marco  Pistolozzi</span>, <span class="hlFld-ContribAuthor ">Ya  Jin</span>, <span class="hlFld-ContribAuthor ">Ting  Zhou</span>, <span class="hlFld-ContribAuthor ">Gaurab  Roy</span>, <span class="hlFld-ContribAuthor ">Ling  Xu</span>, <span class="hlFld-ContribAuthor ">Wen  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of bambuterol analogues as novel inhibitors of butyrylcholinesterase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>126 </em>, 61-71. <a href="https://doi.org/10.1016/j.ejmech.2016.08.061" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.08.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.08.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.08.061%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bbambuterol%252Banalogues%252Bas%252Bnovel%252Binhibitors%252Bof%252Bbutyrylcholinesterase%26aulast%3DWu%26aufirst%3DJie%26date%3D2017%26volume%3D126%26spage%3D61%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Cantalupo</span>, <span class="hlFld-ContribAuthor ">A.  Di Lorenzo</span>. </span><span class="cited-content_cbyCitation_article-title">S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2016,</strong> <em>358 </em>
                                    (2)
                                     , 359-370. <a href="https://doi.org/10.1124/jpet.116.233205" title="DOI URL">https://doi.org/10.1124/jpet.116.233205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.233205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.233205%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DS1P%252BSignaling%252Band%252BDe%252BNovo%252BBiosynthesis%252Bin%252BBlood%252BPressure%252BHomeostasis%26aulast%3DCantalupo%26aufirst%3DA.%26date%3D2016%26date%3D2016%26volume%3D358%26issue%3D2%26spage%3D359%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiong  Xiao</span>, <span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Jinping  Hu</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Yulin  Tian</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, identification, and biological activity of metabolites of two novel selective S1P1 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (10)
                                     , 2273-2279. <a href="https://doi.org/10.1016/j.bmc.2016.03.059" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bidentification%25252C%252Band%252Bbiological%252Bactivity%252Bof%252Bmetabolites%252Bof%252Btwo%252Bnovel%252Bselective%252BS1P1%252Bagonists%26aulast%3DXiao%26aufirst%3DQiong%26date%3D2016%26volume%3D24%26issue%3D10%26spage%3D2273%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua C.  Horan</span>, <span class="hlFld-ContribAuthor ">Daniel  Kuzmich</span>, <span class="hlFld-ContribAuthor ">Pingrong  Liu</span>, <span class="hlFld-ContribAuthor ">Darren  DiSalvo</span>, <span class="hlFld-ContribAuthor ">John  Lord</span>, <span class="hlFld-ContribAuthor ">Can  Mao</span>, <span class="hlFld-ContribAuthor ">Tamara D.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Hui  Yu</span>, <span class="hlFld-ContribAuthor ">Christian  Harcken</span>, <span class="hlFld-ContribAuthor ">Raj  Betageri</span>, <span class="hlFld-ContribAuthor ">Melissa  Hill-Drzewi</span>, <span class="hlFld-ContribAuthor ">Lori  Patenaude</span>, <span class="hlFld-ContribAuthor ">Monica  Patel</span>, <span class="hlFld-ContribAuthor ">Kimberly  Fletcher</span>, <span class="hlFld-ContribAuthor ">Donna  Terenzzio</span>, <span class="hlFld-ContribAuthor ">Brian  Linehan</span>, <span class="hlFld-ContribAuthor ">Heather  Xia</span>, <span class="hlFld-ContribAuthor ">Mita  Patel</span>, <span class="hlFld-ContribAuthor ">Debbie  Studwell</span>, <span class="hlFld-ContribAuthor ">Craig  Miller</span>, <span class="hlFld-ContribAuthor ">Eugene  Hickey</span>, <span class="hlFld-ContribAuthor ">Jeremy I.  Levin</span>, <span class="hlFld-ContribAuthor ">Dustin  Smith</span>, <span class="hlFld-ContribAuthor ">Raymond A.  Kemper</span>, <span class="hlFld-ContribAuthor ">Louise K.  Modis</span>, <span class="hlFld-ContribAuthor ">Lynne C.  Bannen</span>, <span class="hlFld-ContribAuthor ">Diva S.  Chan</span>, <span class="hlFld-ContribAuthor ">Morrison B.  Mac</span>, <span class="hlFld-ContribAuthor ">Stephanie  Ng</span>, <span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">René M.  Lemieux</span>. </span><span class="cited-content_cbyCitation_article-title">Late-stage optimization of a tercyclic class of S1P 3 -sparing, S1P 1 receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 466-471. <a href="https://doi.org/10.1016/j.bmcl.2015.11.090" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.11.090</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.11.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.11.090%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLate-stage%252Boptimization%252Bof%252Ba%252Btercyclic%252Bclass%252Bof%252BS1P%252B3%252B-sparing%25252C%252BS1P%252B1%252Breceptor%252Bagonists%26aulast%3DHoran%26aufirst%3DJoshua%2BC.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D466%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua C.  Horan</span>, <span class="hlFld-ContribAuthor ">Sulagna  Sanyal</span>, <span class="hlFld-ContribAuthor ">Younggi  Choi</span>, <span class="hlFld-ContribAuthor ">Melissa  Hill-Drzewi</span>, <span class="hlFld-ContribAuthor ">Lori  Patnaude</span>, <span class="hlFld-ContribAuthor ">Shawn  Anderson</span>, <span class="hlFld-ContribAuthor ">Steve  Fogal</span>, <span class="hlFld-ContribAuthor ">Can  Mao</span>, <span class="hlFld-ContribAuthor ">Brian N.  Cook</span>, <span class="hlFld-ContribAuthor ">Kristina  Gueneva-Boucheva</span>, <span class="hlFld-ContribAuthor ">Michael B.  Fisher</span>, <span class="hlFld-ContribAuthor ">Eugene  Hickey</span>, <span class="hlFld-ContribAuthor ">Edward  Pack</span>, <span class="hlFld-ContribAuthor ">Lynne C.  Bannen</span>, <span class="hlFld-ContribAuthor ">Diva S.  Chan</span>, <span class="hlFld-ContribAuthor ">Morrison B.  Mac</span>, <span class="hlFld-ContribAuthor ">Stephanie M.  Ng</span>, <span class="hlFld-ContribAuthor ">Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Xu</span>, <span class="hlFld-ContribAuthor ">Louise K.  Modis</span>, <span class="hlFld-ContribAuthor ">René M.  Lemieux</span>. </span><span class="cited-content_cbyCitation_article-title">Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (20)
                                     , 4807-4811. <a href="https://doi.org/10.1016/j.bmcl.2014.09.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPiperazinyl-oxadiazoles%252Bas%252Bselective%252Bsphingosine-1-phosphate%252Breceptor%252Bagonists%26aulast%3DHoran%26aufirst%3DJoshua%2BC.%26date%3D2014%26volume%3D24%26issue%3D20%26spage%3D4807%26epage%3D4811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yulin  Tian</span>, <span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Jinping  Hu</span>, <span class="hlFld-ContribAuthor ">Qiong  Xiao</span>, <span class="hlFld-ContribAuthor ">Wanqi  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of oxazole and triazole derivatives as potent and selective S1P1 agonists through pharmacophore-guided design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 1-15. <a href="https://doi.org/10.1016/j.ejmech.2014.07.081" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.081</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.081%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Boxazole%252Band%252Btriazole%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252BS1P1%252Bagonists%252Bthrough%252Bpharmacophore-guided%252Bdesign%26aulast%3DTian%26aufirst%3DYulin%26date%3D2014%26volume%3D85%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takashi  Tsuji</span>, <span class="hlFld-ContribAuthor ">Keisuke  Suzuki</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Taiji  Goto</span>, <span class="hlFld-ContribAuthor ">Yukiko  Sekiguchi</span>, <span class="hlFld-ContribAuthor ">Takuya  Ikeda</span>, <span class="hlFld-ContribAuthor ">Takeshi  Fukuda</span>, <span class="hlFld-ContribAuthor ">Toshiyasu  Takemoto</span>, <span class="hlFld-ContribAuthor ">Yumiko  Mizuno</span>, <span class="hlFld-ContribAuthor ">Takako  Kimura</span>, <span class="hlFld-ContribAuthor ">Yumi  Kawase</span>, <span class="hlFld-ContribAuthor ">Futoshi  Nara</span>, <span class="hlFld-ContribAuthor ">Takashi  Kagari</span>, <span class="hlFld-ContribAuthor ">Takaichi  Shimozato</span>, <span class="hlFld-ContribAuthor ">Chizuko  Yahara</span>, <span class="hlFld-ContribAuthor ">Shinichi  Inaba</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Honda</span>, <span class="hlFld-ContribAuthor ">Takashi  Izumi</span>, <span class="hlFld-ContribAuthor ">Masakazu  Tamura</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P1 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (15)
                                     , 4246-4256. <a href="https://doi.org/10.1016/j.bmc.2014.05.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BSAR%252Bstudies%252Bof%252Bbenzyl%252Bether%252Bderivatives%252Bas%252Bpotent%252Borally%252Bactive%252BS1P1%252Bagonists%26aulast%3DTsuji%26aufirst%3DTakashi%26date%3D2014%26volume%3D22%26issue%3D15%26spage%3D4246%26epage%3D4256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Jin</span>, <span class="hlFld-ContribAuthor ">Jinping  Hu</span>, <span class="hlFld-ContribAuthor ">Wanqi  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaojian  Wang</span>, <span class="hlFld-ContribAuthor ">Qiong  Xiao</span>, <span class="hlFld-ContribAuthor ">Nina  Xue</span>, <span class="hlFld-ContribAuthor ">Dali  Yin</span>, <span class="hlFld-ContribAuthor ">Xiaoguang  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2014,</strong> <em>90 </em>
                                    (1)
                                     , 50-61. <a href="https://doi.org/10.1016/j.bcp.2014.04.010" title="DOI URL">https://doi.org/10.1016/j.bcp.2014.04.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2014.04.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2014.04.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Ba%252Bselective%252BS1P1%252Breceptor%252Bagonist%25252C%252BSyl930%25252C%252Bas%252Ba%252Bpotential%252Btherapeutic%252Bagent%252Bfor%252Bautoimmune%252Bencephalitis%26aulast%3DJin%26aufirst%3DJing%26date%3D2014%26volume%3D90%26issue%3D1%26spage%3D50%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianfeng  Xu</span>, <span class="hlFld-ContribAuthor ">Frank  Gray</span>, <span class="hlFld-ContribAuthor ">Alex  Henderson</span>, <span class="hlFld-ContribAuthor ">Kirsty  Hicks</span>, <span class="hlFld-ContribAuthor ">Jiansong  Yang</span>, <span class="hlFld-ContribAuthor ">Paul  Thompson</span>, <span class="hlFld-ContribAuthor ">Johann  Oliver</span>. </span><span class="cited-content_cbyCitation_article-title">Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteers. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2014,</strong> <em>3 </em>
                                    (3)
                                     , 170-178. <a href="https://doi.org/10.1002/cpdd.98" title="DOI URL">https://doi.org/10.1002/cpdd.98</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.98%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DSafety%25252C%252Bpharmacokinetics%25252C%252Bpharmacodynamics%25252C%252Band%252Bbioavailability%252Bof%252BGSK2018682%25252C%252Ba%252Bsphingosine-1-phosphate%252Breceptor%252Bmodulator%25252C%252Bin%252Bhealthy%252Bvolunteers%26aulast%3DXu%26aufirst%3DJianfeng%26date%3D2014%26date%3D2014%26volume%3D3%26issue%3D3%26spage%3D170%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidemasa  Hikawa</span>, <span class="hlFld-ContribAuthor ">Maiko  Hamada</span>, <span class="hlFld-ContribAuthor ">Yuusaku  Yokoyama</span>, <span class="hlFld-ContribAuthor ">Isao  Azumaya</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoyl methyl phosphate as an efficient reagent for the selective monobenzoylation of N-Bz-FTY720. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (44)
                                     , 23131-23136. <a href="https://doi.org/10.1039/C4RA02401J" title="DOI URL">https://doi.org/10.1039/C4RA02401J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA02401J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA02401J%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DBenzoyl%252Bmethyl%252Bphosphate%252Bas%252Ban%252Befficient%252Breagent%252Bfor%252Bthe%252Bselective%252Bmonobenzoylation%252Bof%252BN-Bz-FTY720%26aulast%3DHikawa%26aufirst%3DHidemasa%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D44%26spage%3D23131%26epage%3D23136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hidemasa  Hikawa</span>, <span class="hlFld-ContribAuthor ">Maiko  Hamada</span>, <span class="hlFld-ContribAuthor ">Yuka  Uchida</span>, <span class="hlFld-ContribAuthor ">Shoko  Kikkawa</span>, <span class="hlFld-ContribAuthor ">Yuusaku  Yokoyama</span>, <span class="hlFld-ContribAuthor ">Isao  Azumaya</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Desymmetrization of FTY720. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2014,</strong> <em>62 </em>
                                    (10)
                                     , 1041-1044. <a href="https://doi.org/10.1248/cpb.c14-00462" title="DOI URL">https://doi.org/10.1248/cpb.c14-00462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c14-00462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c14-00462%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DEnantioselective%252BDesymmetrization%252Bof%252BFTY720%26aulast%3DHikawa%26aufirst%3DHidemasa%26date%3D2014%26volume%3D62%26issue%3D10%26spage%3D1041%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Jian-Guo  Qi</span>, <span class="hlFld-ContribAuthor ">Gang  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Lin  Tian</span>, <span class="hlFld-ContribAuthor ">Da-Li  Yin</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient method for preparing the sphingosine-1-phosphate receptor agonist, KRP203-phosphate. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2013,</strong> <em>24 </em>
                                    (9)
                                     , 817-820. <a href="https://doi.org/10.1016/j.cclet.2013.05.016" title="DOI URL">https://doi.org/10.1016/j.cclet.2013.05.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2013.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2013.05.016%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DAn%252Befficient%252Bmethod%252Bfor%252Bpreparing%252Bthe%252Bsphingosine-1-phosphate%252Breceptor%252Bagonist%25252C%252BKRP203-phosphate%26aulast%3DWang%26aufirst%3DXiao-Jian%26date%3D2013%26volume%3D24%26issue%3D9%26spage%3D817%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiawang  Liu</span>, <span class="hlFld-ContribAuthor ">Barbara S  Beckman</span>, <span class="hlFld-ContribAuthor ">Maryam  Foroozesh</span>. </span><span class="cited-content_cbyCitation_article-title">A review of ceramide analogs as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (12)
                                     , 1405-1421. <a href="https://doi.org/10.4155/fmc.13.107" title="DOI URL">https://doi.org/10.4155/fmc.13.107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.107%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DA%252Breview%252Bof%252Bceramide%252Banalogs%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DJiawang%26date%3D2013%26volume%3D5%26issue%3D12%26spage%3D1405%26epage%3D1421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shigeki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Sunny Yang  Xiang</span>, <span class="hlFld-ContribAuthor ">Nicole H.  Purcell</span>, <span class="hlFld-ContribAuthor ">Joan Heller  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms and Models for Elucidating the Cardiac Effects of Sphingosine 1-Phosphate (S1P). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 373-397. <a href="https://doi.org/10.1002/9781118531426.ch17" title="DOI URL">https://doi.org/10.1002/9781118531426.ch17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118531426.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118531426.ch17%26sid%3Dliteratum%253Aachs%26atitle%3DMechanisms%252Band%252BModels%252Bfor%252BElucidating%252Bthe%252BCardiac%252BEffects%252Bof%252BSphingosine%252B1-Phosphate%252B%252528S1P%252529%26aulast%3DMiyamoto%26aufirst%3DShigeki%26date%3D2013%26date%3D2013%26spage%3D373%26epage%3D397%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DLysophospholipid%252BReceptors%26aulast%3DChun%26aufirst%3DJerold%26date%3D2013%26volume%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Buzard</span>, <span class="hlFld-ContribAuthor ">Sangdon  Han</span>, <span class="hlFld-ContribAuthor ">Luis  Lopez</span>, <span class="hlFld-ContribAuthor ">Andrew  Kawasaki</span>, <span class="hlFld-ContribAuthor ">Jeanne  Moody</span>, <span class="hlFld-ContribAuthor ">Lars  Thoresen</span>, <span class="hlFld-ContribAuthor ">Brett  Ullman</span>, <span class="hlFld-ContribAuthor ">Juerg  Lehmann</span>, <span class="hlFld-ContribAuthor ">Imelda  Calderon</span>, <span class="hlFld-ContribAuthor ">Xiuwen  Zhu</span>, <span class="hlFld-ContribAuthor ">Tawfik  Gharbaoui</span>, <span class="hlFld-ContribAuthor ">Dipanjan  Sengupta</span>, <span class="hlFld-ContribAuthor ">Ashwin  Krishnan</span>, <span class="hlFld-ContribAuthor ">Yinghong  Gao</span>, <span class="hlFld-ContribAuthor ">Jeff  Edwards</span>, <span class="hlFld-ContribAuthor ">Jeremy  Barden</span>, <span class="hlFld-ContribAuthor ">Michael  Morgan</span>, <span class="hlFld-ContribAuthor ">Khawja  Usmani</span>, <span class="hlFld-ContribAuthor ">Chuan  Chen</span>, <span class="hlFld-ContribAuthor ">Abu  Sadeque</span>, <span class="hlFld-ContribAuthor ">Jayant  Thatte</span>, <span class="hlFld-ContribAuthor ">Michelle  Solomon</span>, <span class="hlFld-ContribAuthor ">Lixia  Fu</span>, <span class="hlFld-ContribAuthor ">Kevin  Whelan</span>, <span class="hlFld-ContribAuthor ">Ling  Liu</span>, <span class="hlFld-ContribAuthor ">Hussien  Al-Shamma</span>, <span class="hlFld-ContribAuthor ">Joel  Gatlin</span>, <span class="hlFld-ContribAuthor ">Minh  Le</span>, <span class="hlFld-ContribAuthor ">Charles  Xing</span>, <span class="hlFld-ContribAuthor ">Sheryll  Espinola</span>, <span class="hlFld-ContribAuthor ">Robert M.  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (13)
                                     , 4404-4409. <a href="https://doi.org/10.1016/j.bmcl.2012.04.129" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.129%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFused%252Btricyclic%252Bindoles%252Bas%252BS1P1%252Bagonists%252Bwith%252Brobust%252Befficacy%252Bin%252Banimal%252Bmodels%252Bof%252Bautoimmune%252Bdisease%26aulast%3DBuzard%26aufirst%3DDaniel%2BJ.%26date%3D2012%26volume%3D22%26issue%3D13%26spage%3D4404%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masayoshi  Asano</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Yukiko  Sekiguchi</span>, <span class="hlFld-ContribAuthor ">Yumiko  Mizuno</span>, <span class="hlFld-ContribAuthor ">Takahiro  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Tamaki</span>, <span class="hlFld-ContribAuthor ">Takaichi  Shimozato</span>, <span class="hlFld-ContribAuthor ">Hiromi  Doi-Komuro</span>, <span class="hlFld-ContribAuthor ">Takashi  Kagari</span>, <span class="hlFld-ContribAuthor ">Wataru  Tomisato</span>, <span class="hlFld-ContribAuthor ">Ryotaku  Inoue</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Yuita</span>, <span class="hlFld-ContribAuthor ">Keiko  Oguchi-Oshima</span>, <span class="hlFld-ContribAuthor ">Reina  Kaneko</span>, <span class="hlFld-ContribAuthor ">Futoshi  Nara</span>, <span class="hlFld-ContribAuthor ">Yumi  Kawase</span>, <span class="hlFld-ContribAuthor ">Noriko  Masubuchi</span>, <span class="hlFld-ContribAuthor ">Shintaro  Nakayama</span>, <span class="hlFld-ContribAuthor ">Tetsufumi  Koga</span>, <span class="hlFld-ContribAuthor ">Eiko  Namba</span>, <span class="hlFld-ContribAuthor ">Hatsumi  Nasu</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of 1,3-thiazolyl thiophene and pyridine derivatives as potent, orally active and S1P3-sparing S1P1 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (9)
                                     , 3083-3088. <a href="https://doi.org/10.1016/j.bmcl.2012.03.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.03.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.03.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.03.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252B1%25252C3-thiazolyl%252Bthiophene%252Band%252Bpyridine%252Bderivatives%252Bas%252Bpotent%25252C%252Borally%252Bactive%252Band%252BS1P3-sparing%252BS1P1%252Bagonists%26aulast%3DAsano%26aufirst%3DMasayoshi%26date%3D2012%26volume%3D22%26issue%3D9%26spage%3D3083%26epage%3D3088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuyoshi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Asano</span>, <span class="hlFld-ContribAuthor ">Yukiko  Sekiguchi</span>, <span class="hlFld-ContribAuthor ">Yumiko  Mizuno</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Tamaki</span>, <span class="hlFld-ContribAuthor ">Futoshi  Nara</span>, <span class="hlFld-ContribAuthor ">Yumi  Kawase</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Yabe</span>, <span class="hlFld-ContribAuthor ">Daisuke  Nakai</span>, <span class="hlFld-ContribAuthor ">Emi  Kamiyama</span>, <span class="hlFld-ContribAuthor ">Yoko  Urasaki-Kaneno</span>, <span class="hlFld-ContribAuthor ">Takaichi  Shimozato</span>, <span class="hlFld-ContribAuthor ">Hiromi  Doi-Komuro</span>, <span class="hlFld-ContribAuthor ">Takashi  Kagari</span>, <span class="hlFld-ContribAuthor ">Wataru  Tomisato</span>, <span class="hlFld-ContribAuthor ">Ryotaku  Inoue</span>, <span class="hlFld-ContribAuthor ">Miyuki  Nagasaki</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Yuita</span>, <span class="hlFld-ContribAuthor ">Keiko  Oguchi-Oshima</span>, <span class="hlFld-ContribAuthor ">Reina  Kaneko</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of CS-2100, a potent, orally active and S1P3- sparing S1P1 agonist. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>51 </em>, 92-98. <a href="https://doi.org/10.1016/j.ejmech.2012.02.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2012.02.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2012.02.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2012.02.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252BCS-2100%25252C%252Ba%252Bpotent%25252C%252Borally%252Bactive%252Band%252BS1P3-%252Bsparing%252BS1P1%252Bagonist%26aulast%3DNakamura%26aufirst%3DTsuyoshi%26date%3D2012%26volume%3D51%26spage%3D92%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kenji  Chiba</span>, <span class="hlFld-ContribAuthor ">Kunitomo  Adachi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (6)
                                     , 771-781. <a href="https://doi.org/10.4155/fmc.12.25" title="DOI URL">https://doi.org/10.4155/fmc.12.25</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.25%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bfingolimod%25252C%252Bthe%252Bsphingosine%252B1-phosphate%252Breceptor%252Bmodulator%252Band%252Bits%252Bapplication%252Bfor%252Bthe%252Btherapy%252Bof%252Bmultiple%252Bsclerosis%26aulast%3DChiba%26aufirst%3DKenji%26date%3D2012%26volume%3D4%26issue%3D6%26spage%3D771%26epage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuyoshi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Masayoshi  Asano</span>, <span class="hlFld-ContribAuthor ">Yukiko  Sekiguchi</span>, <span class="hlFld-ContribAuthor ">Yumiko  Mizuno</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Tamaki</span>, <span class="hlFld-ContribAuthor ">Takako  Kimura</span>, <span class="hlFld-ContribAuthor ">Futoshi  Nara</span>, <span class="hlFld-ContribAuthor ">Yumi  Kawase</span>, <span class="hlFld-ContribAuthor ">Takaichi  Shimozato</span>, <span class="hlFld-ContribAuthor ">Hiromi  Doi</span>, <span class="hlFld-ContribAuthor ">Takashi  Kagari</span>, <span class="hlFld-ContribAuthor ">Wataru  Tomisato</span>, <span class="hlFld-ContribAuthor ">Ryotaku  Inoue</span>, <span class="hlFld-ContribAuthor ">Miyuki  Nagasaki</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Yuita</span>, <span class="hlFld-ContribAuthor ">Keiko  Oguchi-Oshima</span>, <span class="hlFld-ContribAuthor ">Reina  Kaneko</span>, <span class="hlFld-ContribAuthor ">Nobuaki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Abe</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (4)
                                     , 1788-1792. <a href="https://doi.org/10.1016/j.bmcl.2011.12.019" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.12.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.12.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.12.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BCS-2100%25252C%252Ba%252Bpotent%25252C%252Borally%252Bactive%252Band%252BS1P3-sparing%252BS1P1%252Bagonist%26aulast%3DNakamura%26aufirst%3DTsuyoshi%26date%3D2012%26volume%3D22%26issue%3D4%26spage%3D1788%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mike  Frohn</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Pickrell</span>, <span class="hlFld-ContribAuthor ">Jennifer  Golden</span>, <span class="hlFld-ContribAuthor ">Dalia  Rivenzon-Segal</span>, <span class="hlFld-ContribAuthor ">Scot  Middleton</span>, <span class="hlFld-ContribAuthor ">Mike  Fiorino</span>, <span class="hlFld-ContribAuthor ">Han  Xu</span>, <span class="hlFld-ContribAuthor ">Michael  Schrag</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Michele  McElvain</span>, <span class="hlFld-ContribAuthor ">Kristine  Muller</span>, <span class="hlFld-ContribAuthor ">Jerry  Siu</span>, <span class="hlFld-ContribAuthor ">Roland  Bürli</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5- and 6-subtituted benzothiazoles with improved physicochemical properties: Potent S1P1 agonists with in vivo lymphocyte-depleting activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 628-633. <a href="https://doi.org/10.1016/j.bmcl.2011.10.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.10.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.10.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252B5-%252Band%252B6-subtituted%252Bbenzothiazoles%252Bwith%252Bimproved%252Bphysicochemical%252Bproperties%25253A%252BPotent%252BS1P1%252Bagonists%252Bwith%252Bin%252Bvivo%252Blymphocyte-depleting%252Bactivity%26aulast%3DFrohn%26aufirst%3DMike%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D628%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lewis D.  Pennington</span>, <span class="hlFld-ContribAuthor ">Michael D.  Croghan</span>, <span class="hlFld-ContribAuthor ">Kelvin K.C.  Sham</span>, <span class="hlFld-ContribAuthor ">Alexander J.  Pickrell</span>, <span class="hlFld-ContribAuthor ">Paul E.  Harrington</span>, <span class="hlFld-ContribAuthor ">Michael J.  Frohn</span>, <span class="hlFld-ContribAuthor ">Brian A.  Lanman</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Reed</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Han  Xu</span>, <span class="hlFld-ContribAuthor ">Michele  McElvain</span>, <span class="hlFld-ContribAuthor ">Yang  Xu</span>, <span class="hlFld-ContribAuthor ">Xuxia  Zhang</span>, <span class="hlFld-ContribAuthor ">Michael  Fiorino</span>, <span class="hlFld-ContribAuthor ">Michelle  Horner</span>, <span class="hlFld-ContribAuthor ">Henry G.  Morrison</span>, <span class="hlFld-ContribAuthor ">Heather A.  Arnett</span>, <span class="hlFld-ContribAuthor ">Christopher  Fotsch</span>, <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>, <span class="hlFld-ContribAuthor ">Min  Wong</span>, <span class="hlFld-ContribAuthor ">Victor J.  Cee</span>. </span><span class="cited-content_cbyCitation_article-title">Quinolinone-based agonists of S1P1: Use of a N-scan SAR strategy to optimize in vitro and in vivo activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 527-531. <a href="https://doi.org/10.1016/j.bmcl.2011.10.085" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.10.085</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.10.085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.10.085%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQuinolinone-based%252Bagonists%252Bof%252BS1P1%25253A%252BUse%252Bof%252Ba%252BN-scan%252BSAR%252Bstrategy%252Bto%252Boptimize%252Bin%252Bvitro%252Band%252Bin%252Bvivo%252Bactivity%26aulast%3DPennington%26aufirst%3DLewis%2BD.%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D527%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haruto  Kurata</span>, <span class="hlFld-ContribAuthor ">Kensuke  Kusumi</span>, <span class="hlFld-ContribAuthor ">Kazuhiro  Otsuki</span>, <span class="hlFld-ContribAuthor ">Ryo  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masakuni  Kurono</span>, <span class="hlFld-ContribAuthor ">Natsuko  Tokuda</span>, <span class="hlFld-ContribAuthor ">Yuka  Takada</span>, <span class="hlFld-ContribAuthor ">Hiroki  Shioya</span>, <span class="hlFld-ContribAuthor ">Hirotaka  Mizuno</span>, <span class="hlFld-ContribAuthor ">Takaki  Komiya</span>, <span class="hlFld-ContribAuthor ">Takeji  Ono</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Hagiya</span>, <span class="hlFld-ContribAuthor ">Masashi  Minami</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakade</span>, <span class="hlFld-ContribAuthor ">Hiromu  Habashita</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationship studies of S1P agonists with a dihydronaphthalene scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (1)
                                     , 144-148. <a href="https://doi.org/10.1016/j.bmcl.2011.11.048" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.11.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.11.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.11.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationship%252Bstudies%252Bof%252BS1P%252Bagonists%252Bwith%252Ba%252Bdihydronaphthalene%252Bscaffold%26aulast%3DKurata%26aufirst%3DHaruto%26date%3D2012%26volume%3D22%26issue%3D1%26spage%3D144%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maiko  Hamada</span>, <span class="hlFld-ContribAuthor ">Kunitomo  Adachi</span>, <span class="hlFld-ContribAuthor ">Hidemasa  Hikawa</span>, <span class="hlFld-ContribAuthor ">Yuusaku  Yokoyama</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Key Intermediate for the Preparation of FTY720 Analogs. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2012,</strong> <em>60 </em>
                                    (11)
                                     , 1395-1398. <a href="https://doi.org/10.1248/cpb.c12-00477" title="DOI URL">https://doi.org/10.1248/cpb.c12-00477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c12-00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c12-00477%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DSynthesis%252Bof%252Ba%252BKey%252BIntermediate%252Bfor%252Bthe%252BPreparation%252Bof%252BFTY720%252BAnalogs%26aulast%3DHamada%26aufirst%3DMaiko%26date%3D2012%26volume%3D60%26issue%3D11%26spage%3D1395%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susan  Pyne</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Pyne</span>. </span><span class="cited-content_cbyCitation_article-title">Translational aspects of sphingosine 1-phosphate biology. </span><span class="cited-content_cbyCitation_journal-name">Trends in Molecular Medicine</span><span> <strong>2011,</strong> <em>17 </em>
                                    (8)
                                     , 463-472. <a href="https://doi.org/10.1016/j.molmed.2011.03.002" title="DOI URL">https://doi.org/10.1016/j.molmed.2011.03.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmed.2011.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmed.2011.03.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Molecular%2520Medicine%26atitle%3DTranslational%252Baspects%252Bof%252Bsphingosine%252B1-phosphate%252Bbiology%26aulast%3DPyne%26aufirst%3DSusan%26date%3D2011%26volume%3D17%26issue%3D8%26spage%3D463%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of FTY720 (<b>1</b>) and the Active Form, FTY720-P (<b>1</b>-<b>P</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1.  Synthesis of Intermediate Bromides <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) MsCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt; (b) NaI, 2-butanone, reflux; (c) <i>N</i>-protected diethyl aminomalonate, NaH, DMF, 60 °C; (d) NaBH<sub>4</sub>, CaCl<sub>2</sub>, EtOH/H<sub>2</sub>O, rt; (e) Ac<sub>2</sub>O, pyridine, rt; (f) 2,2-dimethoxypropane, <i>p-</i>TsOH·H<sub>2</sub>O, acetone, rt; (g) (i) 4 M HCl/EtOAc, (ii) Ac<sub>2</sub>O, pyridine, rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2.  Synthesis of Biphenyl Compounds <b>3</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (method A) boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, 65 °C; (method B) (i) bis(pinacolate)diboron, PdCl<sub>2</sub>(Cy<sub>3</sub>P)<sub>2</sub>, AcOK, dioxane, 100 °C, (ii) phenyl bromide, Pd(OAc)<sub>2</sub>, S-Phos, K<sub>3</sub>PO<sub>4</sub>, toluene, 100 °C; (a) 35% HCl, EtOH, reflux; (b) LiOH, THF/MeOH/H<sub>2</sub>O, reflux.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3.  Synthesis of Compounds <b>4</b> and <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 10% Pd/C, NH<sub>4</sub>CO<sub>2</sub>H, MeOH, rt; (b) Tf<sub>2</sub>O, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, rt; (c) 1-pentyne, PdCl<sub>2</sub>(CH<sub>3</sub>CN)<sub>2</sub>, X-Phos, Cs<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C; (d) LiOH, MeOH/H<sub>2</sub>O, reflux; (e) 10% Pd/C, MeOH, rt; (f) 4 M HCl/EtOAc, MeOH/EtOAc, rt; (g) <i>p</i>-tolylboronic acid, Cu(OAc)<sub>2</sub>, pyridine, 4 Å molecular sieves, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4.  Synthesis of Diaryl Sulfides <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) bis(neopentyl glycolate)diboron, PdCl<sub>2</sub>(Cy<sub>3</sub>P)<sub>2</sub>, AcOK, dioxane, 100 °C; (b) iodobenzene, Pd(PPh<sub>3</sub>)<sub>4</sub>, NaHCO<sub>3</sub>, DME/H<sub>2</sub>O, 100 °C; (c) thiol, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, DIPEA, dioxane, reflux; (d) 35% HCl, EtOH, 70 °C.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0012.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5.  Phosphorylation of <b>3</b>, <b>4</b>, and <b>5</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>C(OEt)<sub>3</sub>, DIPEA, DMF, 120 °C; (b) (i) (<i>t</i>-BuO)<sub>2</sub>PN(<i>i</i>-Pr)<sub>2</sub>, 1<i>H</i>-tetrazole, CH<sub>2</sub>Cl<sub>2</sub>, rt; (ii) <i>m</i>-CPBA, rt; (c) 35% HCl, EtOH, 50 °C.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6.  Synthesis of Phosphate Esters of <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 35% HCl, EtOH, 80 °C; (b) CH<sub>3</sub>C(OEt)<sub>3</sub>, DIPEA, DMF, 120 °C; (c) (i) (<i>t</i>-BuO)<sub>2</sub>PN(<i>i</i>-Pr)<sub>2</sub>, 1<i>H</i>-tetrazole, CH<sub>2</sub>Cl<sub>2</sub>, rt; (ii) <i>t</i>-Butyl hydroperoxide, rt; (d) thiol, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>·CHCl<sub>3</sub>, DIPEA, dioxane, reflux; (e) 35% HCl, EtOH, 50 °C.</p></p></figure><figure data-id="fig1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/medium/jm-2009-01776q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Effects of compounds <b>1</b> (A) and <b>6d</b> (B) on heart rate in conscious rats (10 mg/kg, po). ΔHeart rate means the change (beat/min) of post-treatment value (day 0) compared to the mean of pretreatment values (from day −3 to day −1) at the corresponding time of each day in the same animals. *: p < 0.05, ** : p < 0.01, significantly different from the corresponding value in the vehicle group (<i>n</i> = 3 or 4, paired <i>t</i>-test). Vehicle background date represent the mean ± SD of each time point data (<i>n</i> = 38). </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-8/jm901776q/production/images/large/jm-2009-01776q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901776q&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i113">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Spiegel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milstien, S.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate: an enigmatic signaling lipid</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1038%2Fnrm1103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=12728273" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=397-407&author=S.+Spiegelauthor=S.+Milstien&title=Sphingosine-1-phosphate%3A+an+enigmatic+signaling+lipid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Sphingosine-1-phosphate: an enigmatic signalling lipid</span></div><div class="casAuthors">Spiegel, Sarah; Milstien, Sheldon</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">397-407</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The evolutionarily conserved actions of the sphingolipid metabolite, sphingosine-1-phosphate (S1P), in yeast, plants, and mammals have shown that it has important functions.  In higher eukaryotes, S1P is the ligand for a family of 5 G protein-coupled receptors.  These S1P receptors are differentially expressed, coupled to various G proteins, and regulate angiogenesis, vascular maturation, cardiac development, and immunity, and are important for directed cell movement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0XUAxYZwqLVg90H21EOLACvtfcHk0ljm_ntn0HvWvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlalt7o%253D&md5=689a33cfeb4bae72637b64cd90e6c910</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm1103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1103%26sid%3Dliteratum%253Aachs%26aulast%3DSpiegel%26aufirst%3DS.%26aulast%3DMilstien%26aufirst%3DS.%26atitle%3DSphingosine-1-phosphate%253A%2520an%2520enigmatic%2520signaling%2520lipid%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2003%26volume%3D4%26spage%3D397%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">Sphingosine-1-phosphate receptors and the development of the vascular system</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1582</span><span class="NLM_x"> (</span><span class="NLM_issue">1−3</span><span class="NLM_x">) </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1582&publication_year=2002&pages=222-227&issue=1%E2%88%923&author=M.+L.+Allendeauthor=R.+L.+Proia&title=Sphingosine-1-phosphate+receptors+and+the+development+of+the+vascular+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DSphingosine-1-phosphate%2520receptors%2520and%2520the%2520development%2520of%2520the%2520vascular%2520system%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1582%26issue%3D1%25E2%2588%25923%26spage%3D222%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span> </span><span class="NLM_article-title">G-protein-coupled receptor S1P<sub>1</sub> acts within endothelial cells to regulate vascular maturation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3665</span><span class="NLM_x">–</span> <span class="NLM_lpage">3667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2003&pages=3665-3667&author=M.+L.+Allendeauthor=T.+Yamashitaauthor=R.+L.+Proia&title=G-protein-coupled+receptor+S1P1+acts+within+endothelial+cells+to+regulate+vascular+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DProia%26aufirst%3DR.%2BL.%26atitle%3DG-protein-coupled%2520receptor%2520S1P1%2520acts%2520within%2520endothelial%2520cells%2520to%2520regulate%2520vascular%2520maturation%26jtitle%3DBlood%26date%3D2003%26volume%3D102%26spage%3D3665%26epage%3D3667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span> </span><span class="NLM_article-title">Design, synthesis, and structure−activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">853</span><span class="NLM_x">–</span> <span class="NLM_lpage">856</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=853-856&author=K.+Adachiauthor=T.+Koharaauthor=N.+Nakaoauthor=M.+Aritaauthor=K.+Chibaauthor=T.+Mishinaauthor=S.+Sasakiauthor=T.+Fujita&title=Design%2C+synthesis%2C+and+structure%E2%88%92activity+relationships+of+2-substituted-2-amino-1%2C3-propanediols%3A+discovery+of+a+novel+immunosuppressant%2C+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DNakao%26aufirst%3DN.%26aulast%3DArita%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DMishina%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DT.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%25202-substituted-2-amino-1%252C3-propanediols%253A%2520discovery%2520of%2520a%2520novel%2520immunosuppressant%252C%2520FTY720%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D853%26epage%3D856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minoguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishina, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teshima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, T.</span><span> </span><span class="NLM_article-title">Synthesis and Immunosuppressive Activity of 2-Substituted 2-Aminopropane-1,3-diols and 2-Aminoethanols</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2946</span><span class="NLM_x">–</span> <span class="NLM_lpage">2961</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000173z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2946-2961&author=M.+Kiuchiauthor=K.+Adachiauthor=T.+Koharaauthor=M.+Minoguchiauthor=T.+Hananoauthor=Y.+Aokiauthor=T.+Mishinaauthor=M.+Aritaauthor=N.+Nakaoauthor=M.+Ohtsukiauthor=Y.+Hoshinoauthor=K.+Teshimaauthor=K.+Chibaauthor=S.+Sasakiauthor=T.+Fujita&title=Synthesis+and+Immunosuppressive+Activity+of+2-Substituted+2-Aminopropane-1%2C3-diols+and+2-Aminoethanols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm000173z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000173z%26sid%3Dliteratum%253Aachs%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DMinoguchi%26aufirst%3DM.%26aulast%3DHanano%26aufirst%3DT.%26aulast%3DAoki%26aufirst%3DY.%26aulast%3DMishina%26aufirst%3DT.%26aulast%3DArita%26aufirst%3DM.%26aulast%3DNakao%26aufirst%3DN.%26aulast%3DOhtsuki%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DTeshima%26aufirst%3DK.%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DT.%26atitle%3DSynthesis%2520and%2520Immunosuppressive%2520Activity%2520of%25202-Substituted%25202-Aminopropane-1%252C3-diols%2520and%25202-Aminoethanols%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2946%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chiba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masubuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawaguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtsuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span> </span><span class="NLM_article-title">FTY720, a Novel Immunosuppressant, Induces Sequestration of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing in Rats. I. FTY720 Selectively Decreases the Number of Circulating Mature Lymphocytes by Acceleration of Lymphocyte Homing</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">5037</span><span class="NLM_x">–</span> <span class="NLM_lpage">5044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=9590253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1998&pages=5037-5044&author=K.+Chibaauthor=Y.+Yanagawaauthor=Y.+Masubuchiauthor=H.+Kataokaauthor=T.+Kawaguchiauthor=M.+Ohtsukiauthor=Y.+Hoshino&title=FTY720%2C+a+Novel+Immunosuppressant%2C+Induces+Sequestration+of+Circulating+Mature+Lymphocytes+by+Acceleration+of+Lymphocyte+Homing+in+Rats.+I.+FTY720+Selectively+Decreases+the+Number+of+Circulating+Mature+Lymphocytes+by+Acceleration+of+Lymphocyte+Homing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing</span></div><div class="casAuthors">Chiba, Kenji; Yanagawa, Yoshiki; Masubuchi, Yumi; Kataoka, Hirotoshi; Kawaguchi, Takafumi; Ohtsuki, Makio; Hoshino, Yukio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5037-5044</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">FTY720, given i.v. or orally at 0.03 mg/kg or more, prolonged skin allograft survival in a dose-dependent manner and showed more potent immunosuppressive activity than cyclosporin A (CsA) or tacrolimus (FK506) in MHC-incompatible rat strains of WKAH donors and F344 recipients.  However, unlike CsA or FK506, FTY720 up to 1000 nM did not affect IL-2 prodn. in allogeneic MLC.  Within 3-24 h after a single oral administration of FTY720 at 0.1-1 mg/kg, the no. of lymphocytes in the rats was markedly decreased in the peripheral blood and thoracic duct lymph and partially in spleen.  By contrast, the no. of lymphocytes in peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN), and Peyer's patches (PP) was increased at the same time.  I.v. transfusion of calcein-labeled rat lymphocytes into rats revealed that FTY720 accelerated lymphocyte homing to PLN, MLN, and PP, dose dependently.  Since FTY720-induced lymphocyte homing was completely blocked by simultaneous treatment of the calcein-labeled lymphocytes with mAbs against CD62L, CD49d, and CD11a before the transfusion, the acceleration of lymphocyte homing by FTY720 appears to be mediated by lymphocyte-homing receptors.  Thus, FTY720 sequesters circulating mature lymphocytes into PLN, MLN, and PP by acceleration of lymphocyte homing and thereby decreases the no. of lymphocytes in peripheral blood, thoracic duct lymph, and spleen.  Based on these observations, sequestration of circulating mature-lymphocytes is presumed to be a main mechanism of the immunosuppressive activity of FTY720.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeImxxYccaHrVg90H21EOLACvtfcHk0lh9qsb0DnoKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtVamsrY%253D&md5=db7da181424c790a0fb07c0dc60badae</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiba%26aufirst%3DK.%26aulast%3DYanagawa%26aufirst%3DY.%26aulast%3DMasubuchi%26aufirst%3DY.%26aulast%3DKataoka%26aufirst%3DH.%26aulast%3DKawaguchi%26aufirst%3DT.%26aulast%3DOhtsuki%26aufirst%3DM.%26aulast%3DHoshino%26aufirst%3DY.%26atitle%3DFTY720%252C%2520a%2520Novel%2520Immunosuppressant%252C%2520Induces%2520Sequestration%2520of%2520Circulating%2520Mature%2520Lymphocytes%2520by%2520Acceleration%2520of%2520Lymphocyte%2520Homing%2520in%2520Rats.%2520I.%2520FTY720%2520Selectively%2520Decreases%2520the%2520Number%2520of%2520Circulating%2520Mature%2520Lymphocytes%2520by%2520Acceleration%2520of%2520Lymphocyte%2520Homing%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D160%26spage%3D5037%26epage%3D5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Kharel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheasley-O’Neill, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setiady, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zigler, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burcin, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, K. S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhard, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson-White, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">Sphingosine Kinase 2 Is Required for Modulation of Lymphocyte Traffic by FTY720</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">36865</span><span class="NLM_x">–</span> <span class="NLM_lpage">36872</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=36865-36872&author=Y.+Kharelauthor=S.+Leeauthor=A.+H.+Snyderauthor=S.+L.+Sheasley-O%E2%80%99Neillauthor=M.+A.+Morrisauthor=Y.+Setiadyauthor=R.+Zhuauthor=M.+A.+Ziglerauthor=T.+L.+Burcinauthor=K.+Leyauthor=K.+S.+K.+Tungauthor=V.+H.+Engelhardauthor=T.+L.+Macdonaldauthor=S.+Pearson-Whiteauthor=K.+R.+Lynch&title=Sphingosine+Kinase+2+Is+Required+for+Modulation+of+Lymphocyte+Traffic+by+FTY720"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKharel%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSnyder%26aufirst%3DA.%2BH.%26aulast%3DSheasley-O%25E2%2580%2599Neill%26aufirst%3DS.%2BL.%26aulast%3DMorris%26aufirst%3DM.%2BA.%26aulast%3DSetiady%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DZigler%26aufirst%3DM.%2BA.%26aulast%3DBurcin%26aufirst%3DT.%2BL.%26aulast%3DLey%26aufirst%3DK.%26aulast%3DTung%26aufirst%3DK.%2BS.%2BK.%26aulast%3DEngelhard%26aufirst%3DV.%2BH.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26aulast%3DPearson-White%26aufirst%3DS.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DSphingosine%2520Kinase%25202%2520Is%2520Required%2520for%2520Modulation%2520of%2520Lymphocyte%2520Traffic%2520by%2520FTY720%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D36865%26epage%3D36872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Mandala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quackenbush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupprecht, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span> </span><span class="NLM_article-title">Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span><span class="NLM_x">–</span> <span class="NLM_lpage">349</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=346-349&author=S.+Mandalaauthor=R.+Hajduauthor=J.+Bergstromauthor=E.+Quackenbushauthor=J.+Xieauthor=J.+Milliganauthor=R.+Thorntonauthor=G.+J.+Sheiauthor=D.+Cardauthor=C.+Keohaneauthor=M.+Rosenbachauthor=J.+Haleauthor=C.+L.+Lynchauthor=K.+Rupprechtauthor=W.+Parsonsauthor=H.+Rosen&title=Alteration+of+Lymphocyte+Trafficking+by+Sphingosine-1-Phosphate+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMandala%26aufirst%3DS.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DQuackenbush%26aufirst%3DE.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DThornton%26aufirst%3DR.%26aulast%3DShei%26aufirst%3DG.%2BJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DRupprecht%26aufirst%3DK.%26aulast%3DParsons%26aufirst%3DW.%26aulast%3DRosen%26aufirst%3DH.%26atitle%3DAlteration%2520of%2520Lymphocyte%2520Trafficking%2520by%2520Sphingosine-1-Phosphate%2520Receptor%2520Agonists%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heise, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cottens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieschl, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumruker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zollinger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span> </span><span class="NLM_article-title">The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">21453</span><span class="NLM_x">–</span> <span class="NLM_lpage">21457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1074%2Fjbc.C200176200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=11967257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=21453-21457&author=V.+Brinkmannauthor=M.+D.+Davisauthor=C.+E.+Heiseauthor=R.+Albertauthor=S.+Cottensauthor=R.+Hofauthor=C.+Brunsauthor=E.+Prieschlauthor=T.+Baumrukerauthor=P.+Hiestandauthor=C.+A.+Fosterauthor=M.+Zollingerauthor=K.+R.+Lynch&title=The+Immune+Modulator+FTY720+Targets+Sphingosine+1-Phosphate+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The immune modulator FTY720 targets sphingosine 1-phosphate receptors</span></div><div class="casAuthors">Brinkmann, Volker; Davis, Michael D.; Heise, Christopher E.; Albert, Rainer; Cottens, Sylvain; Hof, Robert; Bruns, Christian; Prieschl, Eva; Baumruker, Thomas; Hiestand, Peter; Foster, Carolyn A.; Zollinger, Markus; Lynch, Kevin R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">21453-21457</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Immunosuppressant drugs such as cyclosporin have allowed widespread organ transplantation, but their utility remains limited by toxicities, and they are ineffective in chronic management of autoimmune diseases such as multiple sclerosis.  In contrast, the immune modulating drug FTY720 is efficacious in a variety of transplant and autoimmune models without inducing a generalized immunosuppressed state and is effective in human kidney transplantation.  FTY720 elicits a lymphopenia resulting from a reversible redistribution of lymphocytes from circulation to secondary lymphoid tissues by unknown mechanisms.  Using FTY720 and several analogs, we show now that FTY720 is phosphorylated by sphingosine kinase; the phosphorylated compd. is a potent agonist at four sphingosine 1-phosphate receptors and represents the therapeutic principle in a rodent model of multiple sclerosis.  Our results suggest that FTY720, after phosphorylation, acts through sphingosine 1-phosphate signaling pathways to modulate chemotactic responses and lymphocyte trafficking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_6zyZnHOYNbVg90H21EOLACvtfcHk0ljF5SVEEhhpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xkslyqtb4%253D&md5=b59856fffa9ebae7fb8182d18daa025f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200176200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200176200%26sid%3Dliteratum%253Aachs%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DDavis%26aufirst%3DM.%2BD.%26aulast%3DHeise%26aufirst%3DC.%2BE.%26aulast%3DAlbert%26aufirst%3DR.%26aulast%3DCottens%26aufirst%3DS.%26aulast%3DHof%26aufirst%3DR.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DPrieschl%26aufirst%3DE.%26aulast%3DBaumruker%26aufirst%3DT.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DFoster%26aufirst%3DC.%2BA.%26aulast%3DZollinger%26aufirst%3DM.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26atitle%3DThe%2520Immune%2520Modulator%2520FTY720%2520Targets%2520Sphingosine%25201-Phosphate%2520Receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D21453%26epage%3D21457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinamon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesneski, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allende, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2004&pages=355-360&author=M.+Matloubianauthor=C.+G.+Loauthor=G.+Cinamonauthor=M.+J.+Lesneskiauthor=Y.+Xuauthor=V.+Brinkmannauthor=M.+L.+Allendeauthor=R.+L.+Proiaauthor=J.+G.+Cyster&title=Lymphocyte+egress+from+thymus+and+peripheral+lymphoid+organs+is+dependent+on+S1P+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DLo%26aufirst%3DC.%2BG.%26aulast%3DCinamon%26aufirst%3DG.%26aulast%3DLesneski%26aufirst%3DM.%2BJ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DAllende%26aufirst%3DM.%2BL.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520egress%2520from%2520thymus%2520and%2520peripheral%2520lymphoid%2520organs%2520is%2520dependent%2520on%2520S1P%2520receptor%25201%26jtitle%3DNature%26date%3D2004%26volume%3D427%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kappos, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalban, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polman, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haas, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korn, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radue, E. W.</span><span> </span><span class="NLM_article-title">Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1056%2FNEJMoa052643" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=16971719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=1124-1140&author=L.+Kapposauthor=J.+Antelauthor=G.+Comiauthor=X.+Montalbanauthor=P.+O%E2%80%99Connorauthor=C.+H.+Polmanauthor=T.+Haasauthor=A.+A.+Kornauthor=G.+Karlssonauthor=E.+W.+Radue&title=Oral+Fingolimod+%28FTY720%29+for+Relapsing+Multiple+Sclerosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oral fingolimod (FTY720) for relapsing multiple sclerosis</span></div><div class="casAuthors">Kappos, Ludwig; Antel, Jack; Comi, Giancarlo; Montalban, Xavier; O'Connor, Paul; Polman, Chris H.; Haas, Tomas; Korn, Alexander A.; Karlsson, Goeril; Radue, Ernst W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1124-1140</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Fingolimod (FTY720) is a new oral immunomodulating agent under evaluation for the treatment of relapsing multiple sclerosis.  We randomly assigned 281 patients to receive oral fingolimod, at a dose of 1.25 mg or 5.0 mg, or a placebo once daily, and we followed these patients for 6 mo with magnetic resonance imaging (MRI) and clin. evaluations (core study, months 0 to 6).  The primary end point was the total no. of gadolinium-enhanced lesions recorded on T1-weighted MRI at monthly intervals for 6 mo.  In an extension study in which the investigators and patients remained unaware of the dose assignments (months 7 to 12), patients who received placebo underwent randomization again to one of the fingolimod doses.  A total of 255 patients completed the core study.  The median total no. of gadolinium-enhanced lesions on MRI was lower with 1.25 mg of fingolimod (1 lesion, P < 0.001) and 5.0 mg of fingolimod (3 lesions, P = 0.006) than with placebo (5 lesions).  The annualized relapse rate was 0.77 in the placebo group, as compared with 0.35 in the group given 1.25 mg of fingolimod (P = 0.009) and 0.36 in the group given 5.0 mg of fingolimod (P = 0.01).  For the 227 patients who completed the extension study, the no. of gadolinium-enhanced lesions and relapse rates remained low in the groups that received continuous fingolimod, and both measures decreased in patients who switched from placebo to fingolimod.  Adverse events included nasopharyngitis, dyspnea, headache, diarrhea, and nausea.  Clin. asymptomatic elevations of alanine aminotransferase levels were more frequent with fingolimod (10 to 12%, vs. 1% in the placebo group).  One case of the posterior reversible encephalopathy syndrome occurred in the 5.0-mg group.  Fingolimod was also assocd. with an initial redn. in the heart rate and a modest decrease in the forced expiratory vol. in 1 s.  In this proof-of-concept study, fingolimod reduced the no. of lesions detected on MRI and clin. disease activity in patients with multiple sclerosis.  Evaluation in larger, longer-term studies is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4MSvDIuvV7Vg90H21EOLACvtfcHk0ljF5SVEEhhpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsFKku78%253D&md5=2a84e8f5fb92091782406da9dcbc1453</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052643%26sid%3Dliteratum%253Aachs%26aulast%3DKappos%26aufirst%3DL.%26aulast%3DAntel%26aufirst%3DJ.%26aulast%3DComi%26aufirst%3DG.%26aulast%3DMontalban%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DPolman%26aufirst%3DC.%2BH.%26aulast%3DHaas%26aufirst%3DT.%26aulast%3DKorn%26aufirst%3DA.%2BA.%26aulast%3DKarlsson%26aufirst%3DG.%26aulast%3DRadue%26aufirst%3DE.%2BW.%26atitle%3DOral%2520Fingolimod%2520%2528FTY720%2529%2520for%2520Relapsing%2520Multiple%2520Sclerosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D1124%26epage%3D1140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Schwab, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matloubian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cyster, J. G.</span><span> </span><span class="NLM_article-title">Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">1735</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2005&pages=1735-1739&author=S.+R.+Schwabauthor=J.+P.+Pereiraauthor=M.+Matloubianauthor=Y.+Xuauthor=Y.+Huangauthor=J.+G.+Cyster&title=Lymphocyte+Sequestration+Through+S1P+Lyase+Inhibition+and+Disruption+of+S1P+Gradients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwab%26aufirst%3DS.%2BR.%26aulast%3DPereira%26aufirst%3DJ.%2BP.%26aulast%3DMatloubian%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCyster%26aufirst%3DJ.%2BG.%26atitle%3DLymphocyte%2520Sequestration%2520Through%2520S1P%2520Lyase%2520Inhibition%2520and%2520Disruption%2520of%2520S1P%2520Gradients%26jtitle%3DScience%26date%3D2005%26volume%3D309%26spage%3D1735%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bagdanoff, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoviel, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nouraldeen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarver, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jessop, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazelwood, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baugh, S. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardyan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terranova, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednarz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Digeorge-Foushee, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopinathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruce, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimball, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaffield, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Main, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oravecz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span> </span><span class="NLM_article-title">Inhibition of Sphingosine-1-Phosphate Lyase for the Treatment of Autoimmune Disorders</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3941</span><span class="NLM_x">–</span> <span class="NLM_lpage">3953</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900278w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3941-3953&author=J.+T.+Bagdanoffauthor=M.+S.+Donovielauthor=A.+Nouraldeenauthor=J.+Tarverauthor=Q.+Fuauthor=M.+Carlsenauthor=T.+C.+Jessopauthor=H.+Zhangauthor=J.+Hazelwoodauthor=H.+Nguyenauthor=S.+D.+P.+Baughauthor=M.+Gardyanauthor=K.+M.+Terranovaauthor=J.+Barbosaauthor=J.+Yanauthor=M.+Bednarzauthor=S.+Layekauthor=L.+F.+Courtneyauthor=J.+Taylorauthor=A.+M.+Digeorge-Fousheeauthor=S.+Gopinathanauthor=D.+Bruceauthor=T.+Smithauthor=L.+Moranauthor=E.+O%E2%80%99Neillauthor=J.+Kramerauthor=Z.+Laiauthor=S.+D.+Kimballauthor=Q.+Liuauthor=W.+Sunauthor=S.+Yuauthor=J.+Swaffieldauthor=A.+Wilsonauthor=A.+Mainauthor=K.+G.+Carsonauthor=T.+Oraveczauthor=D.+J.+Augeri&title=Inhibition+of+Sphingosine-1-Phosphate+Lyase+for+the+Treatment+of+Autoimmune+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm900278w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900278w%26sid%3Dliteratum%253Aachs%26aulast%3DBagdanoff%26aufirst%3DJ.%2BT.%26aulast%3DDonoviel%26aufirst%3DM.%2BS.%26aulast%3DNouraldeen%26aufirst%3DA.%26aulast%3DTarver%26aufirst%3DJ.%26aulast%3DFu%26aufirst%3DQ.%26aulast%3DCarlsen%26aufirst%3DM.%26aulast%3DJessop%26aufirst%3DT.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHazelwood%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DBaugh%26aufirst%3DS.%2BD.%2BP.%26aulast%3DGardyan%26aufirst%3DM.%26aulast%3DTerranova%26aufirst%3DK.%2BM.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DBednarz%26aufirst%3DM.%26aulast%3DLayek%26aufirst%3DS.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DDigeorge-Foushee%26aufirst%3DA.%2BM.%26aulast%3DGopinathan%26aufirst%3DS.%26aulast%3DBruce%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DT.%26aulast%3DMoran%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%26aulast%3DKramer%26aufirst%3DJ.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DKimball%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DSwaffield%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DA.%26aulast%3DMain%26aufirst%3DA.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DOravecz%26aufirst%3DT.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26atitle%3DInhibition%2520of%2520Sphingosine-1-Phosphate%2520Lyase%2520for%2520the%2520Treatment%2520of%2520Autoimmune%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3941%26epage%3D3953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Dragun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsche, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehler, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budde, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumaye, H. H.</span><span> </span><span class="NLM_article-title">FTY720: Early Clinical Experience</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">544S</span><span class="NLM_x">–</span> <span class="NLM_lpage">548S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2004&pages=544S-548S&author=D.+Dragunauthor=L+Fritscheauthor=T+Boehlerauthor=H.+Petersauthor=K.+Buddeauthor=H.+H.+Neumaye&title=FTY720%3A+Early+Clinical+Experience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDragun%26aufirst%3DD.%26aulast%3DFritsche%26aufirst%3DL%26aulast%3DBoehler%26aufirst%3DT%26aulast%3DPeters%26aufirst%3DH.%26aulast%3DBudde%26aufirst%3DK.%26aulast%3DNeumaye%26aufirst%3DH.%2BH.%26atitle%3DFTY720%253A%2520Early%2520Clinical%2520Experience%26jtitle%3DTransplant.%2520Proc.%26date%3D2004%26volume%3D36%26spage%3D544S%26epage%3D548S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyers, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proia, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S.</span><span> </span><span class="NLM_article-title">Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">309</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">768</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1124%2Fjpet.103.062828" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=14747617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=309&publication_year=2004&pages=758-768&author=M.+Forrestauthor=S.-Y.+Sunauthor=R.+Hajduauthor=J.+Bergstromauthor=D.+Cardauthor=G.+Dohertyauthor=J.+Haleauthor=C.+Keohaneauthor=C.+Meyersauthor=J.+Milliganauthor=S.+Millsauthor=N.+Nomuraauthor=H.+Rosenauthor=M.+Rosenbachauthor=G.-J.+Sheiauthor=I.+I.+Singerauthor=M.+Tianauthor=S.+Westauthor=V.+Whiteauthor=J.+Xieauthor=R.+L.+Proiaauthor=S.+Mandala&title=Immune+Cell+Regulation+and+Cardiovascular+Effects+of+Sphingosine+1-Phosphate+Receptor+Agonists+in+Rodents+Are+Mediated+via+Distinct+Receptor+Subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes</span></div><div class="casAuthors">Forrest, M.; Sun, S.-Y.; Hajdu, R.; Bergstrom, J.; Card, D.; Doherty, G.; Hale, J.; Keohane, C.; Meyers, C.; Milligan, J.; Mills, S.; Nomura, N.; Rosen, H.; Rosenbach, M.; Shei, G.-J.; Singer, I. I.; Tian, M.; West, S.; White, V.; Xie, J.; Proia, R. L.; Mandala, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">309</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">758-768</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Sphingosine 1-phosphate (S1P) is a bioactive lysolipid with pleiotropic functions mediated through a family of G protein-coupled receptors, S1P1,2,3,4,5.  Physiol. effects of S1P receptor agonists include regulation of cardiovascular function and immunosuppression via redistribution of lymphocytes from blood to secondary lymphoid organs.  The phosphorylated metabolite of the immunosuppressant agent FTY720 (2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol) and other phosphonate analogs with differential receptor selectivity were investigated.  No significant species differences in compd. potency or rank order of activity on receptors cloned from human, murine, and rat sources were obsd.  All synthetic analogs were high-affinity agonists on S1P1, with IC50 values for ligand binding between 0.3 and 14 nM.  The correlation between S1P1 receptor activation and the ED50 for lymphocyte redn. was highly significant (p < 0.001) and lower for the other receptors.  In contrast to S1P1-mediated effects on lymphocyte recirculation, three lines of evidence link S1P3 receptor activity with acute toxicity and cardiovascular regulation: compd. potency on S1P3 correlated with toxicity and bradycardia; the shift in potency of phosphorylated-FTY720 for inducing lymphopenia vs. bradycardia and hypertension was consistent with affinity for S1P1 relative to S1P3; and toxicity, bradycardia, and hypertension were absent in S1P3-/- mice.  Blood pressure effects of agonists in anesthetized rats were complex, whereas hypertension was the predominant effect in conscious rats and mice.  Immunolocalization of S1P3 in rodent heart revealed abundant expression on myocytes and perivascular smooth muscle cells consistent with regulation of bradycardia and hypertension, whereas S1P1 expression was restricted to the vascular endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKo2vpih4eoLVg90H21EOLACvtfcHk0ljenJEtpxrXNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygsrg%253D&md5=27183d4991bffbc5d2b88174b1386d5a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.062828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.062828%26sid%3Dliteratum%253Aachs%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DS.-Y.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DDoherty%26aufirst%3DG.%26aulast%3DHale%26aufirst%3DJ.%26aulast%3DKeohane%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DC.%26aulast%3DMilligan%26aufirst%3DJ.%26aulast%3DMills%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DRosenbach%26aufirst%3DM.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DSinger%26aufirst%3DI.%2BI.%26aulast%3DTian%26aufirst%3DM.%26aulast%3DWest%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DV.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DProia%26aufirst%3DR.%2BL.%26aulast%3DMandala%26aufirst%3DS.%26atitle%3DImmune%2520Cell%2520Regulation%2520and%2520Cardiovascular%2520Effects%2520of%2520Sphingosine%25201-Phosphate%2520Receptor%2520Agonists%2520in%2520Rodents%2520Are%2520Mediated%2520via%2520Distinct%2520Receptor%2520Subtypes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D309%26spage%3D758%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Pan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pally, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerini, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinterding, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuesslein-H., B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruns, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. A</span><span> </span><span class="NLM_article-title">Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1227</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1016%2Fj.chembiol.2006.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=17114004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cis7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1227-1234&author=S.+Panauthor=Y.+Miauthor=C.+Pallyauthor=C.+Beerliauthor=A.+Chenauthor=D.+Gueriniauthor=K.+Hinterdingauthor=B.+Nuesslein-H.author=T.+Tuntlandauthor=S.+Lefebvreauthor=Y.+Liuauthor=W.+Gaoauthor=A.+Chuauthor=V.+Brinkmannauthor=C.+Brunsauthor=M.+Streiffauthor=C.+Cannetauthor=N.+Cookeauthor=N.+A+Gray&title=Monoselective+Sphingosine-1-Phosphate+Receptor-1+Agonist+Prevents+Allograft+Rejection+in+a+Stringent+Rat+Heart+Transplantation+Model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Monoselective Sphingosine-1-Phosphate Receptor-1 Agonist Prevents Allograft Rejection in a Stringent Rat Heart Transplantation Model</span></div><div class="casAuthors">Pan, Shifeng; Mi, Yuan; Pally, Charles; Beerli, Christian; Chen, Alice; Guerini, Danilo; Hinterding, Klaus; Nuesslein-Hildesheim, Barbara; Tuntland, Tove; Lefebvre, Sophie; Liu, Yi; Gao, Wenqi; Chu, Alan; Brinkmann, Volker; Bruns, Christian; Streiff, Markus; Cannet, Catherine; Cooke, Nigel; Gray, Nathanael</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1227-1234</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">FTY720 is an immunomodulator with demonstrated efficacy in a phase II trial of relapsing multiple sclerosis.  FTY720-phosphate, the active metabolite generated upon phosphorylation in vivo, acts as a potent agonist on 4 of the 5 known sphingosine-1-phosphate (S1P1) receptors.  AUY954, an aminocarboxylate analog of FTY720, is a low nanomolar, monoselective agonist of the S1P1 receptor.  Due to its selectivity and pharmacokinetic profile, AUY954 is an excellent pharmacol. probe of S1P1-dependent phenomena.  Oral administration of AUY954 induces a profound and reversible redn. of circulating lymphocytes and, in combination with RAD001 (Certican/Everolimus, an mTOR inhibitor), is capable of prolonging the survival of cardiac allografts in a stringent rat transplantation model.  This demonstrates that a selective agonist of the S1P1 receptor is sufficient to achieve efficacy in an animal model of transplantation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHaf5xvh0gbbVg90H21EOLACvtfcHk0lhODMc7ZsFzyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cis7fO&md5=1cedf319326d9dacca79276ec93b408d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DS.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DPally%26aufirst%3DC.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DGuerini%26aufirst%3DD.%26aulast%3DHinterding%26aufirst%3DK.%26aulast%3DNuesslein-H.%26aufirst%3DB.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DChu%26aufirst%3DA.%26aulast%3DBrinkmann%26aufirst%3DV.%26aulast%3DBruns%26aufirst%3DC.%26aulast%3DStreiff%26aufirst%3DM.%26aulast%3DCannet%26aufirst%3DC.%26aulast%3DCooke%26aufirst%3DN.%26aulast%3DGray%26aufirst%3DN.%2BA%26atitle%3DMonoselective%2520Sphingosine-1-Phosphate%2520Receptor-1%2520Agonist%2520Prevents%2520Allograft%2520Rejection%2520in%2520a%2520Stringent%2520Rat%2520Heart%2520Transplantation%2520Model%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D1227%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. M.</span><span> </span><span class="NLM_article-title">SAR studies of 3-arylpropionic acids as potent and selective agonists of sphingosine-1-phosphate receptor-1 (S1P<sub>1</sub>) with enhanced pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">828</span><span class="NLM_x">–</span> <span class="NLM_lpage">831</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=828-831&author=L.+Yanauthor=P.+Huoauthor=J.+J.+Haleauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=S.+M.+Mandala&title=SAR+studies+of+3-arylpropionic+acids+as+potent+and+selective+agonists+of+sphingosine-1-phosphate+receptor-1+%28S1P1%29+with+enhanced+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DHuo%26aufirst%3DP.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26atitle%3DSAR%2520studies%2520of%25203-arylpropionic%2520acids%2520as%2520potent%2520and%2520selective%2520agonists%2520of%2520sphingosine-1-phosphate%2520receptor-1%2520%2528S1P1%2529%2520with%2520enhanced%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D828%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neway, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajdu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keohane, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbach, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shei, G.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parent, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrebet, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergstrom, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Card, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodder, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strulovici, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandala, S. A</span><span> </span><span class="NLM_article-title">Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6662</span><span class="NLM_x">–</span> <span class="NLM_lpage">6665</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492507" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6662-6665&author=J.+J.+Haleauthor=C.+L.+Lynchauthor=W.+Newayauthor=S.+G.+Millsauthor=R.+Hajduauthor=C.+A.+Keohaneauthor=M.+J.+Rosenbachauthor=J.+A.+Milliganauthor=G.-J.+Sheiauthor=S.+A.+Parentauthor=G.+Chrebetauthor=J.+Bergstromauthor=D.+Cardauthor=M.+Ferrerauthor=P.+Hodderauthor=B.+Struloviciauthor=H.+Rosenauthor=S.+A+Mandala&title=Rational+Utilization+of+High-Throughput+Screening+Affords+Selective%2C+Orally+Bioavailable+1-Benzyl-3-carboxyazetidine+Sphingosine-1-phosphate-1+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0492507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492507%26sid%3Dliteratum%253Aachs%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26aulast%3DLynch%26aufirst%3DC.%2BL.%26aulast%3DNeway%26aufirst%3DW.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DRosenbach%26aufirst%3DM.%2BJ.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DShei%26aufirst%3DG.-J.%26aulast%3DParent%26aufirst%3DS.%2BA.%26aulast%3DChrebet%26aufirst%3DG.%26aulast%3DBergstrom%26aufirst%3DJ.%26aulast%3DCard%26aufirst%3DD.%26aulast%3DFerrer%26aufirst%3DM.%26aulast%3DHodder%26aufirst%3DP.%26aulast%3DStrulovici%26aufirst%3DB.%26aulast%3DRosen%26aufirst%3DH.%26aulast%3DMandala%26aufirst%3DS.%2BA%26atitle%3DRational%2520Utilization%2520of%2520High-Throughput%2520Screening%2520Affords%2520Selective%252C%2520Orally%2520Bioavailable%25201-Benzyl-3-carboxyazetidine%2520Sphingosine-1-phosphate-1%2520Receptor%2520Agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6662%26epage%3D6665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hamada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, K.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of the Immunomodulating Compound KRP-203</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">1927</span><span class="NLM_x">–</span> <span class="NLM_lpage">1929</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1055%2Fs-2007-983721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVyju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=1927-1929&author=M.+Hamadaauthor=M.+Kiuchiauthor=K.+Adachi&title=Efficient+Synthesis+of+the+Immunomodulating+Compound+KRP-203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient synthesis of the immunomodulating compound KRP-203</span></div><div class="casAuthors">Hamada, Maiko; Kiuchi, Masatoshi; Adachi, Kunitomo</div><div class="citationInfo"><span class="NLM_cas:title">Synthesis</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1927-1929</span>CODEN:
                <span class="NLM_cas:coden">SYNTBF</span>;
        ISSN:<span class="NLM_cas:issn">0039-7881</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">A practical and concise synthesis of KRP-203 I was achieved by utilizing a palladium coupling reaction mediated by XantPhos and Pd2(dba)3 as the key step.  The coupling reaction of aryl bromide with 3-hydroxythiophenol proceeded chemoselectively to give phenol in spite of the presence of a chlorine and hydroxyl substituent on starting material.  Phenol was converted into KRP-203 by benzylation and removal of the protecting groups in high yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotMYRwXxbNirVg90H21EOLACvtfcHk0lisJfx9tUjE7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVyju74%253D&md5=8931eb11f2ae5ae67f20d6edf3f13eb6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1055%2Fs-2007-983721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2007-983721%26sid%3Dliteratum%253Aachs%26aulast%3DHamada%26aufirst%3DM.%26aulast%3DKiuchi%26aufirst%3DM.%26aulast%3DAdachi%26aufirst%3DK.%26atitle%3DEfficient%2520Synthesis%2520of%2520the%2520Immunomodulating%2520Compound%2520KRP-203%26jtitle%3DSynthesis%26date%3D2007%26spage%3D1927%26epage%3D1929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Shimizu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hakamata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enosawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeyoshi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span> </span><span class="NLM_article-title">KRP-203, a Novel Synthetic Immunosuppressant, Prolongs Graft Survival and Attenuates Chronic Rejection in Rat Skin and Heart Allografts</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">229</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2005&pages=222-229&author=H.+Shimizuauthor=M.+Takahashiauthor=T.+Kanekoauthor=T.+Murakamiauthor=Y.+Hakamataauthor=S.+Kudouauthor=T.+Kishiauthor=K.+Fukuchiauthor=S.+Iwanamiauthor=K.+Kuriyamaauthor=T.+Yasueauthor=S.+Enosawaauthor=K.+Matsumotoauthor=I.+Takeyoshiauthor=Y.+Morishitaauthor=E.+Kobayashi&title=KRP-203%2C+a+Novel+Synthetic+Immunosuppressant%2C+Prolongs+Graft+Survival+and+Attenuates+Chronic+Rejection+in+Rat+Skin+and+Heart+Allografts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DKaneko%26aufirst%3DT.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DHakamata%26aufirst%3DY.%26aulast%3DKudou%26aufirst%3DS.%26aulast%3DKishi%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DK.%26aulast%3DIwanami%26aufirst%3DS.%26aulast%3DKuriyama%26aufirst%3DK.%26aulast%3DYasue%26aufirst%3DT.%26aulast%3DEnosawa%26aufirst%3DS.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeyoshi%26aufirst%3DI.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DE.%26atitle%3DKRP-203%252C%2520a%2520Novel%2520Synthetic%2520Immunosuppressant%252C%2520Prolongs%2520Graft%2520Survival%2520and%2520Attenuates%2520Chronic%2520Rejection%2520in%2520Rat%2520Skin%2520and%2520Heart%2520Allografts%26jtitle%3DCirculation%26date%3D2005%26volume%3D111%26spage%3D222%26epage%3D229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jongsma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Unen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Loenen, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, S. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewijnse, A. E.</span><span> </span><span class="NLM_article-title">Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P<sub>3</sub>)</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">–</span> <span class="NLM_lpage">1311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901776q&amp;key=10.1111%2Fj.1476-5381.2009.00134.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901776q&amp;key=19309361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901776q&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsVWmurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=1305-1311&author=M.+Jongsmaauthor=J.+van+Unenauthor=P.+B.+van+Loenenauthor=M.+C.+Michelauthor=S.+L.+M.+Petersauthor=A.+E.+Alewijnse&title=Different+response+patterns+of+several+ligands+at+the+sphingosine-1-phosphate+receptor+subtype+3+%28S1P3%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P3)</span></div><div class="casAuthors">Jongsma, M.; van Unen, J.; van Loenen, P. B.; Michel, M. C.; Peters, S. L. M.; Alewijnse, A. E.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1305-1311</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Recently, some ligands targeting the sphingosine-1-phosphate receptor subtype 3 (S1P3) have become available.  The characterization of these compds. was mainly based on one functional read-out system, although S1P3 receptors are known to activate different signal transduction pathways.  Therefore, this study pharmacol. characterizes these compds. using different assays.  Using CHO-Flpln cells expressing the human S1P3 receptor the potencies and maximal effects of S1P, FTY720-P, VPC23019, VPC23153, and VPC24191 were detd. in three different assays [inhibition of cAMP accumulation, elevation of intracellular calcium concns. ([Ca2+]i) and S1P3 receptor internalization].  All compds. tested inhibited forskolin-induced cAMP accumulation, increased [Ca2+]i and induced S1P3 receptor internalization but with different potencies and maximal effects.  S1P was the most potent compd. in all assays followed by FTY720-P.  The VPC compds. were generally less potent than S1P and FTY720-P.  Regarding the maximal effects, all compds. except VPC23153, behaved as full agonists in the cAMP accumulation assay.  In the calcium assay, FTY720-P, VPC23019 and VPC24191 displayed partial and VPC23153 weak partial agonist activity, relative to S1P.  Interestingly, treatment with the Gi inactivator Pertussis toxin, did not affect S1P-induced [Ca2+]i elevations but inhibited those in response to the other compds., by about 50%.  This study demonstrated differential response patterns at the S1P3 receptor for a range of ligands.  These differences could indicate the presence of functional selectivity at this receptor as FTY720-P and the VPC compds. seemed to signal predominantly via Gi - whereas S1P activated Gi and Gq-coupled pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtJwYh4HYe37Vg90H21EOLACvtfcHk0lisJfx9tUjE7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsVWmurk%253D&md5=9d02bf85020813c9cd4e7c31e067bb03</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2009.00134.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2009.00134.x%26sid%3Dliteratum%253Aachs%26aulast%3DJongsma%26aufirst%3DM.%26aulast%3Dvan%2BUnen%26aufirst%3DJ.%26aulast%3Dvan%2BLoenen%26aufirst%3DP.%2BB.%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DPeters%26aufirst%3DS.%2BL.%2BM.%26aulast%3DAlewijnse%26aufirst%3DA.%2BE.%26atitle%3DDifferent%2520response%2520patterns%2520of%2520several%2520ligands%2520at%2520the%2520sphingosine-1-phosphate%2520receptor%2520subtype%25203%2520%2528S1P3%2529%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D1305%26epage%3D1311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i112"><a href="/doi/suppl/10.1021/jm901776q">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87832"></div></div></div></div></div><hr /></hr><p class="last">Tables giving the synthetic routes of alcohol compounds and phosphate compounds, preparation details of <b>6a</b> and <b>6a</b>-<b>P</b>, and elemental analysis data. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm901776q/suppl_file/jm901776q_si_001.pdf">jm901776q_si_001.pdf (105.34 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901776q&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm901776q%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-8%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901776q" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679955c4fd3a3bec","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
